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PREFACE
Weight management is multifactorial. It is like peeling an onion. At the core it
seems it is simple math: calories in versus calories burned equals pounds lost or
gained. But it is all the other layers, the factors that influence the core that are unique
and make all the difference, many of which are beyond our control. May this project lead
to a better understanding of the chronic disease of obesity and result in a more
knowledgeable, less biased, kinder hearted and healthier provider and patient
population. May it also serve as a stimulus to finding a cure for this chronic, debilitating
and often life-threatening disease.
“The improvement of understanding is for two ends: first, our own increase of
knowledge; secondly, to enable us to deliver that knowledge to others”. -John Locke
“If you judge people you have no time to love them”- Mother Teresa
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Abstract
Obesity is a multifactorial, individualized, chronic disease that increases known risk
factors for significant comorbidities and mortality. The primary purpose of this EvidenceBased practice project was to improve indicators of obesity (weight, BMI) among
patients served by a free medical clinic, using a tailored multicomponent intervention.
The secondary purpose was to determine if the weight loss intervention was associated
with a decrease in blood pressure and depression symptoms. The intervention was
guided by the Health Promotion Model by Nola Pender. The Johns Hopkins Nursing
Evidence Based Practice Model (JHNEBP) guided implementation of the project. A
comprehensive literature review was completed in five databases, and strong evidence
supported the tailored multicomponent intervention used in this project. Eligible
participants (n=26) took part in the 3-month program. Written education materials were
provided in English and Spanish, and an interpreter was used when appropriate.
Weight, BMI, and BP were measured weekly, then at weeks 8 and 12. The PHQ-9 was
measured at baseline and at week 12. Analysis: Continuous outcome variables and
dichotomous data were analyzed using the nonparametric equivalent of the paired t-test
– the Wilcoxon signed-rank test. A weight or BMI reduction of >3% from baseline is
considered clinically significant. Weight significantly decreased from baseline (228.96
lbs., SD = 57.16) to Week 4 (214.87 lbs., SD = 44.68, p = .026). Mean BMI also
significantly decreased from baseline (39.87kg/m2, SD = 6.19) to week 4 (38.27 kg/m2,
SD = 6.57, p= .028), and from baseline to week 12 (38.64 kg/m2, SD = 6.93, p=.023).
Significantly more patients in the intervention group achieved at least 3% weight loss
between baseline and Week 12, compared to those who did not receive the intervention
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(27% vs 16%, p = .034). Depression improved significantly from baseline to Week 12 (p
= .014). There were no significant differences in SBP or DBP. Conclusions: Based on
these results, a tailored multicomponent weight loss program is effective at reducing
weight, BMI, and depression in the primary care setting.
Search words: obesity AND intervent* OR treat* AND “weight loss” OR BMI OR “waist
circumference” OR “body fat” AND “primary care” OR “primary health care” OR “primary
healthcare”
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CHAPTER 1
INTRODUCTION
Background
In this chapter, the problem of obesity will be described in the global and national
contexts, including its prevalence, pathophysiology, risk factors, clinical presentation,
diagnostic findings, and available treatment options.
Obesity, resulting from excess adiposity and subsequent chemical imbalances
create the systemic chemical effect that increases overall health risk for comorbidities
and mortality, including: depression, hypertension, elevated cholesterol and
triglycerides, cardiovascular disease, cerebrovascular accident, liver and gallbladder
diseases, reproductive diseases, type II diabetes, osteoarthritis, certain cancers and
sleep apnea. Obesity can be prevented and or treated with existing, new and or
evolving discoveries (Doig & Huether, 2014; Goettler, Grosse & Sonntag, 2017; Jensen
et al., 2014; Kushner & Ryan, 2014; Triplett, Repas, & Alvarez, 2014).
Prevalence
Obesity is a global health threat. In 2016, as many as 1.9 billion adults
throughout the world were overweight, of which 650 million adults were obese.
Moreover, 340 million children were overweight or obese, and many of these acquire
lifestyle patterns in childhood that will follow them into adulthood and increase their risk
for lifelong obesity (WHO, 2018).
Since 1975, the global prevalence of obesity has nearly tripled (WHO, 2018),
which may be attributable to increased access to high-calorie food, less active lifestyles,
more sedentary work, and automotive sources of transportation (Rolls et al.,2017). In
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every global region, except for sub-Saharan Africa and Asia there are more people who
are obese than underweight (WHO, 2018). Underserved and minority populations have
a disproportionately higher incidence of obesity and suffer from proportional weight
related comorbidities. Women of these communities are impacted at a higher degree.
All women are at risk for obesity but minority and low-income women and persons living
in certain rural and urban geographical regions are at a higher risk than those living in
affluent regions (ACOG, 2014; Hageman et al., 2017; Katzmarzyk et al., 2018; Kozica et
al., 2015) . “African American and Hispanic women are twice as likely as their white
counterparts to be overweight or obese. Forty-two percent of women with incomes
below 130% of the poverty level are obese” (ACOG, 2014).
Patients with obesity can be found in every clinical practice in the world, but their
disease is often left unaddressed and untreated (McLaughlin, Hamilton & Kipping, 2017;
Pollak et al., 2016). This may be due in part to previously experienced and anticipated
poor treatment from a provider who may have a preconceived bias or stigma regarding
overweight obese patients. This may cause patients to avoid seeking treatment and or
poor compliance (Phelan, et al., 2015). As much as 69% of overweight or obese female
patients have reported a perceived healthcare provider obesity bias (Alberga et al.,
2017). This may have a significant impact on population health, because of the
increased risk of obesity-related comorbidity and mortality (Doig & Huether, 2014; Guan
et al., 2016; Kroes et al., 2017; Kushner & Ryan, 2014; WHO, 2018), being overweight
or obese is linked to more deaths globally than being underweight or starvation.
In the United States, about two-thirds of the population is either overweight or
obese, with approximately 35% of the adult population having a body mass index (BMI)
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in obese range (Bomberg et al., 2017; Kroes, Osei-Assibey, Baker-Searle & Haung,
2016; Kushner & Ryan, 2014). Obesity has an enormous impact on the national, and
therefore global, economy. Medical care costs are estimated to be between $200 and
$220 billion in the United States and approximately $2 trillion globally (Bomberg et al.,
2017). Furthermore, research shows that obesity in the workplace leads to decreased
productivity and increased employee absenteeism (Bomberg et al., 2017; Goettler et al.,
2017).
Obesity is preventable and treatable. Even a 5% to 10% reduction in body weight
can significantly reduce the risk for obesity-related complications and improve quality of
life (Bomberg et al., 2017; Kroes et al., 2016; Jensen et al., 2014; Kushner & Ryan,
2014; WHO, 2018). Because of its high prevalence, lifelong chronicity, substantial
clinical and economic consequences, and high potential to be prevented and treated,
obesity management is justifiably considered a high priority in the primary care setting.
Pathophysiology
Obesity is defined as a body mass index (BMI) of greater than or equal to
30kg/m2 and develops due to an imbalance between caloric intake and caloric
expenditure in persons with a genetic predisposition. The genetic component can be
related to either genotype or a genetic- environment interaction. It can be associated
with either single or multiple genetic defect(s) such as: GWAS or FTO gene, leptin or
melanocortin pathway defect, the congenital deficiency of proprotein convertase
subtilisin/kexin type 1 gene (PCSK1), Down or Prader-Willi syndromes. It can also be
related to endocrine disorders such as: Cushing’s disease, polycystic ovary syndrome,
diabetes or hypothyroidism, as well as hypothalamic injury. The intricate
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pathophysiology involves a multitude of interactions between hormones, cytokines and
neurotransmitters. The adipocytes are the basis for adipose tissue. Alterations in
adipocytes have a systemic effect on chemical balance. Adipocytes secrete multiple
hormones, and cytokines called adipokines. These help to regulate satiety, metabolism,
fat storage, insulin sensitivity, vascular homeostasis, immune response, female fertility,
and energy metabolism (Doig & Huether, 2014; Perreault, 2019a; Triplett, et al., 2014).
Obesity is often accompanied by frequent relapses and cyclical weight gainweight loss (Kushner & Ryan, 2014; Rodriguez-Cristobal, 2017; McLauglin et al., 2017).
Obesity often has a cyclical nature with depression and or anxiety (Kushner & Ryan,
2014; Ma et al., 2019; Rodriguez-Cristobal et al., 2017; Rolls et al., 2017) and relapses
often coincide with exacerbations of weight-related comorbidities, such as: worsening
joint pain, hypertension, increased HbA1c or elevated cholesterol levels.
Risk factors
Because of its impact over the lifespan, obesity is considered a chronic disease
with myriad risk factors (Doig & Huether, 2014; Kushner & Ryan, 2014; McLaughlin et
al., 2017) that can impact every person, at every age, and nearly every system of the
human body. Excess adiposity and subsequent chemical imbalances create the
systemic chemical effect that increases overall health risk for comorbidities and
mortality, including: depression, hypertension, elevated cholesterol and triglycerides,
cardiovascular disease, cerebrovascular accident, liver and gallbladder diseases,
reproductive diseases, type II diabetes, osteoarthritis, certain cancers and sleep apnea
(Doig & Huether, 2014; Kroes et al., 2016; McLaughlin et al., 2017; Tapsell et al, 2017).
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Since the underlying mechanism involves a metabolic imbalance between
calories consumed and calories expended (usually through exercise), it seems intuitive
that a high-calorie diet and sedentary lifestyle are the two most important risk factors for
developing obesity (Hartman et al., 2014; Kroes et al., 2016; Kushner & Ryan, 2014;
Thabault et al., 2016). However, each of these is associated with unique risk factors that
ultimately determine caloric balance. Calorie consumption depends on eating patterns,
the types of foods consumed, the source of calories (i.e. macronutrients), the cultural
meaning of food, ability to access and prepare foods, and emotional responses to food.
Since calorie consumption is the net result of a person’s food choices, eating behaviors,
personal beliefs and values, sociocultural context, and environmental characteristics,
identifying and minimizing all risk factors for a high-calorie diet is virtually impossible.
Likewise, a sedentary lifestyle is the result of both intrapersonal and
interpersonal factors that determine whether or not someone will engage in physical
activity. For example, the decision to start an exercise program at a local gym may
depend on a person’s prior experience with that facility, their level of enjoyment
engaging in a particular exercise, and the cost of gym membership. Other individual
factors may include the availability of appropriate attire, transportation to the gym, and
psychological comfort in a gym environment. Ultimately, these and many other factors
will determine if a person starts the exercise program or not.
However, starting the program does not guarantee that the person will actually
go to the gym and exercise; the person must be willing to forego other competing
demands for their time, energy, and attention so they can physically follow through with
their exercise plan. Still others are unable to engage in physical activity due to chronic
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or acute illnesses that limit mobility or endurance. Despite a nearly limitless array of
physical activities with which to engage, research shows that only 23.2% of U.S. adults
meet the minimum recommendations for exercise and aerobic activity established by
the CDC (2017). Clearly, calorie expenditure relies on a complex interplay between
innumerable factors that are difficult for individuals (and our population) to overcome.
While it is relatively easy to think of obesity as an imbalance between calories
consumed and calories expended, research suggests that genetic risk factors may also
exist. Genotype and interaction of gene-environment are predisposing factors to
obesity. Either single or multiple genetic defect(s) such as: leptin or melanocortin
pathway defect, the congenital deficiency of proprotein convertase subtilisin/kexin type
1 gene (PCSK1), Down or Prader-Willi syndromes or endocrine disorders such as
Cushing’s disease, polycystic ovary syndrome, diabetes or hypothyroidism as well as
hypothalamic injury may be instrumental in the development of obesity.
Pathophysiology is intricate, involving delicate interactions between a multitude of
hormones, cytokines and neurotransmitters producing interlocking systemic effect (Doig
& Huether, 2014; Perrault, 2019a; Triplett et al., 2014).
Additionally, certain medications can be instrumental in weight gain including
some: antipsychotics, antidepressants, antiepileptics, antihyperglycemics,
antihistamines, alpha-blockers, beta-blockers, hormones and glucocorticoids (Perreault,
2019a; Perreault, 2019c) and are limitedly described in Table 1.1. As one intervention, a
medication reconciliation and review will be completed, and whenever possible
medication adjustments may be considered.
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Table 1.1
Medications associated with weight gain
Medication class

Some of the drugs in class

Mechanism of action
causing weight gain

Antidepressants/antianxiety: TCA: nortriptyline,

SSRI:5-HT inhibition;

selective serotonin re-

amitriptyline; SSRI:

MAO-I: increase

uptake inhibitors (SSRI);

paroxetine, citalopram,

concentrations of NE, 5-

monoamine oxidase

escitalopram; TCA:

HT, and DA in neuronal

inhibitors (MOAI); tricyclic

doxepin, imipramine and

synapses;

antidepressants (TCA)

mirtazapine.

TCA: Neuronal receptor
sensitivity change due to
down-regulation of Beta
-adrenergic and 5-HT
receptors

Antipsychotics

thioridazine, olanzapine,

5-HT antagonism

risperidone, clozapine and
quetiapine
Neurologic and mood

lithium, carbamazepine,

Valproate component –

stabilizers

gabapentin and valproate

MOA unknown

Antiepileptic

divalproex

Divalproex
sodium/Valproate
component – MOA
unknown
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Antihyperglycemics

insulin, sulfonylureas,

Plasma insulin/glucose

thiazolidinedione,

levels related to

meglitinides

insulin/antihyperglycemic
therapy

Glucocorticoids

prednisone

Carbohydrate metabolism
is increased at
glucocorticoid receptor
sites

Antihistamines

cyproheptadine

Nonselective 5-HT
receptor antagonist and
anticholinergic drug
decreases ACTH
secretion- and increases
anticholinergic effect

Hormones

progestins,

Alters insulin, glucose or

medroxyprogesterone

glucagon release further
altering carbohydrate
metabolism

Alpha-blockers

terazosin

Slows metabolism and
relaxes smooth muscles

Beta-blockers

propranolol

Beta-2 receptors are
responsible for insulin

8

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
secretion and
glycogenesis
(Crismon, Argo & Buckley, 2014; Dietrich, Smith & Gums, 2014; Drayton & Pelic, 2014;
Lee, 2014; Melton & Kirkwood, 2014; Perreault, 2019c; Saseen & MacLaughlin, 2014;
Schrader & Ragucci, 2014; Teter, Kando & Wells, 2014; Triplitt, Repas & Alvarez, 2014)

Clinical Presentation
Patients with obesity may present to the primary care setting because they are
concerned about their weight, due to a complication arising from their obesity (e.g.
obstructive sleep apnea or low back pain), or for treatment of an unrelated problem (e.g.
headache). They may report a recent weight gain, or they may share that they have
struggled with being overweight since childhood. In any case, the patient should be
weighed, and height measured so that their body mass index (BMI) can be calculated. A
BMI greater than or equal to 30 kg/m2 indicates obesity.
Beyond their BMI, the patient should be asked about their risk factors for obesity,
how their weight affects their health and relationships, and if they feel motivated to lose
weight. This conversation should be nonjudgmental, compassionate, and empathetic,
but because of the clear health benefits of maintaining a normal BMI, it should not be
avoided. The patient should also be asked about: readiness; current and previous
attempts to lose weight, cultural and psychosocial barriers and motivators to weight
loss, emotional health and well-being (Eaton et al., 2016; Kushner & Ryan, 2014;
Samdal et al., 2017; Tapsell et al., 2017; Thabault et al., 2016).

9

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
A physical exam of a person with obesity may reveal the following:
cardiovascular disease, jugular vein distention; reduced peripheral vascular circulation
or varicosities; venous or lymph peripheral edema; pleural fluid retention and or
dyspnea; hepatomegaly with possible ascites; Mallampati scores consistent with sleep
apnea; inflammation; back or joint pain with decreased range of motion; polycystic
ovaries; stress incontinence; hirsutism; rash and or cellulitis or carbuncles (Doig &
Heuther, 2014). Because obesity and hypertension often occur together, a full set of
vital signs including blood pressure should be evaluated. Additional clinical testing might
include an evaluation of gait, cardiopulmonary fitness (e.g. 6-minute walk test), and
anthropometric measurements (Kushner & Ryan, 2014; Tapsell et al, 2017).
Diagnostic Testing
Because obesity is strongly and almost universally associated with a number of
chronic illnesses, it may be appropriate at their primary care visit to review fasting
glucose or HbA1C and a fasting lipid panel that are consistent with current guidelines
(Jensen et al., 2014; Kushner & Ryan, 2014; Tapsell et al, 2017; Uphold & Graham,
2013). Additionally, when possible, adults should have a complete blood count, liver
function studies, a renal panel, and thyroid stimulating hormone, as well as an
electrocardiogram based on patient risk. A referral to cardiology may be indicated if
there is evidence of ischemic heart disease, which may warrant a cardiac stress test or
heart catheterization. Evidence of obstructive sleep apnea should trigger a referral to a
pulmonologist or sleep medicine specialist who can evaluate the patient’s need for
continuous positive airway pressure (CPAP). Evidence of hepatic, renal or thyroid
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disease as well as any disease not routinely addressed in primary care may necessitate
a referral to a specialist as well (Uphold & Graham, 2013).
Treatment Options
Traditionally, obesity treatment has relied on delivering education to the patient
about calorie restricted diets and exercise. In addition, treatment may focus on
preventing or managing the long-term consequences of obesity, such as hypertension
and type 2 diabetes mellitus. Medications, including those presented in Table 1.2 may
also be used to reduce appetite and food cravings or decrease carbohydrate absorption
from the gut.
Table 1.2
Weight loss Pharmacotherapeutic Agents
Drug Class
Gastrointestinal lipase

Generic and Brand Name

Mechanism of Action

Orlistat/ Xenical or Alli

Decreases fat absorption

inhibitor

in the gut by inhibiting GI
lipase

Serotonin 2C Receptor

Locaserin/ Belviq

Agonist

Appetite suppression
through activation of
serotonin receptor in
hypothalamus

Phentermine-Topiramate

Extended release

Exact MOA unknown; May

Combination

Phentermine-Topiramate/

reduce appetite and

Bontril PDM or Bontril slow increase satiety via
release

multiple pathways
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Noradrenergic Agents

Phendimetrazine/ Bontril

Exact MOA unknown; May

PDM or Bontrilslow

reduce appetite and

release

increase satiety via
multiple pathways

Phentermine/ Adipex-P or
Suprenza

Diethylpropion/ Tenuaate
or Tenuate Dospan
Serotonergic Agents-Off

Fluoxetine

Increased 5-HT levels,

Label (not approved for

decreases appetite and

obesity management by

disrupts hunger satiety

FDA)
Glucagon-like peptide-1

Liraglutide/ Victoza

Increases insulin and

receptor/ anti-diabetic- off

decreases glucagon

label

release

Opiate agonist

Naltrexone/ Vivitrol or

Effect not established for

Revia

weight loss. Used in
combination with
bupropion

A noradrenergic/

Buproprion

Action in cerebral reward
–dopamine centers

dopaminergic
antidepressant
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(Curry et al., 2018; Sheehan, Chen, Yanovski & Calis, 2014; Tek, 2016)

Finally, weight loss surgery has been an obesity management option for
decades. Fairly recent improvements in surgical techniques, products, and
interprofessional care coordination have resulted in dramatically beneficial outcomes for
patients undergoing bariatric surgery (Jensen et al., 2014; Kushner & Ryan, 2014;
Uphold & Graham, 2013; Welbourn et al., 2018).
It is clear that one treatment option does not work, or is not appropriate, for every
patient with obesity. Evidence shows that tailored multicomponent interventions are an
effective way to promote weight loss, but this approach can be resource-intensive,
particularly in underfunded primary care settings without access to weight loss
specialists, dietitians, and other team members that focus on obesity management
(Eaton et al., 2016; Cheatham et al., 2018; Kushner & Ryan, 2014). The aim of this
project was to help patients and providers to overcome barriers that prevent weight loss
in adults with obesity through the implementation of theory-driven and Evidence-Based
weight loss interventions.
Data from the Literature Supporting Need for the Project
According to the WHO (2018), obesity is a global health threat. In the United
States obesity prevalence has reached 35% of the adult population (Bomberg et al.,
2017; Kroes et al., 2016; Kushner & Ryan, 2014). It is a known fact that obesity related
comorbidities can decrease physical well-being, functionality and quality of life, as well
as lead to mortality (ADA, 2019b; American Heart Association, 2018; Kroes et al., 2016;
Kushner & Ryan, 2014; Ma et al., 2019; Rodriguez-Cristobal et al., 2017; Tang et al.,
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2016; Thabault et al., 2016; Welbourn et al., 2018). There is much evidence available
as to how to treat obesity, however used separately there has been little impact on this
growing epidemic. Obesity is a multifactorial chronic disease that is often accompanied
by weight-related comorbidities, thus no one treatment will work for each person. This
EBP Project combines multiple interventions into a personalized program that
addresses obesity on an individual level based upon EBP and the patient’s needs and
preferences. The project provides a program and simply accessed tools that can be
easily adopted into any primary care setting.
Data from the Clinical Agency Supporting Need for the Project
The clinical site chosen for this EBP Project is a clinic located in a lowsocioeconomic urban neighborhood in North East Indiana. The clinic mission is based
upon the Gospel of Matthew: 25. They provide medical, vison and dental care as well as
some laboratory services to the underserved population, many of whom are minority,
who are economically disadvantaged and have no insurance. The care is free and
includes a limited range of free pharmaceuticals as well as refurbished glasses and
hearing aids. Referrals to specialists are made based upon need and availability of
service providers. The key stakeholders for this project included: physicians, nurse
practitioners (NP), staff nurses (RN), administrative staff, and volunteers, as well as the
patients. The medical clinic is primarily staffed six days a week by volunteers and
students other than the Medical Director, two NPs, two RNs and a few administrative
staff.
There is a great need for this EBP Project as currently the clinic does not have a
weight management program, other than basic diet information and occasional
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volunteer nutritional counseling from dieticians. Based upon available resources at the
clinical site, as well as project participant resources and capabilities, some potential
interventions that may produce weight loss may not be a possibility, such as: certain
laboratory studies, bariatric referral or the use of some pharmacotherapies.
Comparison group: A retrospective electronic medical record (EMR) review was
conducted prior to initiation of this DNP EBP Project. Patient records were accessed
with the permission of administration and the Medical Director for the use in this project.
Reviewed records had a baseline date of January 2019 and were included in the review
if the patient had a follow up appointment between 3 to 5 months later and the patient
was at least 18 years old, and had at least one BMI greater than or equal to 30 kg/m 2 ,
had a weight and consistent height provided for each visit. Patients were excluded if
they were under 18 years old, the height was incorrectly measured and varied between
visits (eg.5’2” and the next visit 5’5”) or in between visits time was not within then the 3
to 5 months. A total of 25 EMRs were included in this retrospective. There were seven
males and 19 females. The mean age was 46.96 (13.82) years. The mean baseline
weight was 235.10 (54.21) pounds (lbs.) and mean BMI was 38.61 kg/m 2 (7.18). At the
3 to 5- month follow up the group mean was 235.86 (55.36, p=.558) lbs. and mean BMI
was 38.59 kg/m2 (7.31, p=.914). There was no significant change in weight or BMI.
Attainment of a 3% total body weight loss goal was achieved by only 16% of those in
the comparison group.
Purpose of the Evidence-Based Practice Project
The purpose of this project was to improve selected obesity indicators, including
weight, body mass index (BMI), waist circumference, and waist-to-hip ratio, through the
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implementation of an Evidence-Based multicomponent intervention tailored to individual
patient strengths, barriers, and resources. In addition, a secondary aim was to
determine if the weight loss intervention resulted in improvement in health outcomes
related to obesity, including BP, HbA1c, lipids, as well as depression and anxiety
symptoms. The intervention components varied by patient, but in general, options
included diet and exercise education, tracking of caloric intake and exercise, lifestyle
and behavioral counseling, pharmacotherapies, and referrals for psychotherapies and
or bariatric evaluation when appropriate.
PICOT Question
Specifically, this project addressed the following two-part PICOT question.
Will the use of an evidenced based protocol for the assessment and treatment of obese
patients assist adult patients with obesity to achieve better weight loss outcomes over a
three month period compared to usual care as measured by primary outcomes of a
reduction in BMI, waist circumference and waist to-hip ratio. And will the implementation
improve secondary outcomes measured of BP, HbA1c, total cholesterol, HDL, LDL,
triglycerides and the PHQ-9 and the GAD-7 scores.
Significance of the EBP Project
The importance of this EBP Project is represented in reduced weight-related
health risk in a patient population with obesity. Obesity is a global health risk that has
nearly tripled since 1975 (WHO, 2018). The risks associated with obesity and weightrelated comorbidities can be life threatening and impact quality of life for the obese
population. The impact of obesity is seen in poorer health, increased exacerbations of
diseases, decreased mobility, decreased quality of life, and decreased productivity and
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financial resources (Bomberg et al., 2017; Kroes, Osei-Assibey, Baker-Searle & Haung,
2016; Jensen et al., 2014; Kushner & Ryan, 2014; WHO, 2018).
Addressing the clinical problem
Obesity is a significant risk factor for comorbidities and mortality in the general
population however it disproportionally effects those of reduced socioeconomic standing
and the underserved population. Those are the people who are served by this clinical
site. Currently this clinical site does not have a set protocol in place to address the
problem of obesity. This project addresses this issue of obesity and weight-related risks
through a multicomponent individualized tailored weight loss intervention program that
is sustainable and can be simply accessed and utilized within the clinic.
How this project can improve patient outcomes
This EBP Project can improve clinical outcomes by improving overall population
BMI and health risk as evidenced by improved BMI, BP, HbA1c, total cholesterol, HDL,
LDL, triglycerides and PHQ-9 and GAD-7 scores. By improving BMI, BP, HbA1c, total
cholesterol, HDL, LDL, triglycerides cardiovascular risk as well as those associated with
elevated blood glucose and diabetes are reduced (ADA, 2019b; American Heart
Association, 2018; Doig & Heuther, 2014; Kushner & Ryan, 2014; Triplett et al., 2014).
Reduced PHQ-9 and GAD-& scores indicated improved mental health and wellbeing
and can be directly associated with weight loss and improved BMI (Batsis et al., 2018;
Bomberg et al., 2017; Kushner & Ryan, 2014; Ma et al., 2019)
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CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
Theoretical Framework
After a careful and thorough review of the health promotion and disease
prevention literature, the Pender Health Promotion Model was chosen to assist with the
development and implementation of an intervention that was used in this EvidenceBased practice (EBP) project. In this section, a succinct description of the Pender
Health Promotion Model (Pender, 1982; Pender 2011) and an overview of how this
model applies to this EBP project will be provided.
Overview of Theoretical Framework
The Pender Health Promotion Model (HPM; Pender, 1982; Pender, 2011) was
developed by Nola Pender PhD, RN, FAAN, a Professor Emerita at the University of
Michigan and a Distinguished Professor at Loyola University in Chicago, Illinois. The
HPM was developed as a complement to existing models of health protection. In this
theory, Pender states that each person has a unique set of experiences, beliefs, and
attitudes that affect their willingness and ability to change detrimental health behaviors,
such as consuming an unhealthy diet and exercising infrequently. This model was first
presented in nursing literature in 1982 and was revised in 1996. The initial purpose of
the model was to “assist nurses in understanding the major determinants of health
behaviors, as a basis for behavioral counseling to promote healthy lifestyles” (Pender,
1982, p.2; Pender, 2011, p. 2). This model recognizes that a person’s context – their
experiences, feelings, emotions, resources, social barriers, etc. – impacts their health
behavior.
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Assumptions of the HPM are that:
•

People attempt to create living environments in which they can live to
their personal health potential.

•

People are self-aware, thoughtful and able to evaluate their own
capabilities.

•

People strive for positive growth and an equilibrium between change
and stability.

•

People desire to determine their own behavior.

•

People interact with and within their environment, both changing over
time through this interaction.

•

Health care providers are part of the person’s interpersonal
environment throughout their life, impacting the person’s choices.

•

Behavioral change is managed through self-determined change in the
person-environment interaction (Pender, 1982; Pender, 2011).

Health promotion behavior is defined as the “desired behavioral end point or
outcome of health decision-making and preparation for action” (Pender, 2011, p.6).
Using the HPM the healthcare provider, working in a collaborative relationship with the
patient, can assess and intervene to assist with behavioral and lifestyle changes to
promote health. Assessment includes prior behaviors and attempts to change behavior,
personal influences, barriers and benefits, self-efficacy and enjoyment of activities,
social norms and social support, role models within the social network, influences,
commitment to change, and competing demands or barriers to success. Based on their
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assessment findings, the nurse intervenes to support the behavior change through
education, role-playing, problem-solving, and removal of perceived barriers to change.
In the model Pender theorizes that motivation is modified by specific behavioral
variables and that the individuals’ behavior and outcome is determined by two
interrelated paradigms: Individual Characteristics and Experiences, and Behavior
Specific Cognitions and Affect. Examples of Individual Characteristics and Experiences
that may impact the individual’s ability and desire to engage in health behavior change
include whether or not they had previously attempted similar behaviors as well as
biological, psychosocial or sociocultural factors supporting or preventing the
intervention, such as: the individuals’ perceived self-efficacy, perceived benefit and
barriers, interpersonal relationships, options and demand characteristics. All of these
directly influence the individual’s commitment to the plan of action and health promoting
behavioral changes and can be interrupted or curtailed by immediate competing
demands or preferences.
This model is applicable to this project as it provides a frame from which to
develop motivational strategies to encourage weight loss in project participants. This
model accepts that each person is an individual in which motivation to lose weight is
heavily influenced by the life experiences specific to that person and to prior weight loss
behaviors. Therefore, the ideal weight loss intervention will vary from one person to
another based on whether and how they have tried to lose weight in the past, their
perceived facilitators and barriers to weight loss, current lifestyle patterns, and
comorbidities. Therefore, the use of a multicomponent, individualized approach to
treatment may theoretically promote weight loss better than a more generalized (“one-
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size-fits-all”) approach. For example: some patients may prefer walking over group
aerobic activities or use of the My Fitness Pal phone app instead of a paper journal to
track caloric intake and exercise, or face-to face counseling rather than simple written
instructions. If the patient’s preferences are not consistent with the recommended
weight loss interventions, the HPM predicts that these interventions will not be as
effective as they could be if they were more consistent with the patient’s preferences.
Besides matching interventions to the patient’s preferences, perceived barriers
and facilitators, and immediate competing demands, the HPM promotes patient selfefficacy and autonomy. By individualizing the weight loss intervention and allowing the
patient choices, consequently giving them ownership of their treatment and goals, selfefficacy and autonomy are increased. When the person feels that they have the ability
within themselves to lose weight, the HPM model predicts that they are more likely to
change their weight-loss behaviors.
In summary, the Pender HPM describes and explains which intrapersonal,
interpersonal, and environmental factors ultimately predict a person’s ability to adopt
health behaviors that result in weight loss. These predictive factors, which are unique to
each person, serve as opportunities for the advanced practice nurse to design a weight
loss management plan that are likely to result in weight loss success.
Evidence-Based Practice Model: Purpose and Overview
The model selected to guide this EBP project was the Johns Hopkins Nursing
Evidence-Based Practice (JHNEBP) Model. In this section, the JHNEBP Model and how
it applied to this EBP project will be described.
Purpose of EBP Model
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Like other models that have been used to guide EBP projects, the purpose of the
JHNEBP Model is to provide direction to project leaders in integrating Evidence-Based
interventions to solve real-world clinical problems (Dang & Dearholt, 2017). Using a
multi-step and highly detailed approach to EBP adoption, the model supports the use of
EBP as a core competency in nursing practice. Permission to use this model was
obtained June 15, 2018 (Appendix B), from Johns Hopkins Medicine (2017).
Overview of EBP Model
The JHNEBP model is a three-step method that starts with Inquiry: the
recognition and acknowledgement that a fixable problem exists in the health care
environment. Inquiry involves critical thinking to identify the scope of the problem and to
thoroughly assess the complete situation within the clinical setting, including the
context, background, stakeholders and environment. Context refers to the
circumstances in which the problem exists. Background refers to the events or situation
that lead up to the problem. Discovering the background of a problem may lead to
identification of gaps in what is known or done and what is unknown or not done.
Stakeholders include all persons or entities that are affected by or have an interest in
the problem. These can include: the patient, care giver, health care provider and or
community. A stakeholder can also be a third party or parties such as insurance or
government agencies. Environment refers to the surroundings or area in which the
problem exists, such as: a clinic, hospital or the community.
After the context, background, stakeholders, and environment are explored, the
EBP Project Leader begins a three-part group of activities that consists of: 1) Forming a
practice question (P), 2) Discovering best available evidence (E), and 3) Translation of
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this evidence into the practice setting (T) (JHNEBP, 2017). The practice question
guided the design of the EBP project and clarified which evidence to seek; therefore, it
needed to be relevant, precise, accurate and provide clarity.
Based on the practice question, evidence was obtained and evaluated for: study
design/level, study quality, consistency and applicability. In this project, if the evidence
was level III, IV or V or of low quality it was not used as it did not offer the high level of
evidentiary support needed to provide EBP.
Translation refers to converting the best available evidence into a useful and
meaningful form that also incorporates professional experience and patient preferences
(Dang & Deartholt, 2017). This can be difficult because even the highest level and
quality of evidence may be met with translational incompatibilities with reality.
Translation may require modification, education, development of a skill set,
collaboration and a timeline compatible with the EBP intervention or practice
improvement (Dang & Dearholt, 2017). If translation is initially unsuccessful, the EBP
project team might return to the practice question or evidence steps to seek alternative
approaches to use in translation. The “best practice” emerges when the translation step
has been successfully completed, which then results in practice improvements that
could focus on clinical, learning, or operational changes within the health care
environment (Dang & Dearholt, 2017). The JHNEBP Model is pictorially depicted below
(Figure 1.1) and demonstrates the cyclical quality that allows for change, further inquiry,
evidence and translation in practice and learning.
Figure 1.1
The Johns Hopkins Nursing Evidence-Based Practice Model (2017)
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_____________________________________________________________________

(The Johns Hopkins Nursing Evidence-Based Practice Model, 2017).
Model and tools used with permission from Johns Hopkins Hospital and The
Johns Hopkins University (Appendix B).
______________________________________________________________________
Application of EBP Model to DNP Project
This EBP project was concentrated on improving obesity-related patient
outcomes at a free clinic in an underserved community in Northeast Indiana. Weight
management had been identified by the practice as one of the challenges faced by the
patient population at this site. Current interventions being utilized have not produced
significant weight loss, improvement in comorbidities, health promotion or risk reduction.
The uncertainty of how best to promote weight loss in this population served as the
genesis for this project. Research shows that obesity is a multifactorial chronic disease
that is exquisitely difficult to manage in the primary care setting (Bomberg et al. 2017;
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Kushner & Ryan, 2014; Thabault, Burke & Ades, 2016). Moreover, the factors that
cause obesity in one person may not be the same as those that cause obesity in
another person; a “silver bullet” approach to obesity management is therefore unlikely to
be effective.
Because this project deals with a complex clinical problem that exists within a
multifaceted system consisting of the person, their primary care provider, and unique
environmental nuances from one person to the next, it may take several attempts to
arrive at the “best practice” for patients (Eaton et al., 2017; Hartman et al., 2014;
Kushner et al., 2014). With its cyclical approach to identifying best practices, the
JHNEBP Model is congruent with finding a solution to the problem of obesity. This
section will describe how each of the steps of the JHNEBP Model will be used in the
current EBP project.
Inquiry. The first step in the JHNEBP Model is to inquire about the clinical
problem, gaining all pertinent information. In this project, the clinical problem is weight
management among the patient population who have obesity defined as a BMI of > 30.
Many of these patients have significant health risk and weight related comorbidities
including hypertension, Diabetes Mellitus type II (DMII), hyperlipidemia, depression and
or anxiety.
Initial inquiry took the form of anecdotal observations made by the EBP Project
Leader and a meeting with key stakeholders at the Matthew 25 Health and Dental
Clinic. During the observations and meetings, it was noted that a high proportion of
adult clinic patients were obese, no protocol was in place to address obesity at this
clinic, the dietician services were provided by volunteers and only available a few times
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a month, weight loss educational resources were very limited and staff was only able to
provide limited education and coaching for weight loss. Based on these initial findings, a
retrospective electronic medical record (EMR) review was conducted prior to initiation of
this DNP EBP Project. With permission from the Medical Director and administration,
patient records were accessed for the use in this project. Reviewed records had a
baseline date of January 2019 and were included in the review if the patient had a
follow up appointment between 3 to 5 months later. Inclusion criteria included patients
who were at least 18 years old, had at least one BMI greater than or equal to 30 kg/m2,
and had a weight and consistent height provided for each visit. Patients were excluded
if they were under 18 years old, the height was incorrectly measured or varied between
visits (eg.5’2” and the next visit 5’5”) or did not have recorded visits 3 to 5 months from
baseline. A total of 25 EMRs were included in this retrospective. Demographics included
seven males and 19 females, a mean age of 46.96 (13.82) years. The mean baseline
weight was 235.10 (54.21) pounds (lbs.) and mean BMI was 38.61 kg/m 2 (7.18). The 3
to 5-month follow up group mean was 235.86 lbs. (55.36, p=.558) and mean BMI was
38.59 kg/m2 (7.31, p=.914). There was no significant change in weight or BMI.
Attainment of a 3% total body weight loss goal was achieved by only 16% of those in
the comparison group.
Based on the observations at this clinic it was clear that obesity affected a nearmajority of adult clinic patients, obese patients were generally open to assistance with
weight loss, and that the clinic staff could do more to facilitate and promote weight loss
in this population.
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Practice Question. After confirming with clinic staff that they would like to learn
more about how to help patients with obesity manage their weight, an EBP project
question was developed using the PICOT criteria. First, clinic staff wished to focus on
weight management in the adult population, regardless of age, sex, race, ethnicity,
comorbidities, or socioeconomic characteristics. Second, clinic staff were open to a
variety of interventions that focused on lifestyle changes, the use of medications, and
referrals to other team members (e.g. behavioral health, dietician). However, because of
the type of patient population, referral to bariatric specialist could not be a consideration.
They were agreeable to reasonable modifications in their workflow but hiring additional
staff to support the intervention was not going to be an option. Therefore, the
intervention had to be something that the current staff mix at the clinic could implement
within their collective scopes of practice. Third, the comparison group would need to be
a retrospective sample who received routine education and follow-up about obesity, as
described above. Fourth, the outcomes for this project needed to include BMI (and
therefore weight), but clinic staff were also interested in other health-related secondary
outcomes such as blood pressure, glycosylated hemoglobin, and symptoms related to
anxiety and depression. Finally, the time frame for the project was restricted to 6
months (September 2019 to March 2020) with targeted changes in the primary outcome
expected within 3 months of starting the intervention.
These suggestions from the clinic were used to form the initial PICOT Practice
Question for the JHNEBP Model: Primarily, will obese adult patients participating in a
multicomponent tailored weight loss intervention achieve greater reductions in weight,
BMI, and waist circumference, than those receiving the current standard of care over a
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three month period? In addition, clinic staff expressed a strong desire to manage
obesity-related comorbidities as part of the project. Therefore, the effect of this
multicomponent tailored intervention on blood pressure, glycosylated hemoglobin,
anxiety symptoms, and depression symptoms was explored over a three-month period.
Evidence. To determine which intervention(s) to implement, the literature about
obesity and weight management in primary care was thoroughly reviewed using the
strategy and methods described in the section entitled, “Literature Search”. Sources
were appraised using the JHNEBP Appraisal System (Dang & Dearholt, 2017), which
provided a tool to evaluate the quality and strength of evidence. Intervention(s) with the
strongest supporting evidence, and that were also feasible within the clinical site, were
implemented in this EBP project as part of a tailored multicomponent weight loss
program
Evidence applicable to this EBP Project encompassed multicomponent
interventions. According to the evidence, including that provided by the US Preventive
Task Force (LeBlanc et al., 2018) effective weight loss intervention should consist of a
multicomponent approach that addresses diet, aerobic and resistance exercise, lifestyle
modifications, and behavioral counseling. General principles that should underpin all
weight loss recommendations include:
•

Diet – Lean protein, low-fat dairy, unsaturated fats, whole grains, colorful
fruits and vegetables, leafy greens. Overall calorie reduction is
emphasized.

•

Exercise – Aerobic exercise (at least 150 minutes per week of moderateintensity exercise over at least 4 or 5 days). Resistance exercise (at least
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2 days per week of moderate-intensity resistance exercise using
machines, free weights, or resistance bands).
•

Lifestyle Modification - Making healthy food choices, eating at meal-time
and enjoying healthy snacks, limiting alcohol consumption and empty
calories, setting achievable goals and tracking progress through
journaling, logs or food and activity tracking technology. Practicing healthy
sleep and hygiene habits in order to promote a well-rested state to reduce
food cravings.

•

Behavioral Counseling - Assist with the patient’s development of a
sense of self-efficacy and autonomy through motivational counseling in
which the patient makes choices, sets and achieves goals. Assessment
for and treatment of depression and anxiety, with referral to psychiatry if
needed. Use of antidepressant/ antianxiety medications if warranted
(Batsis et al., 2016; Beeken et al., 2017; Curry et al., 2018; Eaton et al.,
2016; Grossman et al., 2017; Hageman et al., 2017; Hartman et al., 2014;
Kozica et al., 2015; Kroes, Osei-Assibey, Baker-Searle & Huang, 2016;
Jensen et al., 2014; Kushner & Ryan, 2014; Samdal et al., 2017)

•

Additional interventions supported in the literature include use of
motivational interviewing (Rodrguez-Cristobal et al., 2017; Szczekala,
Wiktor, Kanadys & Wiktor, 2018; Thabault et al., 2016; Welbourn et al.,
2018), written education tools (Beeken et al., 2017; Thabault et al.,
2016), phone counseling (Harrigan et al., 2016; Hartman et al., 2014),
electronic media or internet based intervention (Beeken et al., 2017;
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Hageman et al., 2017) and or activity tracking technology such as a FitBit
® Garmin® or AppleWatch ® or use of an app such as MyFitnessPal®
(Cheatham, Stull, Fantigrassi & Motel, 2017; Tang, Abraham, Greaves &
Nikolaou, 2016).
Translation. Translation of evidence can be a challenge because a given
Evidence-Based practice may not be feasible within a particular clinic context or
circumstance. Therefore, careful attention was paid to determining, along with input
from clinic staff and patients, which EBP interventions are feasible for this project. This
was completed via meetings with clinic staff and the EBP Project Leader, as well as
during clinic appointments with patients, in which feasibility of the interventions was
determined and an action plan was formulated. Further translation included
implementation of the action plan and evaluation of outcomes as well as determining
any future steps such as: modification to the individual weight loss intervention plan(s)
and or modification(s) to the implementation of the weight loss intervention plan within
the clinical setting (Dang & Dearholt, 2017). Additionally, results of this project will be
disseminated through a published EBP Project Report and as a poster and podium
presentation at a regional or national nursing conference.
Best Practice. According to Dang and Dearholt (2017), it may take several
iterations of the P-E-T process to get it right. After the Practice-Evidence-Translation
process successfully identified a version of the Evidence-Based intervention(s) that
works best at the clinical site, this was referred to as the best practice for weight
management in adult patients with obesity who seek care at this clinical site. The best
practice that results intentionally included multiple potential interventions that could be
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implemented for a patient, based on their unique circumstances, abilities, resources,
and perceived barriers to weight management.
Practice Improvements. The most important clinical practice improvements resulting
from this project included a standardized process for identifying, teaching, and
supporting adult patients with obesity, which had to date been a significant challenge for
clinical staff. Additional clinical practice improvements included: easily accessible
standardized web-based assessment tools and better implementation of obesity
assessment and treatment protocols. Improvements in learning included easily
accessible standardized web-based educational materials for patients and staff.
Operational improvements included the development or revision of clinic policies and
procedures regarding obesity management, improved patient satisfaction with clinical
care, and improvement in objective measures of care quality related to chronic disease
management.
Strengths and Limitations of EBP Model for DNP Project
The JHNEBP Model has been used to guide numerous EBP projects in nursing
since its inception, and it has several important strengths compared to other EBP
translation models for this particular EBP project. First, the model assumes that nursing
is a science and a profession. Some other models, such as the Iowa Model for
Evidence-Based Practice and the Stetler Model do this as well, but many, including the
Rogers’ Model of the Diffusion of Innovations and the Kotter and Cohen’s Model of
Change do not (Dang, Melnyk & Fineout-Overholt et al., 2015; Melnyk & FineoutOverholt, 2015). This is an important strength for this project because the JHNEBP
Model focuses on collecting evidence to answer the inquiry and questions as well as
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support interventions. All of the interventions that had the potential to be utilized within
this EBP project had science and evidentiary support that they were effective.
The JHNEBP Model is further strengthened by the precision and usefulness of its
overall structure, which consists of 19 unique steps that served as guideposts for the
EBP Project Leader and team. This ensures a systematic approach to solving problems
in the clinical setting, particularly for novice EBP project leaders. Moreover, clinical sites
that are not experienced with the EBP project “process” can use the steps of the
JHNEBP Model to increase staff engagement and anticipate process barriers so that
the clinic could sustain the practice changes after the project ended.
A third major strength was the longevity of the Johns Hopkins Nursing Evidence
Appraisal Tool, which has been extensively revised, used, and published over the past
decade. Having a rich history of guiding EBP projects in nursing, this tool has
demonstrated its utility and effectiveness at distinguishing between high-quality and lowquality evidence.
For this particular project, which focused on obesity management, being able to
identify the best available evidence was paramount for two important reasons: First,
weight loss is remarkably difficult, largely due to patient nonadherence to a
recommended weight loss regimen (Eaton et al., 2016; McLaughlin et al., 2017;
Perreault, 2019b). Therefore, clinicians who prescribe weight management interventions
must be able to defend the components of their weight loss prescription using sound
evidence that patients can trust. Second, primary care providers report that obesity
management is extremely challenging (Eaton et al., 2016; Hageman et al., 2017,
Kushner & Ryan, 2014; McLaughlin, 2017; Pollak et al., 2016). A variety of fad diets,
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weight loss supplements, and other “lose weight quick” schemes are promoted through
social media outlets and other sources of consumer information. These approaches to
weight loss are difficult to maintain due to high cost, being over-restrictive, or being
ineffective, and this can lead to patients feeling dissatisfied with the weight loss
experience. Adopting Evidence-Based weight loss practices in the primary care setting
may help clinicians to feel better prepared to teach patients which weight loss strategies
are effective and which ones are not.
Limitations of the model
The Iowa Model of EBP to Promote Quality Care provides guidance for clinicians
when making practice decisions that affect patient outcomes. This model encourages
the identification of ‘triggers’ - practice questions stemming from clinical problems or
new knowledge. These triggers initiate change originating at the top level and will
potentiate systematic research and team forming. This model has specified decision
points at which further investigation and evaluation may take place that is again
potentiated from the top level down (Dang, Melnyk & Fineout-Overholt et al., 2015). The
team aspect of this model would be beneficial when promoting practice change.
The Stetler Model initiated the term evidence in1976 and has since expanded the
term to substantiating evidence. This model utilizes a five-step approach to acquire and
utilize research to facilitate EBP. The steps consist of preparation, validation,
comparative evaluation and decision making, translation and application and a final
evaluation. One progresses through the steps by completing the associated tasks and
moving on to the next level. The user does not return to the beginning of the process,
should a change be needed but rather continues to move forward. This is unlike the
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JHNEBP model in which the user may progress in a circular pattern in which further
investigation and potential research may provide an alternative approach should
evaluation show that a change in plan is required. This is a weakness of the Stetler
Model as this model considers evidence in a use /do not use format in either informal or
formal interventions or protocols in a rigid path that does not provide for alterations. This
model can be utilized by the individual practitioner unlike the Iowa model (Dang, Melnyk
& Fineout-Overholt et al., 2015).
In summary, the JHNEBP Model provided a cyclical step approach to EBP that
included inquiry, development of a practice question, research and finding evidence,
translation of evidence into practice, best practices, and finally practice improvements.
This process was developed specifically for nursing and allows the novice researcher to
utilize its cyclical approach and path to the EBP implementation process that can be
altered as new information or questions arise, utilizing evidence obtained from scientific
inquiry to promote best practice.
Literature Search
Sources Examined for Relevant Evidence
An extensive and comprehensive literature review was completed in order to
support inquiry and to determine best practice for this EBP project. This included a
search of five databases in addition to citation chasing. Evidence was sought out using
CINAHL, MedLine via EBSCO, Joanna Briggs (JBI), PubMed and the Cochrane Library.
In addition, citation chasing was utilized to discover relevant evidence from articles that
were found in the online databases listed above. The CINAHL, MedLine via EBSCO,
and PubMed databases were selected due to their extensive volume of health-related
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research articles and rapid access to high levels of evidence. The Joanna Briggs
Institute database and the Cochrane Library were selected due to the evidence
summaries and systematic reviews accessible through these resources. The expertise
of a health resources librarian was sought to further strengthen the literature review for
this EBP project.
The literature search had several criteria for inclusion: articles published within
five years, adult population, English language, human subjects, study tested an
intervention to treat obesity in a primary care setting, and evidence was level I or II and
of high or good quality. Articles were excluded if: study focused on weight loss for a
condition other than obesity (e.g. type 2 diabetes mellitus, polycystic ovarian syndrome);
the target population included children, pregnant women, or neonates; or the main
intervention tested was irrelevant to the primary care setting (e.g. bariatric surgery).
Results of the literature search are summarized in Tables 2.1 and 2.2.
Table 2.1
Literature Search Summary
______________________________________________________________________
Database
Key search words or phrases
Limiters

CINAHL

obesity
AND intervent* OR treat*
AND “weight loss” OR BMI OR “waist
circumference” OR “body fat”

01/01/2016-06/30/2019;
scholarly peer-reviewed;
English language, human,
and Adult >19 years
Boolean phrase

AND “primary care” OR “primary
health care” OR “primary healthcare”
Cochrane
library

obesity
intervent*
“weight loss”

01/01/2016-06/30/2019
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JBI

obesity

2016-2019

MedLine via
EBSCO

obesity

01/01/2016-06/30/2019;
scholarly peer-reviewed;
English language, human,
and
Adult >19years

AND intervent* OR treat*
AND “weight loss” OR BMI OR “waist
circumference” OR “body fat”

Boolean phrase
AND “primary care” OR “primary
health care” OR “primary healthcare”
PubMed

obesity AND intervent* OR treat*
AND “weight loss” OR BMI OR “waist
circumference” OR “body fat” AND
“primary care” OR “primary health
care” OR “primary healthcare”

01/01/2016-06/30/2019;
English language, human,
and Adult >19years

______________________________________________________________________
Table 2.2
Evidence Search Table
______________________________________________________________________
Database
Yielded
Duplicates
Reviewed
Accepted
CINAHL

52

42

12

2

Cochrane

12

3

2

6

JBI

26

0

1

0

MEDLINE via
EBSCO

156

139

34

5

PubMED

311

147

47

1

Citation
chased
Total

4

0

4

2

561

331

100

16

Evidence Appraisal
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Evidence was appraised for strength and quality using the JHNEBP Evidence
Appraisal Tools (Appendix C) (Dang & Dearholt, 2017; Johns Hopkins Medicine, 2017).
Levels of Evidence
The level of evidence for a source was determined by the study design that was
used in that source. For example, Level I evidence consists only of meta-analyses,
systematic reviews, and randomized controlled trials. Level II evidence consists of
quasi-experimental designs (e.g. cohort, case-control). Level III evidence consists of
nonexperimental designs (e.g. descriptive, qualitative). Level IV evidence consists of
methodically developed guidelines from nationally known experts based upon research
or expert panel consensus. Finally, Level V evidence consists of a synopsis of
published literature without methodically appraisal of evidence. A summary of the
appraisal criteria is provided in Table 2.3. Evidence at Levels I through II were used in
this EBP project.
Appraisal of Relevant Evidence
The Johns Hopkins Nursing Research Evidence Appraisal Tool (Appendix C)
was also used with permission (Appendix B) to evaluate the quality of each source.
Once the level of evidence was determined as level I, II or III, the quality was rated as
high, good or low:
•

High quality evidence was consistent, had results that were transferable,
with an adequate study design, sample size, a sufficient control, and was
able to provide conclusions. They contained fully inclusive literature review
with references to scientific evidence and provided recommendations that
were consistent with their findings.
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•

Good quality evidence that was consistent with results, an adequate
sample size, use of a control, conclusions that were well defined and fairly
decisive, recommendations based upon a relatively inclusive literature
review with mention to some scientific data.

Low quality evidence had samples that were insufficient in size, provided minimal
evidence with inconclusive results that provided little or no conclusions based upon the
work (Dang & Dearholt, 2017; Johns Hopkins Medicine, 2017). A PDF copy of the
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool is
found in appendix C.
The level of chosen evidence are described in Table 2.3.
Table 2.3
Levels of Evidence
______________________________________________________________________
Level
Included
Quality
Design
I

11

High

SR (1)
SR with MA (2)
RCT (8)

I

1

Good

RCT (1)

II

3

High

SR (2)
Quasi-exp. (1)

II

1

Good

SR (1)

______________________________________________________________________
The evaluated works were of either level I or level II and of good or high quality. There
were eleven sources that were level I and high quality (3 systematic reviews, 8
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randomized controlled trials), one randomized controlled trial that was level I and good
quality and two systematic reviews that were level II and high quality.
Levels of Evidence
Level I evidence. A systematic review (SR) completed by Batsis and colleagues
(2016) looks at obesity interventions that can be used with older adults in the clinical
setting. This systematic review of 6 online databases included randomized controlled
trials published between January 2005 and October 2015. Interventions focused on
behavior changes that lasted at least six months. Control groups varied but included
routine care from a health care practitioner/physician, usual care, no exercise, and or
use of a technological device. Primary outcomes measured were quality of life, weight
loss, and physical activity. Weight loss was included as a component of each RCT.
The range of weight loss was 0.5 to 10.7kg (0.1 to 9.3% of baseline body
weight). The greatest weight loss was obtained from programs with both a diet
intervention and an exercise intervention, rather than exercise alone. Combined diet
and exercise also significantly improved quality of life and physical function. This study
provides evidence that supports the use of obesity interventions, including diet and
exercise, to reduce weight, improve physical function, and improve quality of life in the
geriatric population.
Beeken and colleagues (2017) presented evidence from a two-arm, multi-site,
randomized controlled trial (RCT) that tested the effect of a self-guided “Ten Top Tips”
(10TT) leaflet about weight loss, a logbook for documenting weight loss behaviors, and
an initial consultation with a nurse, on weight, BMI, total cholesterol, blood glucose, and
self-reported weight loss behavior, compared to usual primary care. At three months,
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patients in the intervention group lost significantly more weight than the control group
(mean difference = -0.87 kg, 95% CI -1.47, -0.27, p = .004). This weight loss was
maintained over 24 months, but it was not significantly different than the group that
received usual care. Furthermore, Beeken and colleagues (2017) reported statistically
significant reductions in waist circumference, BMI, and systolic blood pressure, and
statistically significant increases in self-reported weight loss behavior, at 3 months after
the intervention, but there was no change in total cholesterol or blood glucose.
Based on these findings, authors reported that the 10TT leaflet was effective for
short term weight loss, reduction in systolic blood pressure, and increased use of weight
loss habits in the primary care setting. It was found to be a low-cost option to use in
primary care, with an average cost around $32 per intervention (leaflet, logbook, and
nurse consultation) This report provides support for the use of written behavioral change
and education materials as a weight loss intervention that could be incorporated into a
multicomponent weight loss intervention and this EBP Project.
Limitations of the study included use of literature as old as 2005; some studies
reviewed focused on diet only or lacked an exercise component, studies did not focus
interventions in primary care; pharmacological and surgical therapy were omitted from
the study. A quality rating of high was applied to this report due to clear statement of
purpose, comprehensive and reproducible strategies; use of Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) criteria to reduce bias and
increase transparency; use of empirical evidence; use of pilot study to provide
consistency; details of studies and consistent result interpretation and generalizability.
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Eaton and colleagues (2016) conducted a RCT over 24 months within a
socioeconomically disadvantaged community in Rhode Island. The purpose was to test
a tailored lifestyle intervention addressing obesity within the obese population in primary
care with the goal of assisting weight loss and increase physical activity. Participants
who were referred through primary care were randomized into one of two groups:
enhanced intervention (EI) (n=106) or standard intervention (SI) (n=105). All participants
received three face-to-face weight loss meetings. The EI group was also provided
individualized telephone counseling and tailored printed and electronic media tools that
focused on diet and exercise. The interventions were tapered after the first year of study
participation. Anthropometric measurements and resting heart rate and blood pressure
were obtained at baseline and at 6, 12, 18, and 24 months. The 7-day Physical Activity
Recall Questionnaire and a ten-minute treadmill were used to assess participants’
perception of moderate physical activity.
Results generally showed weight loss was greater in the EI group versus the SI
group at 6 months (37.2% and 12.9% respectively; p<.01) and at 12 months (47.8% and
11.6% respectively; p<.01), but not at 18 months (31.4% and 26.7% respectively; p=.64)
or at 24 months (33.3% and 24.6% respectively; p=.39). The EI group reported a
significant increase in the number of minutes in which they engaged in physical activity
at 6, 12, 18, and 24 months (95.7, 126.1, 103.6, and 101.3 respectively versus 67.9,
73.7, 63.3 and 75.0 respectively; p = .10, .002, .02, and .12 respectively).
This RCT (Eaton et al., 2016) is of high quality due to its strengths of
consistency, translation and generalizable results, and definitive conclusions. Methods,
study design and interventions are clearly defined and address the purpose of
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evaluating a tailored intervention to promote weight loss and increase activity in the
obese population. Statistical analysis was completed using ANOVA. Prior to the study,
needed sample size was determined with 104 participants needed (

=0.05) for each

arm. This study provided results that were encouraging but it also had limitations
including: only one geographic area; participants from related practice may have biased
results; mainly female participants; use of self-reporting that may have skewed
reliability; multiple modes of intervention delivery- DVD, printed materials and
telephone; and attenuation of participants. The results provided support for the use of a
tailored lifestyle intervention including face-to-face, telephone and or electronic media
interventions for the treatment of obesity.
Hageman and colleagues (2017) completed a three phase, 30 month long RCT
with the primary objective of comparing three weight loss interventions: web-based only
(WO), web-based with peer-led discussion (WD), and web-based with professional
email counseling (WE). Secondary goals included: improvements in healthy eating,
activity, blood pressure and lipids. The study focused upon women living in a rural
community. Phase I lasted from baseline to six months and included guided weight loss
using one of the experimental treatments (WO, WD, or WE). In Phase I, all subjects had
access to web-based diet and exercise recommendations, a weight loss plan, a diet and
exercise log book, a pedometer, weekly goal-setting sessions, and weekly feedback. In
addition, the WD group had access to a peer discussion board and the WE group had
access to the peer discussion board, professional email counseling, feedback about
their discussion board postings from a member of the research team, and scheduled
reminders about their weight loss program. Phase II lasted from 6 to 18 months. During

42

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
this phase, all participants completed weekly weight logs, tracked diet and exercise, and
received online feedback. In addition, the WD group had biweekly peer-led online
discussions for the first 12 months. Phase III lasted from 18 to 30 months. During this
phase, all subjects were encouraged to continue tracking diet and exercise, set goals,
and receive online feedback. In addition, the WD group had access to the peer
discussion board, but there was less input from the research team than before. The WE
group continued to have email consultation available, but only at the participant’s
request.
Results showed that there was statistically significant weight loss in the WO, WD,
and WE treatment groups at 6 months (5.1 kg, 4.1 kg, and 6 kg, respectively). However,
this weight loss was not sustained beyond 6 months, and participants regained
approximately half of the weight lost by 30 months. There were no differences in weight
loss between groups, suggesting that the discussion boards and email coaching did not
significantly impact weight loss more than the web resources alone. There was no
significant improvement in secondary outcomes (waist circumference, daily caloric
intake, minutes of moderate intensity activity, blood pressure, total cholesterol, HDL,
LDL, triglycerides, and fasting glucose).
This study suggests that the use of web-based resources, with or without
supplemental interventions, can facilitate short-term weight loss in women with obesity.
However, this weight loss may not be sustainable beyond 6 months, and there was no
clinically or statistically significant improvement in obesity-related clinical outcomes.
Strengths of this study that led to the high quality rating included: design -three arm trial
of web-based interventions and web-based interventions with enhancements with
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adequate control; sufficient sample with a large cohort of participants-n=301; three
phase time table of 30 months; use of EBP and standardized methods with established
validity such as- Actigraph Accelerometer to track activity and the 1998 Block Health
Habit and History Questionnaire to assess behavioral measures; conclusions based
upon results that countered expected outcomes; clear, consistent and generalizable
results. Though conclusions were based on results of the study and statistical data was
presented, one of the limitations of the study was the absence of methods of analysis.
Other limitations included: a sample of primarily female women of high socioeconomic
background; unknown reason for missing data/observations; nonsignificant weight loss
data for participants who did and did not complete program at 18 months; contamination
and sharing data between group members living in same region; and varying level of
engagement in program.
Harrigan and colleagues (2016) conducted a six month long, three-arm RCT at
Yale University. The study compared the effects of in-person counseling, telephone
counseling, or usual care on the following variables: BMI, body fat percentage, lean
body mass, bone mineral density, waist and hip circumferences, physical activity,
dietary intake, and obesity-related biomarkers (C-reactive protein, insulin, leptin,
adiponetcim, interleukin-6, tumor necrosis factor alpha, and blood glucose). Subjects
received individualized weight loss counseling in a graduated fashion (weekly for 1
month, then every 2 weeks for 2 months, then monthly for 3 months). Dietary
counseling focused mainly on calorie reduction through reduced fat intake, a plantbased diet, and mindful eating practices. Physical activity counseling focused on homebased moderate-intensity activity for at least 150 minutes per week and reducing
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sedentary activity. Usual care consisted of a brochure about nutrition and physical
activity, along with a two-session weight management program if desired.
At six months, subjects in either of the experimental treatment groups had
statistically significant reductions in weight, waist circumference, hip circumference,
dietary intake from fat, and C-reactive protein, and statistically significant increases in
physical activity, fiber intake, and servings of fruit and vegetables per day, compared to
subjects in the usual care group. Weight loss was 6.4% in the in-person counseling
group (p=.004), 5.4% in the telephone-counseling group (p=.009) and 2.0% in the usual
care group (p=.46). There was no statistically significant change in percent body fat,
lean body mass, bone mineral density, sugar intake, or concentrations in insulin, blood
glucose, leptin, adiponectin, IL-6, or TNF-α in any group. These results suggest that
either in-person or telephone-based counseling sessions are more effective than printed
weight-loss information alone for managing obesity. This RCT’s purpose was to
examine the effect of in-person versus telephone counseling versus usual care for the
treatment of overweight/obesity in a female population having survived breast cancer
(Harrigan et al., 2016). Strengths of this study that determined the high quality rating
included: use of a design phase estimated sample size of 30 to provide a 93% power to
detect 3.5kg in weight change between control and intervention groups; use of
Permuted block randomization; use of SAS (9.3) PROC MI for data computations statistical significance set at p<.05 using two-sided tests; population sample and
methods consistent with the purpose and clearly stated including a control group;
interventions adapted from the Diabetes Prevention Program and 2010 US Dietary
Guidelines using the American Cancer Society nutrition and physical activity guidelines;
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and weight loss counseling performed by registered dieticians with specialty
certification. Limitations of the study were: a 15% attrition rate; lower compliance rate
among telephone counseling group; use of self-reporting of activity and use of a
pedometer which may affect accuracy; lack of diversity in population studied may affect
generalizability; possible recruitment bias.
Kozica and colleagues (2016) conducted a two-arm RCT in 42 rural and
socioeconomically disadvantaged Victorian communities in Australia, between 2012 and
2013. The aim of the trial was to evaluate the Healthy Lifestyle Program for women
(HeLP-her) program, which focused on making small sustainable lifestyle and
behavioral changes. There were two arms of the trial: the control group consisted of 20
towns (n=301) and the intervention group consisted of 21 towns (n=348). Both groups
received a face-to-face education session focused on national obesity management
guidelines. The intervention group also received a program manual, telephone
coaching, and text messages to strengthen program content and accountability. The
primary outcomes were weight and BMI, which were measured at baseline and at the
end of 1 year.
Results indicated that subjects in the HeLP-her intervention group lost 0.92 kg
more than subjects in the control group (95% CI -1.67, -0.16) in 1 year. There was high
participant satisfaction with the program, particularly with regards to coaching by either
face-to-face or text messaging, compared to telephone coaching or use of a program
manual. These results suggest that a weight loss program focused on small sustainable
lifestyle changes can result in weight loss over a 1-year period.
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This high quality RCT utilized a mixed methods approach in this large scale
obesity prevention trial that targeted a population at risk (Kozica et al., 2015). This
mixed methods approach consisted of qualitative data use and analysis as well as
quantitative data collection methods including: questionnaires, tools and checklists to
increase generalizability. In order to close knowledge gaps the study chose a variety of
interventions and delivery modes. Limitations of the study included: lack of independent
oversight of checklists that were conducted by research staff; lack of evaluation of
fidelity of motivational interviewing; lack of data collection of delivery modes for lifestyle
modification. Using multiple interventions such as: education, goal setting, behavioral
self-management, action planning, addressing barriers, problem solving and relapse
prevention skills, this report addresses the purpose and proposed interventions of this
EBP Project.
Ma and colleagues (2019) completed a twelve-month long RCT in California. The
purpose was to evaluate the effect of concurrent treatment for obesity and depression
on weight loss. All participants of the control group and the intervention group received
usual care from their physician as well as information about obesity and depression
management and wireless physical activity tracking technology (i.e. a pedometer).
Subjects in the intervention group also received a 12-month intervention that included a
behavioral weight loss counseling intervention, problem-solving therapy, and
antidepressant medications, if indicated. The primary outcomes for this study were BMI
and severity of depression symptoms, which was measured using the Depression
Symptom Checklist (SCL-20).
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After 12 months, the BMI of subjects in the intervention group decreased by 0.7
kg/m2, compared to no change in the control group (95% CI -1.1, -0.2; p = .01). In
addition, depression severity improved significantly in the intervention group compared
to the control group (95% CI -0.4, 0; p = .01). These findings suggest that a
multicomponent care intervention that focuses on both obesity management and
depression management may lead to improvements in both. The purpose of this high
quality RCT was to test the hypothesis that integrated collaborative intervention would
improve depression and obesity over a 12 month time frame as compared to usual care
(Ma et al., 2019). Strengths included: closing the knowledge gap by becoming the first
and largest RCT of its kind; findings were based on results of the study and were
generalizable; sufficient sample size and timeframe; use of a control group; use of
validated testing methods-SCL-20 depression symptom checklist; statistical analysis
completed using linear mixed-effects models to a 95% CI, p-values obtained from
general least square models adjusted for baseline value of outcome, and randomization
of covariates. Limitations of the study were identified, addressed and included: omission
of a formal literature review; limited geographical region in Northern California;
homogeneous high socioeconomic sample; missing data (2% of weight, 9% of SCL-20
at 6 and 12 months); BMI data included from EMR or self–report; drop out data may
have skewed results; continuity of care from other clinical sites would not have been
captured in data. The results support the use of behavioral interventions including
problem solving, and goal setting to promote modest weight loss and lends support to
this EBP Project.
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Rodriguez-Cristobal and colleagues (2017) conducted a 24 month long,
multicenter, cluster RCT between 2008 and 2010. The purpose of which was to
discover whether motivational interventions combined with current practice resulted in
greater weight loss than usual care for the treatment of obesity. Both groups had visits
with their primary care provider every three months, received basic weight loss advice
about diet and exercise, caloric reduction (1200 to 1500 kcal per day), and an exercise
plan. In addition, subjects in the intervention group received a motivation intervention
consisting of graduated visits with trained nurses every 15 days during weeks 1 to 12
followed by monthly sessions during weeks 13 to 32.
Subjects in the intervention group lost 1.5 kg more than those in the control
group (p = .02). Moreover, more subjects in the intervention group achieved a 5% loss
in body weight than in the control group after 2 years (26% vs 18.1%, respectively; p =
.04), but not after 1 year (22.6% vs 16.6%, respectively; p = .09). Authors also
examined changes in cardiovascular risk factors (cholesterol, triglycerides, HDL, LDL,
apolipoproteins A and B, and blood pressure). Subjects in the intervention group had
significantly lower triglycerides (125.9 ± 65.1 vs 135.4 ± 65.6, respectively; p = .0001),
APOA (p = .04) and APOA:APOB ratio (p = .0003) than those in the control group after
2 years. Changes in total cholesterol, HDL, LDL, APOB, and blood pressure were not
statistically significant between groups after 1 year or 2 years. These results suggest
that motivational counseling, in addition to lifestyle modifications, may result in greater
weight loss and reduced cardiovascular risk than lifestyle modifications alone. These
results are applicable to this EBP Project.
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This RCT is of high quality due to its strengths consisting of: randomized design
and intervention provision via primary care therapists, accustomed to the treatment of
overweight and obese patients; dietetic non-pharmacological approach; consistent,
generalizable results; conclusions based on results; sufficient sample size, n=864;
sufficient time frame of 32 months. Limitations of the study included: no formal literature
review; high attrition rate of 52.25 % completed the final visit-reasons not investigated;
missing data not analyzed.
Rolls and associates (2017) tested the efficacy of a behavioral weight reduction
program with the inclusion of two portion control strategies versus standard education
within a RCT conducted over a twelve month period. The trial included women aged 20
to 65 years, with a BMI of > 25 (n=186). All participants completed the Eating Attitudes
Test (EAT) and the Beck Depression Inventory (BDI). Participants were placed in either
the control group or one of two intervention groups. Subjects in the control group
received usual care including advice to eat less and make healthy food choices.
Subjects in one intervention group were instructed to choose foods based on energy
density (ED) in order to promote healthy, satisfying foods while limiting portion size of
high ED foods. Participants in this group were provided a food scale and food
measuring tools as well as illustrated pictorial examples of healthy meal components
and portions sizes. Subjects in the other intervention group were instructed to use preportioned foods in an effort to learn portion control and healthy eating choices.
Pedometers were also provided to both intervention groups.
All three treatment arms resulted in weight loss from baseline after 3, 6, 9, and
12 months, although the pre-portioned group lost more weight within 3 months than the
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standard advice group and the portion-selection group (5.1 kg vs 3.7 kg vs 3.8 kg,
respectively; p <.05 for pre-portion group vs other groups). However, the pre-portioned
group also regained weight faster than the other two groups (p = .0005 for pre-portion
group vs other groups), and all subjects regained at least some weight from their nadir
at approximately 6 months. Weight regain seemed to be attenuated by a higher level of
dietary restraint (i.e. more able to control dietary intake) and adherence to selfmonitoring. Regardless of treatment arm, cardiovascular risk factors improved
significantly in all subjects from baseline to 12 months (blood pressure, waist
circumference, glucose, insulin, insulin resistance, total cholesterol, HDL, and
triglycerides), as did most indicators of reported food consumption (food weight per day,
energy density, calories from beverages, calories from food, fruit intake, grain intake,
protein intake, dairy intake, fats and oils intake, and pre-portioned foods intake). These
results suggest that pre-portioned foods may increase the rate of weight loss over the
short-term, but that weight regain after 3 months is likely.
This piece had several strengths. First, they used a sufficient sample of 186
participants determined using mixed effects model that determined 80% power would
be achieved by a sample of 180. Secondly, there was random assignment of
participants. Thirdly, participants met with registered dieticians and trained
interventionists who used standardized instruction manuals to insure fidelity.
Interventions for the control group included: following healthy dietary guidelines; limiting
caloric intake; meal planning. The second intervention group were taught to choose high
density energy foods and to control portion size. The third intervention group were
instructed to use pre-portioned foods. Primary outcome measured was the trajectory of
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weight change over time using random coefficient model and intended–to-treat model.
Secondary outcomes measured included: cardiometabolic factors, dietary intake,
questionnaire responses and pedometer readings. These were analyzed by linear
mixed effects model with categorical fixed factors. Lack of sample diversity may limit
generalizability and continued use of pre-portioned foods and food measuring tools may
not be sustainable. In total the results from this good quality RCT provide support for the
use of a healthy nutritional plan based upon guidelines like those from Dietary
Guidelines for Americans-2010, utilize portion control along with increase physical
activity and behavioral modification can assist with weight loss.
Samdal and associated (2017) performed a systematic review and metaregression analyses on literature about behavioral change techniques for weight loss
published between January 2007 and April 2013. Interventions included cognitive or
behavioral change strategies (eg. motivational counseling); simple education strategies
were excluded. Outcomes measured were behavioral change technique to promote
goal setting, self-monitoring, problem solving, feedback, social support, for physical
activity and healthy eating (Samdal et al., 2017).
The authors found that, among 35 trials reporting effect of behavior change
technique related to increased physical activity, there were 30 reports of short term (ST)
effect (0.36; [0.24, 0.47] 95%CI), 17 reports of long term (LT) effect (0.25 [0.13, 0.38]
95%CI), and 47 reports of both ST and LT effect (0.31[0.23, 0.40] 95%CI). The effect of
behavioral change techniques on diet was found in 20 reports of ST effect (0.41 [0.20,
0.62] 95%CI),15 reports of LT (0.19 [0.07, 0.31] 95%CI), and 35 reports of ST and LT
effect (0.29 [0.16, 0.42] 95%CI). BCT effect on physical activity and diet in combination
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was found in 50 ST reports (0.37 [0.26, 0.48] 95%CI), 32 LT reports (0.24 [0.15, 0.33]
95%CI), 82 ST and LT reports. The pooled size effect of ST and LT studies were 0.19 to
0.41 with a 95% CI. The CI’s had analogous effect for physical activity and diet,
however LT (0.24) showed a lesser result than ST (0.37) despite 95% CIs that
coincided (0.15 -0.33 and 0.26- 0.48, respectively). There was high heterogeneity
among ST reports (I 2 =71%, p<.0001) and lesser heterogeneity among LT reports (I 2
=59%, p<.0001).
The main results determined in the ST and LT, that behavioral interventions for
diet and physical activity had a small effect however, consistency among studies was
high mainly for ST. LT effect was associated with interventions such as motivational
interviewing, that highlight patient-centered and autonomy facilitating communication.
The results champion the use of self-monitoring, goal setting, in conjunction with
person-centered and autonomy enhancing behavioral counseling. This systematic
review supports the use of a behavioral intervention by the NP in primary care as part of
a multicomponent weight loss intervention.
Strengths of this high quality systematic review and meta-regression analysis
were: the inclusion of 46 RCTs and 2 cluster RCT with a pooled sample of 11,183
providing a sufficient sample for the analysis; study bias was addressed and analyzed
for each of the RCTs; most studies reported analysis of intention-to-treat using baseline
carried forward or random imputation. Attrition bias was found to be higher in long term
due to drop out. This analysis was limited to a 12-month time frame, ending in 2014.
Some individual study characteristics were limited and lacking in refinement. The results
showed that the use of BCT had positive outcomes in the domains of goal setting,
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barrier identification, problem solving as well as obesity risk and biomarker reduction.
Additionally, person-centered methods such as motivational interviewing that support
individual autonomy provided long term effect. These results support the use of BCT,
goal setting and self-monitoring for the treatment of adult obesity.
Tang and partners (2016) completed a SR of RCTs. The purpose was to
determine the effectiveness of self-directed interventions for weight loss through focus
on interventions that did not require ongoing professional interaction beyond an initial
consultation (Tang et al., 2016). Articles published through July 2014 were reviewed.
Interventions included those that: target diet and or physical activity; are self-directed
with limited face-to-face professional contact to < one 90 minute instructional session;
have at least one interactive intervention; or have at least one self-regulatory element
such as goal setting or diary of thoughts and or behaviors. Outcomes measured:
effectiveness of self-directed internet-based interventions; effectiveness of change
technique (eg. goal setting, self-monitoring, feedback, behavioral instruction, social
support) inclusion on self-directed interventions; changes in weight, BMI, waist
circumference.
Results of this meta-analysis showed that participants using self-directed
interventions had greater weight loss than those who received minimal or no
intervention (mean difference = -1.56 kg; 95% CI -2.25, -0.86). The mean individual
weight loss in the intervention group (IG), who would have received any of the
interventions listed above, ranged from 0.6 to 5.3 kg. Compared to no intervention, selfdirected interventions produced significantly greater reduction in BMI (mean difference =
-0.41kg/m2; 95% CI -0.70, 0.11) and waist circumference (mean difference= -2.37cm;
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95% CI -4.12, -0.61). Self-directed interventions included with in this study were
predominately internet based (18 out of 25, 72%). Studies employing change
techniques interventions such as: goal setting, self-monitoring, behavior skills were not
found to be significantly more helpful than those who did not (p=.48, p=.35, p=.26
respectively). However those that employed feedback and social support were found to
be successful (p<.0001, p=.001 respectively). Participants in the internet-based
intervention group experienced greater weight loss and BMI reduction than the control
group (mean difference = -1.72 kg; 95% CI -2.60, -0.84; -0.47kg/m2; 95% CI -0.81, 0.41 respectively). The intervention group also experienced greater waist circumference
loss than control group (mean difference = -2.69 cm; 95% CI -5.01, -0.37).
This study had many strengths and limitations. First it was the first to focus
exclusively on self-directed weight loss measures, many of them internet based. This
provided for specific intervention analysis; however, it was limited by a small sample
size, thus reducing the power to determine effect on a heterogeneous sample and
provide long term conclusions. There was a wide variation found for time of follow up
when meta-analytic calculations were performed that may have resulted from diverse
populations. Additionally, many trials utilized methods that could have biased
interpretation. Targeted study outcomes included physical activity and or diet; selfdirection with no more than initial professional intervention or face-to-face contact; at
least one interactive component (eg. entering personal data); at least one selfregulatory element (eg. diary, goalsetting or review).
The results suggest that self-directed weight loss interventions can provide a
mechanism for modest short-term weight loss, but these would need to be
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supplemented with additional interventions including community resources and clinical
services to achieve long-term significant weight loss. This article is applicable to this
EBP project as part of a multicomponent weight loss intervention.
Tapsell and colleagues (2017) conducted a single blind controlled trial with the
object of determining the effectiveness of interdisciplinary treatment versus usual care
for the treatment of overweight and obese adults. Participants were randomly assigned
to either the control group, an interdisciplinary intervention group, or an interdisciplinary
intervention group with a supply of 30 grams of walnuts per day. Interventions included:
seven clinical counseling sessions that included: diet, exercise and behavioral coaching
from professional nurse and interdisciplinary team based upon the Australian Guide to
Healthy Eating (AGHE); walnuts; quarterly support telephone calls, measures of blood
pressure, anthropometric and biomarkers (eg. lipid panel, fasting blood glucose and
HbA1c); assessment with the International Physical Activity Questionnaire (IPAQ),
Physical and Mental Health 12 Item Short Form Health Survey (SF-12) and the
Acceptance and Action Questionnaire for Weight loss (AAQ-W). Outcomes measured
included: weight loss from baseline and at 12 months; change in blood pressure; fasting
blood glucose and lipids; changes in diet and exercise; psychological measures (AAQW, DASS-21, QoL SF-12) (Tapsell et al., 2017). Individual outcomes measured not
stated.
Primary results indicated that both intervention groups had greater weight loss
than the control group at 3 months and at 6 months. Post hoc analysis indicated that at
3 months the intervention group, and the intervention plus walnut group had a greater
weight loss than the control group (-1.2kg, p=.045; -1.3kg, p=.025). At six months the
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intervention plus walnuts group had a greater weight loss than the control (-2.1kg,
p=.010). The difference between control and intervention plus walnut group was -2.2kg
p=.056 (95% CI). The 12 month adjusted weight change showed an effect significance
of p=.056, consistent with the difference in weight between the intervention plus walnuts
group and the control group of -2.2kg (95%CI -4.6 to0.1kg, p=.068) versus the
intervention group and the control group was -1.9kg (95%CI -4.5 to 0.7kg, p=.228) and
the intervention and the intervention plus walnuts groups -0.3kg (95% CI-2.8 to 2.2kg,
p=1.00). Achievement of 5% weight loss at twelve months (p=.091) among the control
group was 20%, among the intervention plus walnuts group it was 33% and among the
intervention group it was 38%.
Secondary results indicated that blood pressure tended to be lower among all
groups, the difference was not statistically significant (p=.441). Fasting blood glucose
was significantly lower at 3 (p=.040), 6 (p<.001) and 12 months (p=.003), compared to
baseline. While the intervention group plus walnuts measurement of HbA1C at twelve
months remained unchanged from baseline at 5.1 (4.9-5.4; p=.031), it was lower than
baseline for the control and intervention groups 5.2 and 5.1 (5.0-5.4, 4.9-5.4
respectively; p=.031). Lipid panels improved across the board at 3 months. Total
cholesterol (mmol/L) for control, intervention and intervention plus walnut groups
showed lower scores 5.2, 5.0, and 4.8 (4.4-5.6, 4.4-5.5, and 4.3-5.6 respectively;
p=0.193), this trend continued for the control group at 12 months but not for the
intervention or intervention plus walnut groups. Low density lipids (mmol/L) were also
lower at three months (p<.001; < .031) and at six months (p=.020, p=.034). At 12months
HDL rose above baseline (p< .021). Group effect showed better total cholesterol means
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for the intervention plus walnut groups versus intervention or control groups (p=.037 and
p=.001 respectively).
Self-reported caloric and total fat intake were lower than baseline for all groups
at three months (p<.001) and at twelve months (p=.020). Physical activity was higher
than at baseline at all time measures (p<.001). The findings indicated that
interdisciplinary collaboration and intervention with an individualized approach provided
greater results than usual care. The collaborative and individualized method of the
intervention is applicable to the primary care setting and specifically to the
multicomponent approach of this EBP Project.
This study had several strengths and limitations. Strengths included: its
applicability and generalizability within primary care. Secondly, analysis was conducted
using intention-to-treat instead of compliance-based method. Thirdly, possible
confounding variables were controlled. This study addressed gaps in current research
and is transferrable. However, the sample size was small and limited to one clinical
setting in which there was a language barrier, thus limiting access to potential at risk
participants. Between group reporting inaccuracies may skew dietary results. Results of
the study indicated that there is benefit from looking beyond dietary restriction.
Behavioral and psychological factors have a role in weight loss and attrition and regular
patient-clinician interaction (eg. 4 visits within 3 months) seems to provide positive
effect. Primary care is a suitable atmosphere within which obesity and weight loss as
well as weight related risk prevention can be addressed.
In summary, Level I evidence supports the use of primary care interventions that
focus on diet, exercise, self-monitoring of food intake and physical activity, and
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concurrent management of depression as strategies to manage obesity, control
depression symptoms, and reduce cardiovascular risk.
Level II: Cheatham and colleagues (2018) conducted a systematic review using
Preferred Reporting items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines. with the purpose of appraising current evidence related to the efficacy of
wearable activity tracking technology (eg. Fitbit) as part of a comprehensive weight loss
program (Cheatham et al., 2018). A search of five databases was conducted through
December of 2016. Authors found 7184 citations and 25 relevant sources, of which 21
scored 6 or higher (7)/10, and 4 scored a 5/10 using the Physiotherapy Evidence
Database (PEDro) scale indicating moderate to high quality evidence.
Interventions included in the review: behavioral and nutrition counseling; selfmonitoring of diet and activity (eg.website or Smartphone); self-monitoring through
journaling; and use of an activity tracker. Outcomes measured included: BMI, waist
circumference, body composition, physical activity, dietary changes/ caloric intake,
blood pressure and heart rate. Strengths of the study were use of consistent research
technique using PRISMA guidelines and PEDro evidence appraisal. The study filled a
gap in current research. Limitations of the study were, primarily female participants,
diversity in type of studies reviewed and no consistent type of activity tracking, and the
limited age groups studied. Authors found that there was evidence to support the use of
activity trackers as part of a comprehensive weight loss program. These devices, which
included: pedometers, websites, Fitbit, Smartphone and accelerometer, electronic arm
band, activity tracker with Bluetooth, and paper journal, provided statistically significant
short-term weight loss that was superior to weight loss in programs without activity
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trackers. Results suggest that an activity tracker used as part of a multicomponent
intervention may provide positive short term weight loss. These findings provide support
for the use of activity tracking technology (eg. pedometer, Fitbit, Smartphone
applications) as part of a multicomponent weight loss intervention program and this
EBP Project.
Kroes, Osei-Assibey and Baker-Searle (2016) conducted a systematic review the
objective of which was to evaluate evidence concerning the impact of weight/BMI
change on health-related quality of life (HRQoL) in obese adults. This was done through
various weight loss interventions (Kroes et al., 2016). These interventions included:
lifestyle modification and behavioral counseling; dietary and exercise coaching and
education; pharmacotherapies, bariatric intervention; and some measure of healthrelated quality of life (HRQoL) (eg. SF-36, IWQOL-Lite). Outcomes measured included
changes in weight, BMI, body composition, and HRQoL. HRQoL was measured with
either the Short Form Health Survey (SF-36) tool or the Impact of Weight on Quality of
Life (IWQOL-Lite) tool. Results of the pharmaceutical weight loss study using pooled
data, at 52 weeks indicated the mean weight loss was 2.7% from baseline; 34.9% of
participants lost 0.4 % to 9% of baseline. Weight gain was seen in 26.2% of
participants. Changing weight correlated with SF-36 scores (0.2 for weight loss of 04.9% to 2.8 for weight loss > 10 % from baseline). Lifestyle modification included diet,
exercise and behavioral interventions resulted in weight loss that ranged from 3% to
10% from baseline. Multiple studies (n=6) utilized the SF-36 tool to measure HRQoL.
Results showed that regardless of lifestyle intervention, weight loss was associated with
better HRQoL scores (increase of 0.64 in SF-36 for every 5kg weight loss). Weight loss
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and improved physical abilities produced improvement in HRQoL scores as measured
with the SF-36 (mean change 1.65).
This study had many strengths. First a comprehensive search was conducted in
four databases according to PRISMA guidelines identifying 6793 citations of which 32
were included. Analysis of evidence was completed via standard methods. Conclusions
drawn indicate that BMI > 25 typically coincide with decreased HRQoL. Significant
weight loss following bariatric surgery may improve HRQoL. Non-bariatric studies that
provided a weight loss of > 5 % also resulted in improved HRQoL though specific cause
remains unidentified. Both SF-36 and IWQOL-Lite scores that were improved but were
generally related to physical rather than mental HRQoL. Conclusions indicated that
people with obesity have poorer health and thus HRQoL and even a weight loss of 5%
of total baseline can reduce health risk, improve health and HRQoL.
This systematic review was given a Level II high quality rating because of the
inclusion of RCT and quasi-experimental studies and consistent results. It provides
support for the use of an individualized multicomponent weight loss interventions
including those specific to this EBP Project (eg.lifestyle modifications, and
pharmaceuticals) for weight loss to improve all aspects of HRQoL in people with obesity
and within this EBP Project.
Thabault, Burke and Ades (2016) conducted a quasi-experimental study with the
purpose of evaluating an intensive behavioral treatment program to manage obesity
with the adult primary care population, specifically led by nurse practitioners (NPs).
Multicomponent interventions included: use of the 5A’s framework (ask, assess, advise,
agree, and assist); obesity screening and nutritional assessment; motivational
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interviewing; and weight loss education that included a 500-1000kcal reduction with a
goal of a 1-2 pound /week loss and increased physical activity; along with an
introductory packet that included benefits of a healthy lifestyle and weight, dietary and
activity journal, pedometer, questionnaire addressing goals and readiness to change
and nutritional assessment. Outcome variables include weight loss; patient-provider
satisfaction, feasibility; and acceptability.
Data were collected at baseline and at 4 and 12 weeks. Baseline means for
weight, BMI, SBP and DBP were: 229, 37.4, 129 and 71 respectively. After 4 weeks,
mean weight decreased by 6.6 lbs (p < .05), and after 12 weeks, mean weight
decreased by 10.77 lbs (p < .05). Changes in blood pressure were not statistically
significant at either time point. The authors also evaluated the extent to which patients
were satisfied with components of the weight loss program. In general, patients reported
that scheduling was easy, consistent appointments with a nurse practitioner increased
their own accountability to adhere to the program, that providers offered adequate
support, and that use of the weight loss tools was feasible.
Strengths of the study were: used of validated questionnaires, data analysis
using SPSS and Excel XLSTAT Version 2013.5.3, the NP leadership, focus in primary
care, and generalizability of the study. Limitations included: short duration, the study
participants were referrals rather than a random sampling, and lack of further evaluation
of biometric risk markers. Results indicated that a NP-led multicomponent intervention
that focused on nutritional assessment, weight loss education, and motivational
interviewing was satisfactory to patients and resulted in significant weight loss. This
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study provided level II high quality support for this EBP project due to study design and
consistent content and generalizable results.
Welbourn and colleagues (2018) completed a systematic review to appraise
current evidence regarding weight loss interventions used in primary and specialty care
areas, in order to create a tiered model for these interventions centered on obesity
severity. Based on 50 pieces of evidence, including published guidelines, systematic
reviews and RCTs published between 2011 and 2016, the authors recommended a
four-tier model for weight loss. Tier I interventions focus on obesity screening using
standard anthropometric measurements (e.g. weight, BMI) and counseling about diet,
exercise, and lifestyle changes. Tier II interventions included those in Tier I, with the
addition of pharmacotherapies to facilitate weight loss. Tier III included interventions in
Tiers I and II, as well as referral to a multidisciplinary team and a weight loss specialist.
Finally, Tier IV included interventions from Tiers I through III, as well as referral to a
bariatric physician specialist.
Strengths of this research was the use of 50 works of evidence including recently
published guidelines and policy documents, systematic reviews and RCTs obtained
from six electronic databases; use of a NICE accredited process endorsed by 22 UK
societies and nine Royal Colleges addressing obesity. Limitations were not addressed
within the article but included: a UK rather than US specific perspective and guidance;
need for translation into US insurance based medical care climate that is not National
Health Service.
In summary, Level II evidence from this literature review further support the use
of weight loss interventions that focus on patient education, motivational interviewing,
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and self-monitoring of diet and exercise. Moreover, Level II evidence suggests that
multicomponent interventions based on characteristics that are unique to patients,
including their resources, barriers, and preferences, can effectively lead to weight loss
and provide support for this EBP Project.
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Table 2. 4
Appraisal of Evidence
Citation
(APA)
Batsis, J. A.,
Gill, L. E.,
Masutani, R.
K., AdachiMejia, A. M.,
Blunt, H. B.,
Bagley, P. J.,
LopezJimenez, F. &
Bartels, S. J.,
(2016). Weight
loss in older
adults with
obesity: A
systematic
review of
randomized
controlled trials
since 2005.
Journal of the
American
Geriatrics
Society, 65(2)
257-268.

Purpose

To identify
obesity
interventions
that can direct
clinical
recommendatio
ns among the
geriatric
population.

Design

Sample

Systematic
review

The target
population is
communitydwelling
older adults
with obesity.

Interventions
included:
Behavioral,
diet and
exercise
counseling
including
5001000kcal
deficit;
meeting with
diet or
exercise
physiologist
or
specialists;
group
meetings;
pedometer
use and log
or diary;
vitamin
supplements

A thorough
systematic
literature
search was
performed
and found
5,741
citations
published
2006
forward; 19
sources
were used in
the final
review.
Inclusion
criteria:beha
vioral weight
65

Measurement/
Outcomes
Outcomes measured:
Weight (kg) was
measured at intervals
from 6 to 18 months.

Results/
Findings

Weight loss in the
intervention groups
ranged from 0.5 kg
to 10.7 kg (0.1%9.3% of body
Physical function was weight). (p<.01)
measured using
physical performance Dietary interventions
testing, the 6MWT,
produced a larger
the Western Ontario
weight loss than
McMaster Arthritis
exercise alone.
Index, and Functional (p=.52 to p=.001)
Status Questionnaire
at intervals from 6 to Exercise increased
18 months.
physical function but
not weight loss.
Quality of life was
(p=.02)
measured using the
SF-36 at intervals
A combination of
from 6 to 18 months. diet and exercise
interventions
provided the best
improvement in
physical function
and QoL (p=.03)
(Batsis et al., 2016)

Level/
Quality
Level
I
Qualit
y High
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Beeken, R. J.,
Leurent, B.,
Vickerstaff, V.,
Wilson, R.,
Croker, H.,
Morris, S.,
Omar, R. Z.,
Nazareth, I., &
Wardle, J.
(2017). A brief
intervention for
weight control
based on
habitformation
theory
delivered
through
primary care:
results from a
randomized

To test the
hypothesis that
ten top tips
(10TT) can
produce
significantly
better weight
loss than usual
care over a 3
month period.

RCT
Intervention
group
received a
leaflet about
weight loss,
a log book,
and baseline
consultation
with a nurse.
Control
group
received
usual care
from within
their primary
care setting,
but may
have

loss not
involving
pharmacolog
ical or
surgical
intervention.
Exclusion
criteria:
pharmacolog
ical or
surgical
intervention
The sample
included 537
primary care
patients with
obesity.
Inclusion
criteria:
obsess
adults that
were able to
provide
consent.
Exclusion
criteria:
active
psychotic
illness,
pregnant or
terminally ill.

66

and mitigated loss of
muscle and bone
mass seen in the
studies with diet
only interventions.

Weight (kg) was
measured at baseline
and at 3, 6, 12, and
18 months.
Secondary outcomes
included BMI, waist
circumference, blood
glucose, and blood
pressure. These
were measured at 3,
6, 12, and 18
months.

Weight loss in the
intervention group
was greater than
weight loss in the
control group at 3
months (1.68 kg vs
0.84 kg,
respectively; p =
.004).
Weight loss was
sustained in the
intervention group
for up to 24 months.
Mean Glucose
(HbA1c) (mmol l -1 )
at baseline was 5.9
(SD -2.4) CG, 5.8
(SD -2.1)_ IG; 3
months the IG had a

Level
I
Qualit
y High
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controlled trial.
International
Journal of
Obesity,41(2)
264-254.

included
outside
resources
such as
Weight
Watchers ®.

mean glucose of 5.3
versus 6.0 in the
CG. A change of
0.06 (SD -2.85) in
the control group
and 0 (SD -1.79) in
the intervention
group.
SBP was lower in
the intervention
group by 2.98
mmHg (95% CI 5.73, -0.23).
The 10TT leaflet
intervention was
effective for shortterm weight loss,
glucose control, and
BP control.

Cheatham, S.
W., Stull, K. R.,
Fantigrassi, M.,
& Motel, I.
(2018). The
efficacy of
wearable
activity tracing
technology as
part of a weight
loss program:

The purpose
was to appraise
current evidence
related to the
efficacy of
wearable activity
tracking
technology as
part of a
comprehensive
weight loss

Systematic
Review
Of the 25
studies,
various
controls and
interventions
were
applied.
Among them

N=7184;
n=25 that
met inclusion
criteria and
no exclusion
criteria.Inclu
sion criteria
included:
Controlled
clinical trials,
peer
67

A systematic review
conducted based
upon PRISMA
guidelines of
databases through
December of 2016.
Databases included:
PubMed, CINAHL,
SportDiscus,
Proquest and Google
Scholar as well as

Results of outcomes
measured among
studies included (pvalue range):
Weight loss
(p<.001-.05,
p=.0004 to.9)
BMI (p<.01 to.03)
Decreased BP
(p=.25, or p<.05)

Level
II
Qualit
y High
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a systematic
review. The
Journal of
Sports
Medicine and
Physical
Fitness,
58(4)534-548.

program. Three
clinical
questions were
addressed: 1.
“Are activity
trackers
effective as a
single
intervention or
part of a
comprehensive
weight loss
program? . . . 2.
Does the use of
activity trackers
improve
adherence to
weight loss
programs? . . .
3. Are weight
loss programs
using activity
trackers more
effective among
certain age
groups or
sex?”(Cheatham
et al., 2018)

the control
groups
received:
Hypocaloric
diet,
pedometer,
usual
national
guidelines
diet and
exercise
advice and
education,
weigh in and
journal use

reviewed,
and
comparison
of portable
activity
tracking
devices.

Increase physical
activity (p=.04 to
.003, p<.001)
Decreased % body
fat (p=.008 to .9)
Increased weight
control behaviors
(p=.003)
Exclusion
Decreased kcal
criteria: nonintake (p<.001)
English, no
Decreased fat intake
use or no
Outcomes measured: (p<.001)
measuremen weight, BMI, waist
Decreased waist
t of activity
circumference, body
circumference
tracking
composition, physical (p<.05 to p<.0004)
device, or
activity, dietary
Interventions special
changes/ caloric
A total of 25 articles
included:
populations, intake, blood
were reviewed and
behavioral
or case
pressure and heart
each piece of
and nutrition report,
rate
evidence was
counseling;
series,
individually
selfcommentarie
scrutinized and
monitoring of s or
analyzed however a
diet and
dissertations
meta- analysis was
activity
.
not performed.
(eg.website
Based upon
or
individual works, this
Smartphone)
systematic review
; selffindings suggest that
monitoring
activity trackers
through
used as part of a
journaling;
multi-modal
and use of
intervention weight
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citation chasing.
Relevant studies
were graded using
the PEDro scale. 21
studies scored > 6
and 4 studies scored
> 5. All subjects had
a BMI of > 25kg/m2 ,
the majority being
female.
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an activity
tracker.

Eaton, C. B.,
Hartman, S. J.,
Perzanowski,
E., Pan, G.,
Roberts, M. B.,
Risica, P. M.,
Gans, K. m.,
Jakicic, J. m. &
Marcus, B. H.
(2016). A
randomized
clinical trial of a
tailored
lifestyle

The aim of the
study was to
test a tailored
lifestyle
intervention to
improve activity
and achieve
weight loss in an
obese primary
care population.

RCT
Standard
care for both
groups IG
and CG
included: 3
face-to-face
meetings
with lifestyle
counseling,
and
pamphlets .

Intervention
(IG) n=105,
control (CG)
n=106.
The sample
was 79%
women, 16%
minorities,
with a mean
age 48.6
years, and
mean BMI
37.8 kg/m2,
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Outcomes measured
included: weight loss,
and physical activity
(walking) .

loss program
provide short term
results over
standard care.
Consistent research
findings indicate that
multi-modal
interventions in
general provided the
best weight loss
outcomes. In every
article the
intervention group
had a significantly
greater weight loss
than the control
group and or an
increase in physical
activity was found.
Results: Percentage
of sample that had
5% loss of body
weight from of
baseline was
greater in IG than
CG (p<0.001). At 6
months the IG
37.2% and CG
12.9%; at 12 months
CG 26.7%; and at
18 months IG 31.4%
and CG 26.7% and
at 24 months IG

Level
I
Qualit
y High
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intervention for
obese,
sedentary,
primary care
patients.
Annals of
Family
Medicine,
14(4) 311-319.

Hageman, P.
A., Pullen, C.
H., Hertzog,

“This trial
compared the
effectiveness of

IG also
received
phone call
counseling ,
weekly
mailings
focused on
diet,
exercise and
behavioral /
lifestyle
interventions
and DVDs.

who were
sedentary.
Inclusion:
adult18 to 80
years, BMI
>, sedentary,
English
literate and
able
toprovide
consent.
Exclusion
criteria:
family
member
enrolled in
the study,
health
condition
making
participation
unsafe.

RCT
Interventions
: all groups

n=301
women with
BMI of 2870

33.3% and CG
24.6% had a 5%
reduction in weight.
Activity increased
significantly more
among the IG than
the CG (p=0.04).
The mean difference
in physical activity
minutes among the
groups: at 6 months
IG 95.7 and CG
68.3; at 12 months
IG 126.1 and CG
73.7; at 18 months
IG 103.7 and CG
63.7 and at 24
months IG 101.3,
CG 75.4 (Eaton et
al., 2016).
Conclusions indicate
that a tailored
lifestyle intervention
in obese sedentary
populations was an
effective tool to
promote weight loss
and increased
activity with optimal
effect at 12 months.
Outcomes measured: Mean body weight
Level
per group at
I
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M., Pozehl, B.,
Eisenhauer, C.
& Boeckner, L.
S. (2017).
Web-based
interventions
alone or
supplemented
with peer-led
support or
professional
email
counseling for
weight loss
and weight
maintenance in
women from
rural
communities:
Results of a
clinical trial.
Hindawi,
Journal of
Obesity, 2017,
1-21. Retrieved
from:
https://www.nc
bi.nlm.nih.gov/
pmc
/articles/
PMC539
6444/pdf/

a web-based
only (WO)
intervention with
web-based
supplemented
by peer-led
discussion (WD)
or professional
email
counseling (WE)
across 3 phases
to achieve
weight loss and
weight
maintenance in
women from
underserved
rural
communities”
(Hageman et al.,
2017).

including the
control group
(WO) had
web-based
interventions
with identical
content that
included diet
and exercise
plans,
behavioral
change
plans, based
upon 2010
Dietary
Guidelines
for
Americans
and 2008
Physical
Activity
Guidelines
for
Americans
and Healthy
People
2010. One
intervention
group also
received
supplementa
l peer led
counseling

45kg/m2
ages 40-69
years, were
randomly
assigned to
1 of 3
groups:
Web-based
only/control
(WO) n=101;
Web-based
and peer led
discussion
(WD) n=100;
Web-based
and
professional
email
counseling
(WE) n=100
Inclusion:
rural living,
female, BMI
28-45kg/m2,
not on
medications
that affected
weight,
English
literate, able
to use
telephone
and
71

Primary: body weight
and waist
circumference
Secondary:
attainment of
specified weight loss,
eating and activity
targets

baseline, 6, 18 and
30 months:
WO: 93.6 (SD 13.7),
88.0 (14.6), 88.9
(14.8), 89.4 (14.0)
respectively.
WD: 94.5 (12.9),
89.4 (13.9), 89.6
(13.6), 90.4 (13.3)
respectively.
WE: 93.3 (12.6),
87.2 (13.5), 88.3
(15.5), 89.5 (16.7)
respectively.
At the 6 month
mark, the mean
weight loss was:
WO 5.1 (SD6.0) kg
WD 4.1 (5.6)kg
WE 6.0 (6.3) kg with
42%, 38% and 51 %
meeting the > 5%
total body weight
loss.
Body weight kg:
Comparison at 6, 18
and 30 months: pb,
mean difference
(SD)
“WOvsWD: p=.138,
0.9 (-0.8 to 2.7);
p=.360, 0.2(-1.1 to

Qualit
y High
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JOBE20171602627.pdf

(WD) and
the second
intervention
group
received
professional
email
counseling
(WE).

computer,
internet and
DVD access,
able to drive.
Exclusion:
diabetes
type I or II
with insulin
use, 10% or
greater
weight loss
in past 6
months,
current
enrollment in
weight loss
program or
research
study,
physical or
mental
restrictions.

72

1.6); p=.268, -0.4(1.8 to 0.9).
WO vs WE: p=.188,
-0.8 (-2.5 to 0.9),
p=.411, -0.2 (-1.5 to
1.2), p=.444, -0.191.4 to 1.2).
WD vs WE: p=.047,
-1.7 (-3.4 to 0.0),
p=0.563, -0.4 (-1.7
to 1.0), p=.632, 0.3
(-1.0 to 1.7).
Waist
circumference:
at 6, 18 and 30
months: pb, mean
difference (SD)
WO vs WD: p=.070,
1.6 (-0.5 to 3.7).
p=.497, -0.01 (-1.5
to 1.4), p=.479, 0.04 (-1.5 to 1.4).
WO vs WE: p=.461,
0.1 (-2.0 to 2.2),
p=.441, -0.1 (-1.5 to
1.3), p=.463, -0.1
(1.5 to 1.3). WD vs
WE: p=.164, -1.5 (3.5 to 0.6), p=.891, 0.1 (-1.6 to 1.4),
p=.970, -0.03 (-1.5
to 1.4)”
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Harrigan, M.,
Cartmel, B.,
Loftfield, E.,
Sanft, T.,
Chagpar, A. B.,
Zhou, Y.,
Playdon, M.,
Li, F. & Irwin,
M. L. (2016).
Randomized
trial comparing
telephone
versus inperson weight
loss counseling
on body
composition
and circulating
biomarkers in

The purpose
was to examine
the effect of inperson versus
phone based
weight loss
counseling
versus usual
care on body
composition,
physical activity,
diet and
biomarkers at 6
months.

RCT
Control:
usual care:
diet and
exercise
advice
based upon
US dietary
guidelines
and the
LEAN book.
Interventions
:
In-person
and phone
counseling
included 11,

Female
breast
cancer
survivors
with BMI
>25kg/m2,
ages 59 +
7.5 years.
n=33 inperson
counseling
group (IP),
n=34
telephone
counseling
group (TC)
and n=33
usual care
group (UC).
73

(Hageman et al.,
2017)
Results showed that
the web-based
intervention had
short term effect for
weight loss in this
rural population.
However at 30
months weight
regain by as much
as 50% was found
within the population
studied.
Biomarkers and
Results indicated
height and weight,
that at 6 months the
waist circumference, mean weight loss
activity and diet were was IP
measured at baseline 6.4%,(p=0.004,) TC
and at 6 months.
5.4%(p=0.009) and
UC 2.0% (p=0.46).
C-reactive protein
reduced 30% IP &
TC; versus 1% UC
(p=0.05).
Both IP and TC
were effective
weight loss
strategies that had
positive effects on
C-reactive protein
level reduction.

Level
I
Qualit
y High
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women treated
for breast
cancer: the
lifestyle,
exercise and
nutrition
(LEAN) study.
Journal of
Clinical
Oncology,
34(7)669-676.

Kozica, S.L.,
Lombard, C.
B., Ilic, D., Ng,
S., Harrison, C.
L. & Teede, H.

30 minute
sessions
over 6
months that
focused on
diet and
exercise
advice
based upon
US dietary
guidelines.
and
behavioral
therapy.

The aim of the
study was to
“conduct a
process
evaluation within

RCT
Control:
The CG
received

Inclusion:
Breast
cancer
survivors Dx
within 5
years, stage
0-3, BMI.>25
kg/m2,
completed
chemotherap
y or radiation
at least 3
months prior,
physically
capable,
English
literate and
agree to
random
assignment.
Exclusion:
pregnancy,
CVA or MI in
past 6
months, or
uncontrolled
mental
illness.
N=649;
Control
group (CG)
n=301;
intervention
74

The HeLP-her Rural
program took place in
Australia and New
Zealand beginning in

Results on Likert 1-5
+SD indicated that
face-to-face delivery
methods to be the
most desired by

Level
I
Qualit
y High
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J. (2015).
Acceptability of
delivery modes
for lifestyle
advice in a
large scale
randomized
controlled
obesity
prevention trial.
BMC Public
Health,
15(9)699-712.
doi:10.1186/s1
2889-0151995-8

the context of a
large-scale rural
obesity
prevention
program
measuring
implementation
fidelity, dose
delivered,
context, reach
and
acceptability of
diverse delivery
modes” (Kozica
et al., 2015)

standard
care-group
education
from
National
Guidelines.
Intervention:
low intensity
lifestyle
intervention
that
included:
simple
lifestyle
advice via
face-to-face
group
session,
pone
coaching,
text
messages,
and an
interactive
manual.

group (IG)
n=348;
females,
aged 39.6+
6 years, BMI
28.8
+6.9kg/m2,
from low
socioecono
mic rural
communities
.
The
intervention
group was
sub divided
into clusters
of n=15
allowing for
attrition.
Inclusion:
female, aged
18-50 years,
living in one
of 41
selected
towns. No
exclusion
criteria
stated.

75

2012 and lasting 12
months.
At 1 year, CG n=233,
IG n=259
Data collection
included: interviews,
checklists and
questionnaires that
were analyzed using
chi-square and ttests.
Outcomes measured:
Acceptability of mode
for lifestyle advice:
face-to-face, text
messaging,
telephone coaching,
program manual.

participants, with at
least one session
being the key to
success.
Group education
sessions was the
most highly valued
component of the
interventions.
Lifestyle advise
delivered through a
multicomponent
program was
recommended to
optimize
acceptability and
effect.
Quantitative results
at 12 months
(n=190):
Group sessions
were preferred over
telephone coaching
(p<.00) or program
manual (p<.00). text
messaging scored
slightly higher than
phone coaching
(p<.00) and program
manual (p<.000;
phone coaching
scores were lower
than all interventions
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except program
manual (p=.63). No
statistical difference
between group
sessions and text
messages (p=.13).

Kroes, M.,
Osei-Assibey,
G., BakerSearle, R. &
Huang, J.
(2016). Impact
of weight
change on
quality of life in
adults with
overweight
/obesity in the
United States:
a systematic
review. Current
Medical
Research and
Opinion,
32(3)485-508.

The objective of
this study was to
“review
published
evidence on the
impact of
weight/BMI
change on
health-related
quality of life
(HRQoL) in
adults from the
US with
overweight/obes
ity” (Kroes et al.,
2016)

Systematic
review (SR)
Of the
studies
included
Interventions
comprised:
the SF-36 or
the IWQOL
Lite to
measure
HRQoL,
lifestyle
approaches:
diet,
exercise,
counseling,
pharmaceuti
cal
therapies, or
bariatric
surgery

N=6793
titles were
identified of
which 32
meet
inclusion
criteria and
did not meet
one or more
exclusion
criteria.
Upon further
review n=20
provided
adequate
data and
were
included in
the SR.
Inclusion:
Englishlangu
age,
published
2008
76

This SR was
conducted using
PRISMA guidelines.
A comprehensive
data base search of
MEDLINE, Embase,
Econ Lit and the
Cochrane Library.
Inclusion criteria
included: studies in
US, adults, BMI >25,
with > 1 year follow
up quantified weight
change and
measurement of
HRQoL.
Studies design and
outcomes were
heterogeneous, with
HRQoL.
Outcomes
measurement
obtained via

Results indicated
that that
pharmacotherapies
and lifestyle
intervention, 5%10% weight loss
was achieved
HRQoL also
improved; lifestyle
interventions
coincided with SF36 scores PCSW
increased by 0.64
for every loss of 5kg
(p<.001)
.Pharmaceutical
studies weight loss
coincided with minor
changes in SF-36
scores (0.2 to 2.8).
Bariatric surgery
offered the greatest
weight loss, > 20%,
and improved

Level
II
Qualit
y High
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Ma, J.,
GoldmanRosas, L., Lv,
N., Xiao, L.,

The objective is
to “test the
hypothesis that
an integrated

RCT
Usual care
group (UC)
n=205 as

forward,
adult
population,
overweight/o
bese, followup 1 year or
greater,
change in
HRQoL
measure
(SF-36 and
or IWQOLLite).
Exclusion:
Comorbitiy
focus, not
obesity
related.

the Short form 36
(SF-36) or the
IWQOL Lite.
Improved HRQoL
was seen in studies
in which weight-loss
was obtained.

HRQoL scores.
Studies reporting
SF-36 post bariatric
surgery: p<.008
week 92, and at 2
years p<.02 from
baseline, IWQOLLite scores from
baseline reported
significant
improvements,
specifically physical
function and selfesteem both
(p<.001).
Conclusion: there
was an association
between
overweight/obesity
and lower HRQoL
scores;
corresponding
amount of weight
loss and increased
HRQoL was found
among evidence
reviewed.

N=409,
adults, BMI
> 30 (>27 for
Asian

The study: Research
Aimed at Improving
Both Mood and

Findings provided
statistically
significant results at
12 months.

77

Level
I
Qualit
y High
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Snowden, M.
B., Venditti, E.
M., Lewis, M.
A., GoldhaberFiebert, J. D. &
Lavori, P. W.
(2019).
Effective of
integrated
behavioral
weight loss
treatment and
problemsolving therapy
on body mass
index and
depressive
symptoms
among patients
with obesity
and
depression:
The RAINBOW
randomized
clinical trial.
Journal of the
American
Medical
Association
(JAMA), 321(9)
869-879.

collaborative
care intervention
would
significantly
improve both
obesity and
depression at 12
months
compared with
usual care” (Ma
et al, 2019.)

well as
intervention
group (IG)
n=204
received
medical care
from
personal
physicians,
including
information
on weight
management
and mental
health
services and
wellness
programs
routinely
available in
their primary
care office.
The UC
group also
received an
activity
tracker.
The IG
received the
same initial
information
as UC but

adults), and
PHQ-9 score
> 10,
primary care
patients in
Northern
California,
study dates:
9/30/201401/12/2017,
with 12month follow
up by
01/17/2018.
Inclusion:
adult, obese,
depressive
symptoms
(PHQ-9
score > 10),
English
literate.
Exclusion:
plan to
relocate,
serious
comorbiditie
s
(undefined),
pregnancy,

78

Weight (RAINBOW)
integrated
Behavioral weight
loss treatment and
problem-solving
therapy with
antidepressant
pharmacotherapies.
Outcomes measure
weight loss/BMI,
PHQ-9, GAD-7 and
SCL-20 scores. t-test
analysis or x2 test
analysis for
unadjusted
bivariables and Wald
asymptomatic 95%
CI for unadjusted
proportions.

Intervention group
(IG) versus usual
care (UC):
Weight loss/BMI
reduction: mean
baseline to 12
months: 36.7 (SD
6.9) to 35,9 (SD 7.1)
between group
mean -0.7 (95% CI,
-1.1 to -0.2) p=0.01.
Depressive
symptoms:
SCL20: IG mean
score reduced from
1.5 (SD 0.5) to 1.1
(SD 1.0)
IG -0.3 versus UC
1.5 (SD 0.6) to 1.4
(SD 1.3) between
group scores mean
difference , -0.2
(95% CI, -0.4 to 0)
p=0.01. SCL 20
scores improved by
at least 50% at 6
months (31% IG
versus 16% UC) full
depression
remission
SCL<0.50(IG 18%
versus UC 6%)
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also
received
multimedia
lifestyle and
self-care
materials as
well as
health
coaching
from
dieticians on
a weekly
basis, as
well as
psychiatry
and primary
care
providers
routinely.

RodriguezCristobal, J. J.,
AlonsoVillaveerde, C.,

The aim of the
study was “to
investigate
whether a

RCT
The
intervention

N=864,
overweight/o
bese
patients
79

In between group
GAD-7 scores: -1.2
(95% CI, -1.2 to 0.3) at 6 months; 1.5 (95% CI, -2.4 to
-0.5) at 12 months.
Conclusions indicate
by study results:
Among adults with
obesity and
depression a
collaborative
intervention
approach to
treatment that
included behavioral
weight loss
treatment and
problem-solving
therapies, as well as
antidepressant
pharmacotherapies
as needed provided
significantly greater
results in weight
loss and reduction
depressive
symptoms than
usual care.
Outcomes measured: Results: Weight loss
Weight, cholesterol,
kg mean at 1 year:
triglycerides, HDL,
CG, 1.3 kg, (0.1
LDL, apolipoproteins SE)59.3% were at

Level
I
Qualit
y High
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Panisello, J.
M., Trave’Mercade, P.,
RodriguezCorte’s, F.,
Marsal, J. R. &
Pena, E.
(2017).
Effectiveness
of a
motivational
intervention on
overweight/obe
se patients in
primary
healthcare: a
cluster
randomized
trial. BMC
Family
Practice, 18:74
(2017) 1-8. doi:
10.1186/s1287
5-017-0644-y

motivational
intervention
together with
current clinical
practice, was
more efficient
than traditional
intervention in
the treatment of
overweight and
obesity and
whether this
intervention
reduces
cardiovascular
risk factors
associated with
overweight and
obesity”
(RodriguezCristobal et al.,
2017).

group (IG)
received 32
group based
sessions
(every 15
days and
then monthly
for weeks 13
through 32)
of
motivational
intervention
along with
standard
12001500kcal/da
y diet and
exercise
education/co
unseling,
anthropomet
ric
measures,
blood tests:
triglycerides,
APOA1
APOB-100,
HDL and
LDL
cholesterol .

ages 30-70
years with
BMI >25,
from a
multicenter
were
randomly
assigned to
either the
intervention
group (IG) or
the control
group (CG)
n=446, .
Inclusion:
Aged 30-70
years,
overweight
or obese,
any gender,
registered
medical
history or
new
diagnosis.
Exclusion
criteria not
defined.

The control
group (CG)
80

A and B, and blood
pressure

or below baseline,
and mean 50/16.6%
had lost > 5%. IG
1.8 kg,(0.4 SE)
95%CI, 0.47;1.36(p=.33)
61.8% were at or
below baseline and
mean 64/22.6% had
lost > 5%.
Weight loss kg
mean at 2 year: CG,
1.0 kg, (0.4SE)
55.8% were at or
below baseline, and
mean 36/18.1% had
lost > 5%. IG 2.5 kg,
(0.5SE) 95%CI0.31;
2.74 (p=.01)65.5%
were at or below
baseline, and mean
64/26.9% had lost >
5%.
The study showed
that the combination
of usual care
combined with
professional group
based motivational
interventions
significantly
increased
maintenance and
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n=446, who
received
standard
care with
visits every 3
months:
standard
12001500kcal/da
y diet and
exercise
education/co
unseling
based on
national
guidelines,
anthropomet
ric
measures,
blood tests:
triglycerides,
APOA1
APOB-100,
HDL and
LDL
cholesterol.
Rolls, B. J.
James, B. L. &
Sanchez, C. E.
(2017). Does
the
incorporation of

The purpose of
the research
was to test
whether the
efficacy of a
behavioral

weight loss. Also, a
focus on
psychological
aspects of patient
health may
contribute to long
term weight loss
success.

RCT

N=186
overweight
All three
(19%) or
groups were obese
given equally (81%)
intensive
women.
81

Participants were
randomly assigned to
either the control
group/standard advice
(SAG); the portion
selection group (PSG)

Results: weight loss
for PPG was higher
than other groups
(P=0.021) however
this group later
regained more

Level
I
Qualit
y
Good
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portion-control
strategies in a
behavioral
program
improve weight
loss in a 1-year
randomized
controlled
trial?.
International
Journal of
Obesity,
41(3)434-442.

weight loss
program would
be improved by
incorporating
either one of
two portion
control
strategies:
prepackaged
meals or portion
selection versus
standard advice

behavioral
program/
counseling.

Inclusion:
Female,
aged 20-65
years, BMI
The SAG/
28-45
control group kg/m2,
were
Exclusion:
instructed to BO >
eat less food 160/100mm
and make
Hg,
healthy food reported
choices.
weight
The PSG
change
were
>4.5kg in
instructed to past 3
choose
months,
portions
medically
based on
unstable,
energy
limited
density and
physical
food
activity
measuremen tolerance,
t tools/scale. current
The PPG
special diet
were
or weight
instructed to loss
build meals
program
around preenrollment,
portioned
pregnant or
foods using
lactating,
food
scores of
vouchers for >19 on
purchase.
Eatin
82

or the Pre-portioned
foods group (PPG).
Outcomes measures
were assessed at 12
months for 151
participants (81%).
Weight change/
trajectory,
Secondary outcomes:
dietary consumption
questionnaire
responses and
pedometer readings.
cardiometabolic
factors: blood
pressure, waist
circumference,
glucose, insulin,
insulin resistance,
total cholesterol, HDL,
and triglycerides

weight (P=0.0005).
Thus resulting in
insignificant weight
loss across groups
at 6 months (mean +
se 5.2 +0.4kg) or 12
months (4.5 +
0.5kg). After 1-year
weight loss mean
was 6% of baseline.
Secondary
outcomes:
SBP(p=.0061), DBP
(p=.0003), Waist
circumference
(p<.0001), Glucose
(p=.0015), Insulin
(p<.0001), insulin
resistance
(p<.0001),
Total cholesterol
(p=.0007, HDL
(p=.0001), LDL
(p=12), Triglycerides
(p=.0032)
Conclusions:
Though early weight
loss was found
using pre-packaged
or portion
controlled/selection
foods, this did not
last. The use of pre-
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Attitudes
Test, or >25
on Becks
Depression
Inventory.
Samdal, G. B.,
Eide, G. E.,
Barth, T.,
Williams, G. &
Meland, E.
(2017).
Effective
behaviour
change
techniques for
physical activity
and healthy
eating in
overweight and
obese adults:
systematic
review and
metaregression
analysis.
International
Journal of
Behavioral
Nutrition and
Physical
Activity,
14(1)42-56.

The aim of the
SR to “explain
heterogeneity in
results of
interventions to
promote
physical activity
and healthy
eating for
overweight and
obese adults, by
exploring the
differential effect
of behavior
change
techniques
(BCTs) and
other
intervention
characteristics”
(Samdal et al.,
2017)

SR with
metaregression
analysis
Interventions
:
Behavioral
change
techniques:
Motivational
interviewing
and selfdeterminatio
n theory
(SDT),
Acceptance
and
commitment
theory
(ACT),
Change
theory/techni
que (CT),
Health at
Every Size
(HAES),

packaged or portion
controlled/selection
foods did not lead to
greater long term
weight loss versus
standard advice.
N=6283
SR using PRISMA of
IBM SSPS statistics
articles; 584 RCT > 12 weeks
were used to
titles
duration; January
complete metashowed
2007 to October 2014; analysis.
relevance
adult populationsPhysical activity
after initial
mean age 40 years;
(PA) was addressed
screening.
Mean BMI >30.
in 35 trials (30
Abstract
Primary outcomes
ST,0.36 effect size
screening
measured: healthy
(ES) 95% CI; 17 LT,
for inclusion diet and physical
0.25 ES 95%CI; and
exclusion
activity.
47 both ST and LT,
criteria
0.31 ES 95%CI).
produced
Diet was addressed
n=48
in 26 trials (20
studies that
ST,0.41 ES 95%CI;
provided
15 LT, 0.19 ES
evidentiary
95%CI; and 35 ST
support and
and LT, 0.29 ES
were
95%CI). PA and diet
relevant to
were both
this project.
addressed in 61
These 48
trials (50 ST, 0.37
articles
ES 95%CI;32 LT,
contained
0.24 ES 95%CI; and
82 outcome
82 both ST and LT,
reports and
no data).
a pooled
83

Level
I
Qualit
y High
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doi:
10.1186/s1296
6-017-0494-y

mindfulness,
other
For
Diet and
physical
activity,
goal setting,
self monitoring,
feedback,
social
support,

population
of 11,183
participants.
Intervention
s were
either shortterm (ST) <
6 months or
long-term
(LT) > 12
months.
Inclusion:
Behavioral
change
intervention,
cognitive
behavioral
strategies
or
intervention.
Exclusion:
Did not
include
Behavioral
change
intervention,
cognitive
behavioral
strategies
or
intervention.
For physical
activity and
84

ST Meta-regression
data: Goal setting: b
0.480; 95% CI
0.257-0.705
p<0.001. Feedback
behaviour: b 0.219,
95% CI -0.040,
0.479 p=0.096. Selfmonitoring behavior:
b 0.398, 95% CI
0.164, 0.632,
p=0.001.LT metaregression data:
Goal setting: b
0.228 ; 95% CI
0.056, 0.327
p=0.057. Selfmonitoring behavior:
b 0.184, 95% CI
0.009, 0.360,
p=0.040. Feedback:
b 0.249, 95%CI
0.085, 0.412, p=
0.004
Conclusions that
there are both
similarities and
differences in BCTs
the are effective to
promote healthy
eating and
increased activity
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healthy
eating
improveme
nt

Tang, J. C. H.,
Abraham, C.,
Greaves, C. J.
& Nikolaou, V.
(2016). Selfdirected
interventions to
promote weight
loss: a
systematic
review and
meta-analysis.
Health
Psychology
Review, 10(3)
358-372.

The focus of this
study was on
interventions
that did not
involve on going
professional
interaction/
contact, other
than an
introductory
face-to-face
session.
Research
questions
included: “1.
How effective
are self-directed
interventions . . .
to promote
short, medium
and long-term
weight loss in
adults? 2. Are
particular

Systematic
review and
metaanalysis
Interventions
:
target diet
and or
physical
activity; selfdirected with
limited faceto-face
professional
contact to <
one 90minute
instructional
session; had
at least one
interactive
intervention;
or had at

N= 5226
from
database
search and
N=3 from
other
sources.
After
removal of
duplications
n= 3884;
Of these
n=27 RCTs
that met
inclusion
and did not
meet one or
more
exclusion
criteria and
were
included in
the

85

Articles included were
published prior to July
2014, study data of
RCTs of self-directed
weight loss or weight
control interventions
Database search:
MEDLINE, Embase,
PsychINFO, CINAHL,
the Cochrane Library.
Outcomes measured:
effectiveness of selfdirected internetbased interventions;
effectiveness of
change technique
inclusion (eg. goal
setting, selfmonitoring, feedback,
behavioral instruction)
on self-directed
interventions;
changes in weight,

and maintenance.
The results support
goal setting, selfmonitoring and
behavioral/personcentered
counseling/motivatio
nal interviewing that
support autonomy.
Results: people who
utilized self-directed
(mostly internet
based) interventions
lost a greater
amount of weight
than those who
received minimal or
no intervention/
treatment; Selfmonitoring: (MD= 1.56kg, CI -2.25, 0.86) (SMD = - 0.41,
95% CI – 0.60, 0.23, l2=79% ; p=<
0.00001). The mean
weight loss among
the intervention
group ranged
between 0.6 to 5.3
kg.
Change techniques:
Goal setting: was
not significantly

Level
I
Qualit
y High
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Tapsell, L. C.,
Lonergan, M.,
Batterham, M.
J., Neale, E. P.,
Martin, A.,
Thorne, R. . .
.Peoples, G.
(2017). Effect
of
interdisciplinary
care on weight
loss: a
randomized
controlled trial.
BMJ Open,

modes of
delivery of selfdirected weight
loss
interventions
more or less
effective? 3. Do
particular
frequently
employed
change
techniques
enhance
effectiveness?”
(Tang et al.,
2016)

least one
selfregulatory
element
such as goal
setting or
diary of
thoughts and
or behaviors.

The objective
was “ to
determine
effectiveness of
a novel
interdisciplinary
treatment
compared with
usual care on
weight loss in
overweight and
obese
volunteers”
(Tapsell et al.,
2017).

Single
blinded RCT
Participants
were
randomized
into one of
the three
groups: CG,
IG or IWG.
The CG
received the
usual care.
The all were
provided

quantitative
synthesis.
Inclusion:
RCTs
published in
English
prior to
August
2014, selfdirected
weight loss,
weight
control
intervention
s.
Exclusion
criteria not
stated.
Initial
sample:
Control
group/usual
care (CG)
n=126;
Intervention
group (IG)
n=125 and
intervention
plus
walnuts
(IWG)
n=126.
Inclusion:
86

BMI, waist
circumference

difference between
groups IG CG.
Conclusions
indicated that selfmonitoring and selfdirected including
on-line formats
could be used to
assist with weight
loss generating
modest but
significant effect.

.
Outcomes measured:
weight loss from
baseline and at 12
months; change in
blood pressure;
fasting blood glucose
and lipids; changes in
diet and exercise;
psychological
measures (AAQ-W,
DASS-21, QoL SF-12)

Results:
At the 3 month
mark, there was a
significantly greater
weight loss in the IG
and IWG than Cg: (1.2 kg, p=0.045, I ; 1.3kg , p=0.025
IWG) and at 6
months for IWG (2.1 kg, p=0.010). At
12 months the
weight change
adjusted for
baseline weight

Level
I
Qualit
y High
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2017 (7)
e014533.
doi:10.1136/bm
jopen-2016014533

Thabault, P. J.,
Burke, P., J., &
Ades, p. A.
(2016).

The purpose of
the study was to
“ evaluate a
nurse

standard
weight loss
materials
including
healthy diet
and exercise
as well as
nurse lead
weight loss
advice. The
IG also
received
interdisciplin
ary advice
from
dietician,
and
psychologist.
IWG
received
interdisciplin
ary advice
and food
supplement
of 30g of
walnuts daily

Resident of
the Illawarra
region,
aged 25-54
years, BMI
25-40kg/m2,
English
literate.
Exclusion:
Not English
literate,
severe
medical
condition or
terminal
conditionlife
expectancy
<1year,
illegal drug
use,
alcoholism/r
egular
alcohol use
.50g/day,
other major
impediment
s

showed effect of
p=0.056 reflective of
CG- IWG difference
of -2.2kg (95% CI 4.6 to 1,0kg,
p=0.068) compared
to CG -IG: -1.9kg
(95%CI -4.5 to
0.7kg, p=0.228) and
difference between
IG and IWG: -0.3kg
(95% CI -2.8 to 2.2
kg, p=1.00)
Conclusions
indicated that the
intervention sample
achieved
significantly greater
weight loss
outcomes than the
control/ usual care.
Interdisciplinary
interventions
produced more
clinically significant
outcomes that were
better sustained.

Quasiexperimental study

Convenienc
e sample
n=38
Inclusion:

Weight, BMI and BP
were assessed at
initial visit and 4 and
12 weeks. Initial

87

Outcomes measured:
weight loss; patientprovider satisfaction,

Level
II
Qualit
y High
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Intensive
behavioral
treatment
weight loss
program in an
adult primary
care practice.
Journal of the
American
Association of
Nurse
Practitioners,
28 (2016) 249257.

practitioner lead
intensive
behavioral
treatment (IBT)
program for
obesity
implemented in
an adult primary
care practice”
(Thabault et al.,
2016).

No control
group.
Intervention:
5A’s
framework
(ask, assess,
advise,
agree, and
assist);
obesity
screening
and
nutritional
assessment;
motivational
interviewing;
and weight
loss
education
(5001000kcal
reduction
with a goal
of a 1-2
pound /week
loss and
increased
physical
activity);
introductory
packet
(educationbenefits of a

Aged 18
feasibility; and
years or
acceptability
older,
primary
care
patients of a
patientcentered
medical
home
practice in
New
England,
Medicare,
Medicaid, or
commercial
insurance.
Exclusion
criteria not
identified.
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mean/SD were:
weight 229/36,
(males: 252/35;
females: 215/29)
BMI 37.4/4.6
(males: 36.8/3.7;
females: 37.9/5.1)
,SBP 129/14, DBP
71/13; At 4 weeks:
weight 223/34, BMI
36.3/4.4, SBP
128/9, DBP 73/10;
At 12 weeks: weight
219/34, BMI 36.3/
4.4, SBP 131/15,
DBP 73/12. Using
paired t-test after 4
visits weight loss
was significant
(6.6lbs, p<0.05); for
males (8.9lbs
p<0.05); for females
(5.2lbs p<0.05). At
12 weeks the mean
weight loss was:
males 11.73 lbs
(p<0.05) and
females 10.16lbs
(p<0.05).
Patient satisfaction
was measured with
a Likert scale
questionnaire that
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healthy
lifestyle and
weight,
dietary and
activity
journal,
pedometer,
questionnair
e addressing
goals and
readiness to
change and
nutritional
assessment)
initial and 13
follow up
weight loss
counseling
sessions,
anthropomet
ric
measures,
Welbourn, R.,
Hopkins, J.,
Dixon, J. B.,
Finer, N.,
Hughes, C.,
Viner, R. &
Wass, J.
(2018).
Commissioning
guidance for

A SR of current
evidence for
commissioning
primary/second
ary weight
assessment and
management for
patients with
severe or
complex

achieved a 75%
response rate that
indicated favorability
in all categories:
appointments,
weight loss
counseling and
tools.
Conclusions
indicated that NP
led IBT programs
were an effective
means for adults in
primary care to
achieve weight loss
and was well
received by the
patient population.

SR

A total of
2,560
References
references
included
were
pathways,
identified
protocols
from 6
and
databases,
infrastructure of which
for pediatric
n=50 were
to adult
89

Outcomes included:
weight loss pre and
post intervention,
quality of life,
psychological health
(depression, anxiety
and self-esteem),
mobility, social
function and diabetes.

The results provided
4 tiers of guidance
for the following
health domains:
general
practitioners/primary
care actions
recommended:
anthropometric body
measurements,

Level
II
Qualit
y
Good
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weight
assessment
and
management in
adults and
children with
severe
complex
obesity.
Obesity
Reviews: An
Official Journal
of The
International
Association for
the Study of
Obesity,
19(1)14-27.

obesity. The
purpose of the
SR was to
“produce a
model for
organization of
multidisciplinary
team clinics that
could be
developed in
every
healthcare
system”
(Welbourne et
al., 2018)

populations
with obesity.
Diabetes,
included:
diet,
exercise,
bariatric,
dietetics/pha
rmacotherapi
es,

included in
the SR.
Included in
the SR:
guidelines
published
between
2011 and
2016.
Inclusion:
Published
guidelines,
systematic
reviews,
RCTs
published
from 2011
to 2016.
Exclusions:
revision
(bariatric)
surgery.
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specialist referral
criteria, diabetic
management and
referrals for bariatric
surgery; in specialist
clinic/ adult weight
assessment and
management:
interdisciplinary
teams including
bariatric physician,
dietician, nurse
specialist,
psychologist/psychia
try & physical
therapist and access
for patients with
special disabilities;
Diabetic/ DMII care
HbA1c <6.9, referral
for bariatric
specialist,
assessment of CV
risk; Psychological
and lifestyle issues:
referrals to
specialist,
medication history
and evaluation of
psychotropic drugs;
Post bariatric
surgical care:

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
interdisciplinary
care.
The evidence
provided guidelines
for standard of
treatment on a 4
level scale initiating
with primary/general
practice: universal
interventions routine
anthropometric
measurements thus
reducing stigma,
and diet, exercise
and healthy lifestyle
counseling. Tier 2
multicomponent
weight management
that includes tier 1
components plus
pharmacotherapies.
Tier 3 includes tier 1
and 2 as well as a
multidisciplinary
team and specialist
assessment. The 4th
tier includes bariatric
specialist
assessment as well
as the first 3 tiers.

91

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
•

Note: Appraisal tool utilized in this evidence appraisal was the Johns Hopkins Nursing Research Evidence
Appraisal Tools, ©The Johns Hopkins Hospital/ Johns Hopkins University School of Nursing (Dang & Dearholt,
2017).
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Construction of Evidence-Based Practice
Synthesis of Critically Appraised Literature
According to the WHO (2018) the global incidence of obesity has nearly tripled
since 1975. In 2016, approximately 13% of the global adult population was obese, and
39% were overweight (WHO, 2018). Given the overwhelming and growing prevalence
of obesity, and the significant impact of obesity on morbidity and mortality, managing
obesity is of paramount importance in the primary care setting. This EBP Project strove
to address whether the use of an evidenced based multicomponent protocol for the
assessment and treatment of obese patients assist adult patients with obesity to
achieve better weight loss outcomes compared to usual care including: a reduction in
BMI, waist circumference and waist to-hip ratio, as well as improve secondary outcomes
measures of BP, HbA1c, total cholesterol, HDL, LDL, triglycerides and the PHQ-9 and
the GAD-7 scores.
The current literature supports the use of a tailored multicomponent approach to
weight loss that is unique to each patient with obesity. Furthermore, high-quality
evidence demonstrates that the following interventions can effectively reduce weight,
BMI, waist circumference, and other obesity indicators:
•

Anthropometric measurement (eg. height, weight, BMI, waist
circumference, and waist-to-hip ratio) (Tapsell et al., 2017; Welbourn et
al., 2018)

•

Nutritional assessment (Hageman et al., 2017; Thabault et al., 2016;
Wellbourn et al., 2018)
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•

Individualization or tailoring of interventions (Eaton et al., 2016; Cheatham
et al., 2018; Tang et al., 2016)

•

Diet and exercise counseling that included: caloric reduction from between
500 -1000kcal per day and use of a healthful diet( lean protein, fresh fruits
and vegetables, whole grains and low fat; portion control); increased
exercise to at least 150 minutes per week, on most days that included
aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et al.,
2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; RodriguezCristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et
al., 2016; Welbourn et al., 2018).

•

Behavioral and lifestyle counseling and modification (eg. face-to-face, or
telephone, printed tools; not eating in front of the television, social eating,
stress, goal setting) (Batsis et al., 2016; Beeken et al., 2017; Cheatham et
al., 2018; Eaton et al., 2016; Hageman et al., 2017; Harrigan et al., 2016;
Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; RodriguezCristobal et al., 2017; Samdal et al., 2017; Tang et al., 2016; Tapsell et al.,
2017; Welbourn et al., 2018)

•

Motivational counseling (Rodriguez-Cristobal et al., 2017; Samdal et al.,
2017, Thabault et al., 2016; Welbourn et al., 2018

•

The 5A’s (ask, assess, advise, agree, and assist) counseling and
intervention (Thabault et al., 2016)

•

Self-guided weight loss plan (eg. Ten Top Tips/10TT, online diet plans)
(Beeken et al., 2017; Hageman et al., 2017; Tang et al., 2016)
94

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
•

Self-monitoring of diet and activity log, goals using a diary, or tracking
device (eg. Fitbit®, Smartphone application, pedometer, or online tracker)
(Cheatham et al., 2018; Ma et al., 2019; Rolls et al., 2017; Tang et al.,
2016)

•

Peer groups, discussion boards and weekly meetings (Hageman et al.,
2017)

•

Psychosocial (eg. PHQ-9, GAD-7, SF-12, SF-36, SCL-20, IWQoL) (Kroes
et al., 2016; Ma et al., 2019; Tapsell et al., 2017) and readiness evaluation
(eg. AAQ-W) (Tapsell et al., 2017) with referral and treatment for
depression and anxiety

•

Specialist collaboration (eg. dietician, psychologist, bariatric) (Kroes et al.,
2016; Tapsell et al., 2017; Wellbourn et al., 2018)

•

Pharmacotherapies, use of weight loss medications (Kroes et al., 2016;
Wellbourn et al., 2018)

In addition, the following interventions appear to significantly improve
cardiovascular risk, cardiovascular and or metabolic biomarkers, quality of life, or
physical function:
•

Nutritional assessment (Hageman et al., 2017; Thabault et al., 2016;
Wellbourn et al., 2018)

•

Individualization or tailoring of interventions (Eaton et al., 2016; Cheatham
et al., 2018; Tang et al., 2016)

•

Diet and exercise counseling that included: caloric reduction from between
500 -1000kcal per day and use of a healthful diet (lean protein, fresh fruits
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and vegetables, whole grains and low fat; portion control); increased
exercise to at least 150 minutes per week, on most days that included
aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et al.,
2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; RodriguezCristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et
al., 2016; Welbourn et al., 2018).
•

Behavioral and lifestyle counseling and modification on regularly
scheduled bases (eg. face-to-face, telephone, text messages, or printed
tools; not eating in front of the television, social eating, stress, goal setting)
(Batsis et al., 2016; Beeken et al., 2017; Cheatham et al., 2018; Eaton et
al., 2016; Hageman et al., 2017; Harrigan et al., 2016; Kozica et al., 2015;
Kroes et al., 2016; Ma et al., 2019; Rodriguez-Cristobal et al., 2017;
Samdal et al., 2017; Tang et al., 2016; Tapsell et al., 2017; Welbourn et
al., 2018)

•

Motivational counseling (Rodriguez-Cristobal et al., 2017; Samdal et al.,
2017, Thabault et al., 2016; Welbourn et al., 2018

•

The 5A’s (ask, assess, advise, agree, and assist) counseling and
intervention (Thabault et al., 2016)

•

Self-guided weight loss plan (eg. Ten Top Tips/10TT, online diet plans)
(Beeken et al., 2017; Hageman et al., 2017; Tang et al., 2016)

•

Self-monitoring of diet and activity log, goals using a diary, or tracking
device (eg. Fitbit®, Smartphone application, pedometer, or online tracker)
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(Cheatham et al., 2018; Ma et al., 2019; Rolls et al., 2017; Tang et al.,
2016)
•

Peer groups, discussion boards and weekly meetings (Hageman et al.,
2017)

•

Psychosocial (eg. PHQ-9, GAD-7, SF-12, SF-36, SCL-20, IWQoL) (Kroes
et al., 2016; Ma et al., 2019; Tapsell et al., 2017) and readiness evaluation
(eg. AAQ-W) (Tapsell et al., 2017) with referral and treatment for
depression and anxiety

•

Specialist collaboration (eg. dietician, psychologist, bariatric) (Kroes et al.,
2016; Tapsell et al., 2017; Wellbourn et al., 2018)

•

Pharmacotherapies, use of weight loss medications (Kroes et al., 2016;
Wellbourn et al., 2018)

Evidence presented suggested that prior to initiating any form of intervention,
patients should be screened for obesity. This would involve measurements of height,
weight and calculating BMI. BMI > 30 is consistent with obesity, however, this
measurement can be deceiving in a patient with large muscle mass. Therefore, waist
circumference and waist-to-hip ratio should also be measured. Since obesity carries
known health risks, screening for comorbidities such as: hypertension, diabetes,
hyperlipidemia, depression and or anxiety should also be completed when possible
(Batsis et al., 2016; Beeken et al., 2017; Cheatham et al., 2018; Eaton et al., 2016;
Harrigan et al., 2016; Tapsell et al., 2017; Thabault et al., 2016; Wellbourn et al.,
2018).
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Provider use of the 5A’s (ask, assess, advise, agree, and assist) (Thabault et al.,
2016) counseling and intervention technique as well as motivational interviewing or
counseling techniques (Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Thabault
et al., 2016; Welbourn et al., 2018) were interventions shown in Level I and Level II
evidence to illicit open conversation, aid in assessment and treatment, and develop
relationships that improve successful weight loss. Determining participant weight loss
history, readiness to lose weight, bias(es), physical as well as psychosocial barriers and
limitations can produce better outcomes (Kroes et al., 2016; Ma et al., 2019; Tapsell et
al., 2017)
Obesity is a multifactorial chronic disease often accompanied by comorbidities.
Therefore no one specific intervention can consistently meet each individual’s needs.
Multiple individualized interventions may be necessary to produce weight reduction
(Cheatham et al., 2018; Eaton et al., 2016; Ma et al., 2019; Sambal et al., 2017; Tapsell
et al., 2017; Thabault Burke & Ades, 2016). These interventions may have included
collaboration with one or more specialists when necessary (eg. dietician,
endocrinologist, psychologist, bariatric) (Kroes et al., 2016; Tapsell et al., 2017;
Wellbourn et al., 2018).
The evidence compiled for this EBP project offered a multitude of potential
interventions, however at this clinical site many were unrealistic for this patient
population. Those that had merit in this setting are discussed further.
On the surface, the treatment of obesity would appear to be simple, however
obesity and its’ treatment is complex. For these reasons evidence supports a
multicomponent approach. Multiple studies (Batsis et al., 2016; Cheatham et al., 2018;
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Kozica et al., 2015; Kroes et al., 2016; Kushner & Ryan,2014; Ma et al., 2019;
Rodriguez-Cristobal et al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et al.,
2016; Welbourn et al., 2018) and the Guidelines (2013) for Managing Overweight and
Obesity in Adults from the NIH (Jensen et al., 2014), advocate for a reduced caloric
intake with use of healthy use of a healthful diet (eg. lean protein, fresh fruits and
vegetables, whole grains and low fat) as well as portion control. This diet includes: a
700kcal/day reduction or use of a 1200 to 1500kcal/day plan for adult females and 1500
to 1800kcal/day for males, along with increased physical activity. However, a
standardized program may not work for all patients (eg. diabetes or a personal with
physical limitations). In these cases, individualization is necessary (Batsis et al., 2016;
Harrigan et al., 2016; Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al.,
2019; Rolls et al., 2017; Tapsell et al., 2017; Thabault Burke & Ades, 2016).
Increased physical activity for weight loss is supported by Level I and Level II
evidence. Recommended activity consists of at least 150 minutes per week, on most
days that included aerobic activity (eg. brisk walking) (Batsis et al., 2016; Cheatham et
al., 2018; Kozica et al., 2015; Kroes et al., 2016; Ma et al., 2019; Rodriguez-Cristobal et
al., 2017; Rolls et al., 2017; Tapsell et al., 2017; Thabault et al., 2016; Welbourn et al.,
2018) has been shown to increased caloric expenditure, increase physical functionality
and mobility and aid in weight reduction. Again, this will need to be modified to the
individual as patients have circumstances that may be prohibitive to exercise such as:
physical limitations, climate, comorbidities, responsibilities, and personal desire.
Motivation and enjoyment are a key to increased exercise (Batsis et al., 2016; Beeken
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et al., 2017; Eaton et al., 2016; Harrigan et al., 2016; Kroes et al., 2016; Samabal et al.,
2017; Tapsell et al., 2017; Thabault Burke & Ades, 2016).
Weight loss behavioral and motivational counseling is considered to be the gold
standard in weight loss (Harrigan et al., 2016) and is supported by Level I and Level II
evidence. Counseling can be presented in various forms such as motivational
counseling, behavioral counseling or psychotherapy. It can be implemented using
various methods (eg. face-to-face, texting, or telephone) and through different media
(eg. verbal, video or print materials). The best results come from frequent and continued
behavioral and motivational counseling encounters, however the goal is to help the
patient to be autonomous and self-monitoring (Hageman et al., 2017; Harrigan et al.,
2016; Hartman et al., 2014; Kozica et al., 2015; Ma et al., 2019; Pollak et al., 2016;
Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Tapsell et al., 2017; Thabault
Burke & Ades, 2016). Peer groups, online discussion boards and weekly meetings have
also been supported by high level evidence to be effective interventions when used
alone or as part of a multicomponent weight loss program (Hageman et al., 2017)
There are many potential barriers to weight loss. Despite these barriers,
motivation can be achieved via a multitude of interventions. High levels of evidence
support the use of validated tools to assess readiness to lose weight (eg. the
Acceptance and Action Questionnaire for Weight/AAQ-W). Readiness has a direct
correlation to successful weight loss (Tapsell et al., 2017; Thalbault et al., 2016;
Welbourn et al., 2018). Therefore, a patient must be emotionally ready regardless of
physical need. Additionally, weight loss success is greater in patients who have a sense
of autonomy and self-efficacy, as well as those who set goals for themselves and who
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hold themselves accountable for those goals (Hageman et al., 2017; Harrigan et al.,
2016; Hartman et al., 2014; Kushner & Ryan, 2014; Kozica et al., 2015; Ma et al., 2019;
Rodriguez-Cristobal et al., 2017; Samdal et al., 2017; Tapsell et al., 2017).
Autonomy, self-efficacy and weight loss may have improved through self-guided
weight loss plans (eg. Ten Top Tips/10TT, online diet plans) (Beeken et al., 2017;
Hageman et al., 2017; Tang et al., 2016) as well as goal setting and self-monitoring
through the use of diet and activity log, goals using a diary, or tracking device (eg.
Fitbit®, Smartphone application, pedometer, or online tracker) (Cheatham et al., 2018;
Ma et al., 2019; Rolls et al., 2017; Tang et al., 2016).
There is high level support for the use of tracking technology such as: FitBit® or
AppleWatch® or smart phone applications such as MyFitnessPal®, along with weight
loss, behavioral and motivational counseling, have been shown to increase physical
activity and weight loss within the young and middle aged population (Beeken et al.,
2017; Cheatham et al., 2018; Tang et al., 2016). Several studies offered group or peer
led activities in an on-line format to increased autonomy, stimulate self-monitoring and
provide access to those in remote or limited access communities in an effort to promote
weight loss (Beeken et al., 2017; Cheatham et al., 2018; Hageman et al., 2017;
Hartman et al., 2014; Kozica et al., 2015; Tang et al., 2016). In order to self-monitor and
achieve set goals, various methods have been supported in the literature such as the
use of a food and exercise journal (Hartman et al., 2014) or tracking technology such
as: MyFitnessPal® (Tang et al., 2016) that can be used to track caloric intake, activity
and search menu items and nutrition information. It also sends the user reminders to log
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in. These have been shown to be effective mechanisms and enhance both short-term
and long-term weight loss success.
In addition to treating comorbidities that can affect weight (eg. depression) (Ma et
al., 2019) high level evidence supports the use of pharmacotherapies to enhance weight
loss when accompanied by diet, exercise and lifestyle modifications (Kroes et al., 2016;
Wellbourn et al., 2018). There are many drug classes that assist with weight loss,
among them are: gastrointestinal lipase inhibitors (eg. Orlistat/ Xenical), serotonin 2C
receptor agonists (eg. Locaserin/ Belviq), phentermine-topiramate combinations (eg.
Bontril), and noradrenergic/ dopaminergic antidepressants (eg. Buproprion). Off label
use of serotonic agents (eg. Fluoxetine) have not been approved by the FDA for weight
loss, but have been used to treat depression, panic disorder, obsessive compulsive
disorder and bulimic eating disorder (Sheehan, Chen, Yanovski & Calis, 2014; Tek,
2016)
Best Practice Model Recommendation
The clinical site for this EBP project was in an underserved community free clinic.
All the patient population had limited financial resources, and had difficulty with keeping
follow-up appointments, thus limiting possible weight loss interventions. This was taken
into consideration when designing this EBP project.
Obesity is a multifactorial chronic disease and no one intervention will work for
each individual with consistency (Cheatham et al., 2018; Eaton et al., 2016; Kushner &
Ryan, 2014; Ma et al., 2019; McLaughlin et al., 2017; Sambal et al., 2017; Tapsell et al.,
2017). The literature review identified an individualized multicomponent intervention as
the best practice in the treatment of obesity in adults. This multicomponent intervention
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should include identifying patients who are obese by measuring weight and BMI at each
visit. For those with a BMI > 30, a waist circumference measurement and waist to hip
ratio should be obtained as well as an obesity history and health assessment for risks
associated with obesity (Batsis et al., 2016; Beeken et al., 2017; Cheatham et al., 2018;
Eaton et al., 2016; Harrigan et al., 2016; Tapsell et al., 2017). Prior to starting any
intervention, and after determining the need for weight reduction, a weight loss
readiness assessment should be completed as there is a direct correlation with
readiness and weight loss success (Rolls et al., 2017). Because obesity is often
associated with comorbidities, screening for hypertension, diabetes, hyperlipidemia,
depression and or anxiety should also be completed when possible (Kroes et al., 2016;
Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls et al., 2017; Tapsell et al., 2017).
Anthropometric assessment of height, weight, BMI, was completed at baseline and at
each visit. Waist circumference and waist to hip ratio should be completed at baseline
and week 12. Validated and simple assessment tools, specifically the PHQ-9, as well as
the GAD-7 should be incorporated to complete depression and anxiety screening at
baseline and at three months. Laboratory studies should be completed at baseline and
if necessary, at three months provided the patient is able to complete the studies.
Obese patients had a personalized intervention that includes weight loss with a
healthy diet with caloric reduction to 1200 to 1500 kcal per day for women and 1500 to
1800 kcal per day for men, or a caloric reduction of 500 kcal to 700 kcal per day, or use
of an evidence based diet. It also involves increased activity, ideally at least 150
minutes per week spanning over at least four days per week. Additionally, lifestyle and
weight loss behavioral counseling should be implemented for a period of at least six
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months. For this project the first three months of the weight loss counseling would take
place during the intervention phase after which clinic staff would provide the remaining
follow-up. This behavioral counseling may include motivational counseling, autonomy
and self-efficacy building, and goal setting. Additionally, possible individualized use of
internet resources such as the National Heart Lung and Blood institute (NIH) Aim for
Healthy Weight page and www.choosemyplate.gov may be recommended. Printed
educational tools obtained from validated web sites such as: NIH, American Diabetes
Association (ADA) or the American Heart Association (AHA) may be provided (Batsis et
al., 2016; Harrigan et al., 2016; Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma
et al., 2019; Rolls et al., 2017; Tapsell et al., 2017). Medication adjustment utilizing
pharmacotherapies that do not have side effects of weight gain and or use of antiobesity medications may be helpful for some patients (Kroes et al., 2016; Ma et al.,
2019). For a select group of adults with BMI > 40 or > 35 with obesity-related
comorbidities, bariatric surgery may be beneficial and a referral would be provided in
the primary care setting if the patient does not respond to multicomponent interventions
(Batsis et al., 2016; Harrigan et al., 2016;; Kroes et al., 2016; Tapsell et al., 2017) .
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
Evidence showed that tailored multicomponent interventions were an effective
way to promote weight loss in adults with obesity. Many facilities, including the clinic
used for this EBP Project do not use a standard protocol to promote weight loss.
Instead, patients may receive basic education regarding the benefit of caloric reduction
and increased activity to promote weight loss but lack individualized attention to the
patient’s resources and personal needs. At this site, obesity management is a challenge
despite both staff and patients placing weight loss as a high priority for the population
being served.
This project included the EBP project manager’s collaboration with: a family
practice physician, nurse practitioners (NP), registered nurses (RN), medical assistants
(MA), dietician, as well as the office manager, all of whom appreciated the significance
of the practice change for the treatment of obesity within this clinical setting. A great
many barriers exist when treating obesity including: the stigma associated with obesity,
propensity of providers to ignore this chronic disease and provider personal bias, lack of
use of affordable and effective treatment options, lack of understanding and knowledge
related to obesity and treatment, inappropriate prescribing of medications including
those that contribute to weight gain or underuse of anti-obesity pharmacotherapies, all
of which contribute to the aversion to provision of best practice recommendations in the
management of obesity.
The aim of this project was to help patients and providers to overcome barriers
that prevent weight loss in adults with obesity through the implementation of theory-
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driven and Evidence-Based best practices. The purpose of this project was to improve
selected obesity indicators, including weight, body mass index (BMI), waist
circumference, and waist-to-hip ratio, through the implementation of an Evidence-Based
multicomponent intervention tailored to individual patient strengths, barriers, and
resources. In addition, a secondary aim was to determine if the weight loss intervention
resulted in improvement in health outcomes related to obesity, including BP, HbA1c,
lipids, as well as depression and anxiety symptoms. The intervention components
varied by patient, but in general, options included diet and exercise education, tracking
of caloric intake and exercise, lifestyle and behavioral counseling, pharmacotherapies,
and referrals when appropriate.
Participants and Setting
This EBP project was conducted in a free family practice clinic in Northeast
Indiana that provides primary care to the underserved population across the lifespan.
This was the only site utilized for this practice implementation. This site was staffed by
two Masters-prepared NPs and a Medical Doctor who also functions as the Medical
Director, volunteers who function in various clinical and non-clinical capacities, and a
small group of non-clinical and administrative staff. The Medical Doctor had been a
physician since 2007 and is Board Certified in Family Medicine. He is an accomplished
Family Medicine physician and an Associate Professor at Indiana University School of
Medicine. The EBP project manager had never been a member of staff within this
facility, thus eliminating the chance of recruiting her own patients into the project sample
and, therefore, potential selection bias. Permission for the project’s implementation was
provided on August 29, 2019 by the Medical Director who approved the project, agreed
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with the benefit of the project to the clinic and patient population, identified the project
as feasible at this primary location, as well as promoted interest for the project among
the clinic’s staff.
Eligible participants were recruited during their appointments at the clinic and
through in-house advertisement of the program from September 20 to December 10,
2019. Patients who expressed interest were initially interviewed by the project manager
to evaluate eligibility. The project manager, the Medical Director and the NPs reviewed
the patient charts to determine eligibility based on diagnosis and health risks. Patients
who were at least 18 years of age with a BMI of at least 30kg/m2; could understand,
speak, read and write in English or communicate through a translator; and were able to
commit to the three-month study timeline were eligible. Patients were excluded from the
project if they were pregnant or lactating, had cognitive impairment, were not ready to
lose weight, or were already in an organized weight loss program. Though patients were
asked to commit to the entire three-month length of the project, they were free to drop
out at any time. Patients who reasonably could have been harmed by the weight loss
interventions were excluded from the study.
Weight loss in the adult population is challenging due to a wide variety of
personal factors, including environmental influences and demands, biological and
behavioral factors, sociocultural factors, socioeconomics, prior history with weight loss
programs, and self-efficacy (Bomberg et al., 2017; Ceccarini et al., 2015; Hageman et
al., 2017; Kozica et al., 2015; Pender, 2011; Samdal et al., 2017; Thabault et al., 2016).
Research shows that obesity is often the result of lifelong dietary and inactivity habits
that are heavily ingrained within the obese individual and changing these habits can be
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exquisitely difficult. Thus, it was believed that the merit of this project was to empower
patients with obesity to use individualized weight loss interventions that would be most
appropriate given their unique personal factors.
Outcomes
Multiple anthropometric, clinical, and laboratory outcomes were measured at
baseline and monitored over time, in accordance with the literature. The primary
outcome measures were weight and body mass index. Additional weight-related
outcomes included waist circumference and waist-to-hip ratio. All of these additional
measures are important predictors of morbidity and mortality and associated diseases
of the cardiovascular system, metabolic disorders, diabetes, musculoskeletal
dysfunction and various cancers (Batsis et al., 2016; Eaton et al., 2016; Hageman et al.,
2017; Harrigan et al., 2016; Ma et al., 2019; Tang et al., 2016; Tran et al., 2018).
Anthropometric measures of weight and BMI were collected at baseline and at follow-up
visits (each week for 4 weeks, then monthly for 2 months). Waist circumference and
waist-to-hip ratio were collected at baseline but not at week 12. Anthropometric
measurements were collected using standardized procedures and equipment at the
practice site are included in Appendix J.
Secondary outcomes included depression, anxiety, blood pressure, glycosylated
hemoglobin (HbA1c), and a fasting lipid panel (total cholesterol, low-density lipoprotein,
high-density lipoprotein, and triglycerides). Each of these secondary outcomes is
considered either a predictive factor or consequence of obesity, or both (Beeken et al.,
2017; Grossman et al., 2017; Kushner & Ryan, 2014; Rodriguez-Cristobal et al., 2017;
Tapsell et al., 2017; Thabault et al., 2016).

108

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
Obesity is often associated with chronic mental illnesses including depression
and anxiety. Both of these conditions can contribute to obesity (Kushner & Ryan, 2014;
Ma et al., 2019; Tapsell et al., 2017; Thabault et al., 2016) as well as predict the failure
of obesity treatment (Kushner & Ryan, 2014; Ma et al., 2019; Tapsell et al., 2017;
Thabault et al., 2016). Both depression and anxiety were measured at baseline and
depression was measured at 3 months afterwards using the Patient Health
Questionnaire -9 (PHQ-9) and Generalized Anxiety Disorder-7 Questionnaire (GAD-7).
These questionnaires are included in Appendices G and H respectively.
Blood pressure, chronic hyperglycemia, and dyslipidemia are strong predictors of
cardiovascular disease, and they are often present along with obesity in adults (ADA,
2019b; AHA, 2018; Curry et al., 2018; NIH, 2019). Because blood pressure is generally
measured at each clinic visit as part of standard care, it was measured according to the
same schedule as the anthropometric measures. Laboratory data (HbA1c and lipid
panel) were obtained at baseline in patients that qualified for the test and were
financially able to cover the cost if any. However, no participants completed follow up
studies 3 months afterwards. Laboratory results are included in Appendix K.
Intervention
Because singular interventions are generally ineffective at managing obesity, the
“intervention” for this EBP project consisted of a set of activities that were tailored to
each participant’s strengths, resources, and challenges. The tailored multicomponent
weight loss program featured the following categories, organized along the mnemonic,
“NEWER ME”: Nutrition, Exercise, Weight loss support, Emotional support, Referrals,
Medications, and Expanded accountability. This section will describe the intervention
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options within each of these categories and how patients will be matched to weight loss
options based on their strengths, resources, and challenges.
Choosing the “Right” Components
All patients were asked to complete a HPM questionnaire (Pender, 2011) about
their individual strengths, resources, and challenges when they were enrolled into the
project. In addition, the patient was screened upon enrollment for weight loss readiness,
depression, and anxiety to determine the appropriateness and scope of certain program
components (e.g. emotional support). Those participants who were deemed unready for
the intervention based upon their answers were to be excluded at that time. No
participant was excluded. In addition, participants who screened positive for either
depression or anxiety at the enrollment visit were referred to a Behavioral Health
Specialist. The project leader worked with the participant to select specific weight loss
strategies based on the patient’s responses to the questionnaire and screening tools,
thus promoting autonomy, self-efficacy and accountability. Based upon how well the
participant was doing at each subsequent visit, modifications to the plan were made,
including addition and or subtraction of interventions.
Nutrition
Since a calorie deficit is paramount for all weight loss programs, all participants
were instructed to follow a calorie-restricted diet. Depending on their weight loss goals
and the participant’s personal preference, the patient was prescribed one of three types
of diets. The three types of diets for participants without comorbidities based upon
National Guidelines (2013) for Managing Overweight and Obesity in Adults (Jensen et
al., 2014; Kushner & Ryan, 2014) include eating diets that contain low unsaturated fats,
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vegetables and fruits, lean proteins, whole grains and low-fat dairy, as well as
increasing water and fiber intake. Caloric restriction components include one of the
three following plans:
•

Caloric intake of 1200-1500kcal/day for women or 1500-1800kcal/day for men

•

500kcal/day or 750kcal/day caloric deficit

•

Use of an evidence–based diets that restricts certain foods such as high fat,
high carbohydrate, low fiber foods to create caloric deficit such 0as
www.choosemyplate.gov or Weight Watchers ® (Madigan, 2014)

In addition, participants with specific dietary needs (e.g. iron, calcium, stable
vitamin K) or restrictions (e.g. sugar, sodium, saturated fat) according to their medical
history were prescribed these along with their calorie restriction. Based upon the
participants personal learning style, nutritional education was provided to all patients in
visual, verbal and written form as well as through use of hands on examples such as
product nutrition labels, plates, a deck of cards, measuring cups and spoons for
participants who are kinesthetic learners. (Appendix M). Participants were asked to
track their caloric intake in their food and exercise log, either via paper journal
(Appendix R) or a technology-based application of their choice.
Exercise
The primary way in which calories are expended to produce a calorie deficit is
through physical exercise. While there is a wide variety of exercise modalities available,
the four main types this intervention will focus on are aerobic, resistance, stretching,
and water based. Based on national guidelines for obesity management, all patients
were prescribed a minimum exercise plan of moderate intensity exercise for 150
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minutes per week, exercising on at least four days per week (Kushner & Ryan, 2014).
Though walking was the most recommended and chosen form of exercise, participants
could choose what type of exercise they wanted to use. This could be through a formal
gym membership and use of equipment and facilities, swimming, bicycling, walking or
aerobic activity as desired and tolerated. Education about physical exercise was
provided to all patients in both verbal and written form or demonstrated through a
professional trainer or instructor at a gym of their preference, such as an aerobics
instructor at a class at their personal gym or YMCA (Appendix N). Participants were
asked to track their activity in their food and exercise log.
Weight Loss Support
Participants could choose to utilize commercial weight loss programs such as
Weight Watchers ® and or the use of community exercise facilities if they felt they
needed the extra weight loss support. Per participant preference they may have chosen
to utilize their personal gym or YMCA or work out with family or friends. The participants
had a choice of how they elected to increase physical activity to meet the guidelines as
tolerated and physically capable.
Emotional Support
Each participant was screened for the presence of depression and anxiety at
baseline and for depression at the three-month mark using the Patient Health
Questionnaire-9 (PHQ-9) as well as the Generalized Anxiety Disorder-7 (GAD-7)
respectively. These screening tools were available at the clinical site in multiple
languages. The PHQ-9 questions the frequency of depressed mood during the past two
weeks. (Appendix E). Participants who screened positive using the PHQ-9, indicated by
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a global cut-off score of 10 or more, received a referral to a behavioral health provider to
determine if they should be treated for depressive disorder (American Psychology
Association, 2019; Wang et al., 2015; Williams & Nieuwsma, 2019). The GAD-7
required the participant to answer seven specific questions related to anxiety-related
symptoms using a Likert-type scale (Appendix F). Global scores at or above 5 would
receive a referral to a behavioral health provider to determine if they should be treated
for generalized anxiety disorder (Ahmad et al., 2017; Plummer et al., 2016).
Emotional support included: motivational counseling; teaching the participant to
adopt positive rather than negative self-talk or placing blame; recognizing the misuse of
the terminal words always and never when describing behaviors; developing problem
solving strategies to manage food intake and situations; learning assertiveness and that
they were allowed to say no; identifying stressors and food triggers and the techniques
to reduce stressors and emotional eating; or asking for help and enlisting the assistance
of family and friends in weight loss efforts. Additional emotional supportive measures
included meditation and practicing mindfulness (Perreault, 2019b; Rodriguez-Cristobal
et al., 2017; Samdal et al., 2017; Szczekala et al., 2018; Thalbault et al., 2016;
Welbourn et al., 2018).
Referrals
Referrals to a bariatric surgeon should be provided for participants with a BMI of
or greater than 40kg/m2 or BMI of or greater than 35kg/m2 with comorbidities, who are
highly motivated to lose weight and have not responded to non-surgical medically
supervised interventions (Kroes et al., 2016; Jensen et al., 2014; Kushner & Ryan,
2014; Welbourn et al., 2018). This includes behavioral treatment with or without
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pharmacotherapies and lost enough weight or maintained weight loss to meet target
goals for health risk reduction. These participants should have been referred to a board
certified and qualified bariatric surgeon. Unfortunately, in the current clinical setting, with
this patient population, bariatric surgery was not a possibility as the participants did not
have health insurance or financial resources to cover the costs. During the time frame of
this EBP Project there were no pro bono bariatric surgery options. Therefore, patients
who expressed an interest in receiving bariatric surgery for weight loss were provided
with information about local physicians who could offer this service, but this referral
would not be made unless patients requested information.
Referrals were also provided as needed for: mental health counseling and or
psychotherapies; physical therapist and or orthopedic referral for participants with
musculoskeletal dysfunction; dietitian for specific dietary needs not met by this program;
and specialist providers for management of comorbidities such as cardiologist,
endocrinologist or pain management (Kushner & Ryan, 2014; Ma et al., 2019; Tapsell et
al., 2017; Welbourn et al., 2018) as these providers were available at or accessible
through the clinic.
Medications
Medication interventions included: a review of each participant’s current
medications and discussion of potential drugs that could cause weight gain as well as
possible alternatives to their use; starting or switching to antidepressant with the least
potential for weight gain; starting weight loss medications; and medication education.
Specific drugs that are known to cause weight gain include some of the following:
tricyclic anti-depressants (TCA), monoamine oxidase inhibitors (MAOI’s), selective
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serotonin reuptake inhibitors (SSRI’s), insulin, sulfonylureas, beta blockers,
contraceptives, and steroid hormones. Alternative choices include: bupropion
(norepinephrine-dopamine reuptake inhibitor, NDRI), protriptyline (TCA), fluoxetine
(SSRI), or sertraline (SSRI), metformin (bioguanide), liraglutide (GLP-1 receptor
agonist), orlistat (lipase inhibitor), angiotensin-converting-enzyme inhibitor (ACE-I),
calcium channel blockers (CCB), barrier methods of contraception, and nonsteroidal
anti-inflammatory agents. Changes in medication regimens were made in collaboration
with the provider, as appropriate, and within the limitations of this free clinic’s formulary.
Use of pharmacotherapies for weight loss for participants with a BMI of 30kg/m 2 or
higher, or a BMI of 27 kg/m2 or higher with comorbidities is indicated (Jensen et al.,
2014; Kushner & Ryan, 2014). Recommended pharmacotherapies include orlistat,
lorcaserin or phentermine/topiramate XR. Lorcaserin is newer and has shown positive
results as it affects appetite due to its high affinity for the 5-hydroxytryptamine 2C
receptor, a subtype of 5-HT receptor that binds the endogenous serotonin (Jensen et
al., 2014; Kushner & Ryan, 2014). However, due to site limitations, phentermine and
topiramate are the drugs usually prescribed and are provided at no charge to the
patients when pharmacotherapies are indicated. Other options may have been
prescribed if the patient chose but would have needed to be obtained from an outside
pharmacy and would not be free of charge. During this project no participant chose to
use any weight loss specific pharmacotherapies.
Expanded Accountability
Participants tracked caloric intake and physical activity through either a paper
journal or electronic technology/app (eg. FitBit®, MyFitnessPal®, SmartWatch®)
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immediately after each meal and activity for weekly and monthly review with the
program manager. Participants were asked to keep a daily journal and track mood and
challenges, use of weight loss interventions and progression of goals and were offered
simple journaling tools to use if they chose (Appendix R) or they purchased a journal or
created their own document. Behavioral and lifestyle education and counseling was
provided and reinforced at each appointment to enhance autonomy and accountability.
To expand autonomy and accountability, diet and exercise journals were
reviewed for use and content, usually completed via verbal self-reporting. Along with
reinforcement of weight loss education, observation of caloric intake and food
substance was discussed with the participant. Encouragement and motivational
counseling were provided, and modifications were addressed at each appointment as
needed. Daily journals were reviewed with each participant via verbal interaction and
self-reporting, looking for behavioral concerns and use of interventions and potential
need for modifications. Additionally, review of realistic goals and progression toward
successful attainment through lifestyle and behavioral modification was discussed with
the participant at each visit to provide for further autonomy and self-efficacy.
Comparison
The comparison data for this project were obtained through a retrospective
review of electronic medical records (EMR) prior to project implementation on
September 20, 2019. The review consisted of a sample (n=25) of patients from the
Matthew 25 Health and Dental Clinic who met the eligibility criteria for this project and
who were seen in that clinic approximately 3 to 5 months apart. The goal of this
retrospective review was to determine if standard care at the clinic resulted in
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statistically significant weight loss over the period with this type of patient population.
The standard care weight loss intervention at that time consisted of advice to lose
weight with a healthy diet, to increase physical activity to at least 150 minutes per week
with exercise on most days of the week.
Characteristics of this comparison sample (n =25) are provided in Table 4.2. As
described in Chapter 2, this standard care intervention did not result in statistically
significant weight loss. In fact, the mean baseline BMI was the same as the mean BMI 3
to 5 months after their baseline visit (38.60 kg/m2 [SD 7.17] vs. 38.58 kg/m2 [SD 7.31])
respectively.
Planning
A great deal of time and commitment was dedicated to the planning phase of this
EBP Project in order to safeguard quality, provide evidentiary support for content, as
well as increase the likelihood of a successful outcome. This project was originally
planned and slated to begin at a federally qualified health clinic in Northwest Indiana.
However, after a change in clinic leadership, the project was relocated to the current
site. This change in clinical location and client population resulted in significant
alterations in the timeline, stakeholder support, and design of the project, and delayed
commencement of the project by approximately 2 months.
After discussion with key stakeholders at the current project site, as well as
reflecting on prior clinical experience as a staff nurse, the need for practice change
became apparent. Upon the completion of a comprehensive and exhaustive literature
search for the best and current evidence practice recommendations were determined
and were incorporated within this EBP Project. The project manager planned the project
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with close collaboration from key stakeholders including patients, physician, NPs, RNs,
MAs, volunteers, and the office manager. The intended project was reviewed and
discussed. Based on stakeholder input, the EBP Project was revised to meet the needs
and resources at the clinical site. Support for the project and permission for
implementation was granted by the Medical Director on August 29, 2019. Project
planning and modification continued with the contributions from the project manager,
project faculty advisor, key stakeholders, and through additional research as well as
feasibility of EBP interventions within this specific clinical setting.
Data
For this project, a combination of anthropometric, clinical, and laboratory data
was to be collected using standardized procedures used by providers at the practice
site.
Anthropometric Data. The anthropometric measures in this study were height,
weight, BMI, waist circumference, and waist-to-hip ratio. Height in inches and
centimeters and weight in pounds and kilograms were both measured using the digital
scale that is normally used at the clinical site (Health-O-Meter Model 600KL). The scale
was zeroed before each patient use according to the manufacturer’s instructions. The
BMI was automatically calculated in the clinic’s EMR system when height and weight
data were entered. Weight and BMI were measured at each visit. Waist and hip
circumferences were measured in centimeters using a standard tape measure. The
waist circumference was measured at the level of the right iliac crest, and hip
circumference was measured at the level of the right greater trochanter. Waist
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circumference and waist-to-hip measures were completed at baseline but due to clinical
resources and protocol, it was not completed at the week 12 visit.
Clinical Data. The clinical measures used in this study were blood pressure,
weight loss readiness, depression symptoms, and anxiety symptoms. Blood pressure
will be measured in mmHg using the portable digital blood pressure device in the clinic
(Welch Allyn Model 901058). This device had an accuracy +5 mmHg. Blood pressure
was measured at each visit to screen for hypertension and to determine change with
weight loss.
Weight loss readiness was measured using two tools. The Acceptance and
Action Questionnaire for Weight-Related Difficulties (AAQ-W) (Appendix G) and the
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) Tool (Appendix H). The
AAQ-W, used with permission (Appendix T), measures pragmatic avoidance and
psychological rigidity that play a part in health problems including weight control. This
tool targets weight control interventions (e.g. acceptance of tough or unpleasant
emotions) (Lillis & Hayes, 2008). The AAQ-W tool correlates with the common levels of
avoidance and rigidity as measured by the AAQ (r-0.58, p<0.001), obesity-related
quality of life using ORWELL (r=0.64, p,0.001), psychological distress using GHQ
(r=0.40, p<0.01) and BMI (r=0.39, p<0.001). There was also a correlation with selfreported binge eating (r=0.36, p<0.01) and exercise sessions per week (r= -0.30,
p<0.01) as well as making healthy food choices while dining out (r= -0.40, p<0.01)
(Palmeria, Cunha, Gouveia, Carvalho & Lillis, 2016). This tool was administered via
written format and is considered an effective and validated tool to measure weight loss
readiness.
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Additionally, weight loss readiness was measured with the WEL-SF tool. The
WEL-SF measures eating self-efficacy or one’s belief in their ability to perform in a
given situation. Low self-efficacy is correlated to lower weight loss success and high
self-efficacy is correlated to greater weight loss success. Self-efficacy for eating is a
predictor of acquired weight loss behaviors. This tool asks the participant to reflect on
how confident they feel in relation to situations in which overeating may become a
problem. In its original form the Weight Efficacy Lifestyle Questionnaire (WEL) is a
routinely utilized measure of eating self-efficacy that comprises 20-efficacy and five
circumstance related elements. The short-form WEL (WEL-SF) is a much shorter form
of the tool that still addresses key aspects. There is a significant correlation between
total scoring of the WEL-SF and WEL: Pearson's r value of 0.968 and parallel r2 value of
0.937. The WEL-SF is a valid measure of eating self-efficacy with 94% of the variability
of the WEL (Ames, Heckman, Grothe & Clark, 2012). This tool was administered via
written format and is considered an effective and validated tool to measure weight loss
readiness. These tools were administered to patients only upon enrollment in the
project.
Because weight, depression and anxiety have a correlation (Kushner et al., 2014;
Ma et al., 2019) screening of depression and anxiety was also to be completed. The
Patient Health Questionnaire-9 (PHQ-9) (Appendix E) questions the frequency of
depressed mood during the past two weeks. Participants who screened positive using
the PHQ-9, indicated by a cut-off score of 10 or more, received further evaluation and
referral to a behavioral health provider to determine if they should be treated for
depressive disorder. PHQ-9 scores greater than 10 provides the most ideal balance
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between sensitivity at between 0.871 to 0.88 and specificity at between 0.835 to 0.88
and a Cronbach’s alpha of test-retest reliability of 0.809 and 0.882, respectively
(American Psychology Association, 2019; Kroenke, Spitzer, & Williams, 2004; Wang et
al., 2015). For this project, the administration of the PHQ-9 was twofold. It was
administered via written format at baseline and at 12 weeks to screen for depression
and to determine change in depression symptoms when accompanied by weight loss.
The PHQ-9 is recognized as an effective validated tool useful when diagnosing and
planning treatment for depression and providing continuity of care.
The Generalized Anxiety Disorder (GAD-7) (Appendix F) tool was used to screen
for anxiety disorders, again the purpose of which was twofold. It was to be administered
via written format at baseline and at week 12 to screen for anxiety and to determine
change in anxiety symptoms when accompanied by weight loss. This tool involves
DSM-5 criteria and requires the participant to answer seven specific questions related to
anxiety-related symptoms using a Likert-type scale. A score at or below four indicates
no or minimal anxiety; between five and nine indicates mild anxiety; between ten and
fourteen indicates moderate anxiety; and fifteen or greater indicates severe anxiety. The
GAD-7 has a Cronbach's alpha of 0.92 (Ahmad et al., 2017). Plummer and colleagues
determined as a cut-off a score of eight to detect GAD during a systematic review and
meta-analysis in a population of n=5223, and at this score, the GAD-7 had a pooled
sensitivity of 0.83 (95% CI 0.71-0.91) and specificity of 0.83 (95% CI 0.71-0.91).
Additionally, they found that scores between 7 and 10 had similar results. However, a
cutoff score of 10 was identified as the optimal point for sensitivity 0.89 and specificity
0.82. At that score the GAD-7 had a test–retest reliability of p = 0.85 (Rutter & Brown,
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2017). For this project, the GAD-7 was administered at baseline but after reevaluation of
clinical resources and protocol, it was not completed at the week 12 visit. The GAD-7 is
recognized as an effective validated tool useful when diagnosing and planning
treatment and continuity of care.
Laboratory Data. Laboratory outcomes in this project included the hemoglobin
A1c and a fasting lipid panel, consisting of the HDL, LDL, and total cholesterol. Blood
samples were collected and analyzed using normal clinic procedures (at an off-site
laboratory), and results were recorded from the electronic medical record.
At a cut-off value of 6.5%, hemoglobin A1c has a sensitivity of 0.852 and a
specificity of 0.823 to detect clinically significant diabetes mellitus (Yap et al., 2017) – a
potentially disastrous consequence of chronic obesity. Hemoglobin A1c will be
measured upon enrollment and at the 3-month follow-up visit if clinically appropriate.
Hypercholesterolemia is associated with cardiovascular diseases such as
atherosclerosis and coronary heart disease. Adipose tissue is an active endocrine and
metabolic site, linked to the development of these chronic diseases. Much of the
metabolism of cholesterol takes place within adipose tissue. Hypercholesterolemia has
been proven toxic to smooth muscle cells, hepatocytes, and cardiomyocytes, and to
induce cholesterol excess causing adipocytes hypertrophy thus leading to
cardiovascular diseases (Aguilar & Fernandez, 2014). Hypercholesterolemia,
specifically LDL cholesterol is associated with a 20% higher risk of cardiovascular
disease and total cholesterol is associated with a 10 to 20% higher risk of premature
cardiovascular morbidity and mortality (Upadhyay, 2015). For lipid panels, with a total
cholesterol end point of 210, the sensitivity is 0.70 and specificity is 0.925 for detection
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of LDL cholesterol greater than or equal to 130 and a sensitivity of 0.967 and specificity
of 0.856 for detection of non-HDL cholesterol greater than or equal to 160. At a total end
point of 230, the sensitivity is 0.749 and the specificity is 0.920 for identifying LDL
cholesterol greater than or equal to 160 and a sensitivity of 0.986 and specificity of
0.898 for non-HDL cholesterol greater than or equal to190 (Aguilar & Fernandez, 2014;
Kim et al., 2019; Nantsupawat et al., 2018). Obese population have a higher hazard
ratio than non-obese population with BMI below 30kg/m2, specifically an all-cause
mortality of 1.94 (95%CI:1.11-3.42) and those with CVD have a hazard ratio of 1.84
(95%CI:1.15-2.93) compared to non-obese population. An adjusted hazard ratio for
death due to CVD at a 95% CI for obese patients with hypercholesterolemia is 1.04
(0.77-1.41; p=0.780). The adjusted hazard risk for death/overall mortality at a 95%CI for
obese patients with hypercholesterolemia is 0.86 (0.60-1.22; p=0.388) (Ponce-Garcia et
al., 2015).
Time
The baseline visit occurred when the participant came to the clinic for a primary
care visit during the enrollment period (September 20 through December 10, 2019).
Participants were to return to the clinic every seven days for the next 3 weeks to check
weight and BMI, as well as to reinforce their weight loss plan. After their third weekly
follow-up visit, they were to return to the clinic once per month to collect data and
reinforce their weight loss plan. On their final visit (3 months after enrollment), a final set
of anthropometric, clinical, and laboratory data were to be collected, and participation in
the project was finished. Participants were encouraged to continue their weight loss
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plan or make modifications at the recommendation of their primary care team. The EBP
Project timeline can be found in Appendix I.
Collection. Data collection took place during in person face-to-face encounters
with the project manager and clinical providers and staff from September 20, 2019
through March 3, 2020. This recruitment process was continuous through December 10,
2019, with starting and completion dates varying among participants, but ending at the
12-week mark after initial visit for each participant. It began at the initial baseline patient
appointment when the patient was provided with the description of the EBP Project and
interventions. Once the participant agreed to participate in the project, they were given
the initial weight loss packet containing the PHQ-9, GAD-7, AAQ-W, and WEL-SF
assessment tools. Based on these results, the patient was given individualized weight
loss instructions using the NEWER-ME framework. Along with the PHQ-9, GAD-7,
AAQ-W, WEL-SF, the participant’s anthropometric and blood pressure measurements
were completed and recorded, using the safeguards that were in place to protect health
information. When indicated, secondary outcome measures data: HbA1C and lipids
(total cholesterol, HDL, LDL and triglycerides), were also recorded with the identical
safeguards.
All data was collected under HIPPA and CITI guidelines. To maintain anonymity
participants were provided with a four-digit numeric code upon enrollment in the project
that was their identifier for data collection. This code consisted of two letters and two
numbers: AA01, AA02, AA03 and so on for those participants evaluated on the first day,
and AB01, AB02, AB03 and so on for those participants evaluated on the second day of
the first week of the project. Those participants who enter during the second week of the
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project will be given a code BA01, BA02, BA03 and so on as above. A list of participants
and their corresponding codes was kept in a password protected Microsoft Excel®
spreadsheet as well as a paper copy kept in a locked filing cabinet. The code was
recorded on all assessment tools in the upper margin including demographics,
anthropometric measurements, AAQ-W, WEL-SF, PHQ-9, GAD-7 and spreadsheets.
The code served as the method to identify each participant and compare
comprehensive data. Data collected using paper-and-pencil forms encoded with the
participant’s four-digit numeric code, was then entered into a password-protected Excel
spreadsheet within 8 hours of collection. All paper forms were retained in a locked filing
cabinet in the EBP Project Manager’s locked office. Upon completion of the project, all
paper forms were shredded and only the electronic data were retained.
Management and analysis. In order to perform statistical analysis and
comparisons of data, the project manager had access to the specified folder kept in the
locked cabinet. Participant data and codes remained safely stored when not in use by
the project manager. No identifying information was disclosed, and participants were
only referenced by code during communication regarding the EBP Project. Upon project
completion, all participant information including code list and all paper forms were
shredded and only the electronic data were retained.
The retrospective (comparison) and the prospective (intervention) samples were
described using appropriate measures of central tendency and dispersion. Continuous
descriptive variables (age, weight, height, waist and hip circumference, waist-to-hip
ratio, BMI, SBP, DBP, HbA1c, total cholesterol, LDL, HDL, triglycerides, PHQ-9, GAD-7)
were summarized using means and standard deviations. Categorical descriptive
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variables (ethnicity, sex, age) were summarized using frequencies and proportions
(Figures 4.2, 4.3, 4.4). All data analyses were completed using the Statistical Package
for Social Sciences (SPSS) Version 25. The reference for SPSS was Cronk (2017). The
code book used in this project is included in Appendix S. Descriptive analysis included
means and standard deviations for continuous variables. Due to sample size,
continuous dichotomous outcome variables were analyzed using Wilcoxon signed rank
tests and assigned a level of significance equal to .05. Whether continuous or
categorical, descriptive variables that were significantly different between the
retrospective and prospective samples were identified as potential confounders.
To determine if the NEWER-ME tailored weight loss intervention resulted in
statistically significant weight loss in the prospective sample, the means for the
continuous anthropometric measures (weight and BMI) along with blood pressure were
compared from baseline to the final study visit using Wilcoxon signed rank tests.
Differences with a p-value less than .05 were considered statistically significant.
However, no week 12 comparison data were available for waist circumference, waist-tohip ratio, laboratory measures (hemoglobin A1c, lipid levels) or GAD-7 global scores.
The number of patients with clinically significant weight loss (i.e. greater than 3%
of their baseline BMI) was compared between the retrospective sample (comparison
group) and the prospective sample (intervention group) using Wilcoxon signed rank
tests. A difference with a p-value less than .05 was considered statistically significant.
Protection of Human Subjects
The protection of human subjects was sustained throughout this EBP Project.
The project manager was educated regarding all ethical aspects via graduate ethics
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coursework as well as through the completion of the NIH Protection of Human Research
Participants course in April 2018 and all precautions to protect participants and preserve
their anonymity were taken. The course certificate can be found in the appendices
(Appendix A). The project manager applied for and ultimately gained approval and
exempt status for this EBP Project from the Valparaiso University Institutional Review
Board (IRB) on September 12, 2019.
Confidentiality was maintained through use of a private space when meeting with
participants. Prior to beginning any interventions, all potential participants were provided
with the description of the EBP Project and interventions and a list of patient rights. No
patient was coerced, pressured or threatened to participate. All potential participants
were informed that their involvement was voluntary, and that they could withdraw from
the project at any time without retribution or penalty. They were advised that the project
would not result in additional cost beyond what they would normally pay for primary care
at the clinic. They were informed that this was a DNP EBP project and standard of care
and were told about the need for data collection and safeguards in place to maintain
privacy. All potential participant questions were answered to their satisfaction. Only
pertinent demographic and clinical data were collected. All collected data remained in
secure location and patient confidentiality would be maintained via safeguards,
participant four-digit coding, passwords and locks. Upon completion of the project, all
paper forms and participant codes were shredded and only the electronic data were
retained. Because this project did not fall under the purview of “Human Subjects
Research,” the requirement for informed consent was waived.
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Chapter 4
FINDINGS
The purpose of this project was to implement an Evidence-Based protocol
incorporating a multicomponent intervention tailored to individual patient strengths,
barriers, and resources. The primary purpose of this EBP project was to improve
selected obesity indicators, including anthropometric measures of weight, BMI, and the
achievement of 3% weight loss from baseline. The secondary purpose was to determine
if the weight loss intervention resulted in improvement in BP as well as depression
symptoms measured with the PHQ-9. Analyses consisted of participant demographics
and primary and secondary outcomes.
Findings. Findings indicated that participants had statistically significant weight
loss in pounds from baseline to week 4. This weight loss was not sustained at week 8
but was significant among those who finished the program beyond week 8. Changes in
BMI were statistically significant from baseline to weeks 4 and 12, but not from baseline
to week 8. Neither SBP nor DBP were significantly improved from baseline for weeks 4,
8 or 12. Depression as measured by PHQ-9 scores decreased from baseline to week
12, and results were statistically significant.
Participants
Size. In total 26 participants started the program with staggering start dates and
were followed for twelve weeks. There was moderate attrition (38.5%) with 16
participants completing at least one follow-up visit during the 12-week project period
(see Figure 4.1). Participants cited one or more reasons for program discontinuation,
including: outside commitments or disinterest (n=12), weather (n=2), transportation
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difficulties (n=2), illness or exacerbation of disease (n=1), pregnancy (n=1), obtained
insurance (n=1), and eleven participants cited ‘other’ as the reason or were unable to be
contacted.
Figure 4.1. Attrition percentages of project group
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Characteristics. The prospective sample is described in Table 4.1 and Figures
4.2, 4.3, 4.4 and 4.5. Most participants identified as white and Hispanic/Latino (77%),
female (81%), and able to speak some English (77%). All clinic patients were at or
below 200% of poverty level, and none had health insurance. The mean age of the
sample was approximately 40 years.
Table 4.1. Demographic variables for prospective group
Variable

Frequency

Number of Participants

26

Age, mean (SD)

39.73 (11.09)
18 – 57

Age, min-max

129

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
Sex
Female, n (%)

21 (80.8)

Male, n (%)

5 (19.2)

White, n (%)

26 (100)

Race

Ethnicity
Hispanic / Latino, n (%)

20 (77)

Non-Hispanic / Latino, n (%)

6 (23)

Able to Speak English
Yes, n (%)

20 (77)

No, n (%)

6 (23)

Income
Below poverty level, n (%)

26 (100)

Above poverty level, n (%)

0 (0)

Insurance Coverage
No third-party payer, n (%)

26 (100)

Any third-party payer, n (%)

0 (0)
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Figure 4.2. Race and ethnicity: prospective group
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Figure 4.3. Gender
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Figure 4.4. Age

Participant Age

6%0%
26%

18-27 years
28-37 years
38-47 years
48-57 years

11%

57%
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Figure 4.5. Primary Language

Language

23%
English speaking
Spanish only
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Changes in outcomes
Statistical testing. For most of the variables in this project, participants served
as their own controls. Due to the small number of matched observations (n = 26),
differences in continuous outcome variables between baseline and follow-up visits (i.e.
2 to 4 weeks after baseline and 5 to 12 weeks after baseline) were tested for statistical
significance using the nonparametric equivalent of the paired t-test – the Wilcoxon
signed-rank test.
To analyze whether the intervention resulted in achievement of at least 3% body
weight loss, compared to no intervention, the target weight loss for each participant was
calculated by multiplying their weight in pounds at baseline by a factor of 0.03. If the
difference between their final follow-up weight and their baseline weight was equal to or
larger than their 3% goal, they were identified as having “Met” their 3% goal. If this
difference was less than their 3% goal, they were identified as having “Not Met” their
goal.
The comparison group for this analysis consisted of a retrospective convenience
sample of patients who were seen at the project site prior to beginning this project.
Participants were included in this retrospective sample if they were seen at the clinic
within the last year, had at least 2 documented weights within 5 months apart, and
otherwise met the project’s eligibility criteria. Race and ethnicity data were not available
for comparison. Characteristics of this comparison group are provided in Table 4.2.
Briefly, participants in the comparison group tended to be older than those in the project
group, but there was a similar tendency for participants in the comparison group to be
female, have no insurance, and live in poverty.
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Table 4.2. Retrospective comparison group demographic characteristics
Variable

Frequency

Number of Participants

25

Age in years, mean (SD)

46.96 (13.81)
19 – 71

Age, min-max
Sex
Female, n (%)

18 (72)

Male, n (%)

7 (28)

Income
Below poverty level, n (%)

25 (100)

Above poverty level, n (%)

0 (0)

Insurance Coverage
No third-party payer, n (%)

25 (100)

Any third-party payer, n (%)

0 (0)

The difference between achievement of at least 3% weight loss between
baseline and the latest follow-up visit for the prospective group was tested for statistical
significance using the chi-square test of independence. For all inferential analyses,
differences were considered statistically significant if their p-value was below .05. All
analyses were completed using the Statistical Package for Social Sciences (SPSS)
Version 25.
Weight. The mean weight in pounds at baseline was compared to the mean
weight at Week 4 (i.e. from any follow-up visit between weeks 2 and week 4), Week 8
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(i.e. from any follow-up visit between weeks 5 and 8), and at Week 12 (i.e. from any
follow-up visit between weeks 9 and 12). A decrease in mean weight was seen between
week 1 and week 4 (228.96 lbs [SD 47.16] vs 214.87 lbs [SD 44.68], respectively),
which was statistically significant (p = .026). However, weight loss from baseline to
Week 8 (228.96 [SD 47.16] vs 221.73 [SD 37.01], respectively; p = .686) and from
baseline to Week 12 (228.96 [SD 47.16] vs 221.57 [SD 52.20], respectively; p = .088)
was not statistically significant (Table 4.3) (Figure 4.8).
Body mass index. The mean BMI at baseline was compared to the mean BMI at
Week 4, (i.e. from any follow-up visit between weeks 2 and week 4) and at Week 12
(i.e. from any follow-up visit between weeks 9 and 12). A statistically significant
decrease in mean BMI was seen from baseline to week 4 (39.87 kg/m2 [SD 6.19] vs
38.27 kg/m2 [SD 6.57], respectively; p = .028) and from baseline to week 12 (39.88
kg/m2 [SD 6.19] vs 38.64 kg/m2 [SD 6.93], respectively; p = .023), but not from baseline
to week 8 (i.e. from any follow-up visit between weeks 5 and 8), (39.87kg/m2 [SD 6.19]
vs 40.58 kg/m2 [SD 6.45], respectively; p = .180) (Table 4.3).
Met 3% weight loss goal. In the prospective group, ten participants out of 26 lost
weight however, only 27% of all participants met the goal of a 3% total body weight loss
at twelve weeks (Table 4.3) (Figure 4.7). In comparison with the retrospective group
who had only four participants out of twenty-five, or 16%, reach the 3% total weight loss
goal (p=.034) (Figure 4.6).
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Figure 4.6. Retrospective group who met 3% total weight loss goal

Retrospective Data:
Met 3% Total Weight Loss Goal

16%

Met 3% Goal n=4
Did not meet 3% Goal n=21

84%

Figure 4.7. Prospective group who met 3% total weight loss goal

Prospective Group Met 3% Total
Weight Loss Goal

27%

Met 3% Total Weight Loss Goal n=7
Did Not Meet 3% Total Weight Loss
Goal n=19

73%

Waist circumference and waist-to-hip ratio. These variables were not measured
at follow-up due to staff and clinical time limitations. Therefore, a comparison of neither
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waist circumference nor waist-to-hip ratio between baseline and follow-up could be
calculated. Baseline means were 117.26 cm (SD 12.72) and 0.96 (SD 0.10) respectively
(Table 4.3).
Blood pressure. The mean SBP at baseline (127.96 mmHg) was compared to the
mean SBP at weeks 4 (123.75 mmHg, SD 15.03), 8 (134.6 mmHg), and 12 (132.33
mmHg, SD 19.79). There were no statistically significant differences in mean SBP
between baseline and any follow-up time frame, although there was a tendency for SBP
to be higher at the week 12 follow-up visits compared to baseline (Table 4.3) (Figure
4.9). (Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data
includes last recorded measure weeks 9, 10, 11, 12)
The mean DBP at baseline (77.96 mmHg) was similarly compared to mean DBP
at weeks 4 (70.08 mmHg, SD 8.03), 8 (74.8 mmHg), and 12 (78.50 mmHg, SD 8.03).
The DBP at week 4 was not significantly lower than baseline (p = .814), nor at weeks 8
(p = .273) or 12 (p = .754) (Table 4.3) (Figure 4.9). (Week 4 data includes last recorded
measure weeks 2, 3 or 4 and week 12 data includes last recorded measure weeks 9,
10, 11, 12)
Depression. The mean PHQ-9 score at baseline (10.25) was compared to the
mean PHQ-9 score at week 12 only (5.87). There was a statistically significant reduction
in depression severity during this time frame (p = 0.14) (Table 4.3) (Figure 4.9).
Anxiety. The GAD-7 was not measured at the week 12 follow-up visit because of
staffing and clinical time constraints and current clinical practice policy. Therefore, a
statistical comparison of anxiety between baseline and follow-up could not be
calculated. Mean score at baseline was 8.375 (SD 5.41).
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Lab Data. Mean glycosylated hemoglobin, total cholesterol, LDL, HDL, and
triglycerides were only measured at baseline (Table 4.3). Therefore, no statistical
comparisons between baseline and follow-up could be calculated for any of these
biomarkers. HbA1c and lipid tests data were only available at baseline. Mean HbA1c
was 6.28 (SD 1.04), lipid test means included total cholesterol 180.14 (SD 47.15), LDL
88.83 (SD 31.37), HDL 51.57 (SD 13.35) and triglycerides 207.57 (SD 111.99).
Secondary outcome data included blood pressure, HbA1c and lipid tests,
depression and anxiety screening. No data was available for HbA1c or lipid tests for
week 12. PHQ-9 scores ranged from 0 to 16, with a mean score of 6.3 (SD 5.8) (Figure
4.9). One GAD-7 score was recorded for week 12, the score was 1 for this participant
who scored a 3 at baseline.
Table 4.3. Statistical analyses of outcome variables
Outcome

Baseline

Weight in pounds, mean (SD)

Follow-Up

228.96

Wk 4 =

(47.16)

214.87

Significance
p = .026

(44.68)
Wk 8 =

p = .753

221.73
(37.01)
Wk 12 =
221.57
(52.20)
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BMI kg/m2, mean (SD)

39.87 (6.19) Wk 4 =

p = .028

38.27 (6.57)
Wk 12 =

p =.023

38.64 (6.93)
Met 3% weight loss goal, n (%)

0 (0)

Wk 12 = 7

p =.001

(27)
Waist circumference, mean (SD)

Waist-to-hip ratio, mean (SD)

117.26 cm

Wk 12= 103

(12.72)

cm

0.96 (0.10)

Wk 12=
0.88

SBP, mean (SD)

127.96

Wk 4 =

(15.81)

123.75

p = .814

(15.03)
Wk 8 =

p = .686

134.6
(16.41)
Wk 12 =

p =.754

132.33
(19.79)
DBP, mean (SD)

77.96

Wk 4 =

(12.30)

70.08 (8.03)
Wk 8 = 74.8
(11.69)
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Wk 12 =

p =.798

78.50 (9.18)
Depression, mean (SD)

9.38 (5.66)

Wk 12=

p = .014

5.87 (5.82)
Anxiety, mean (SD)

8.0 (5.47)

Hemoglobin A1c, mean (SD)

6.28 (1.03)

Total cholesterol, mean (SD)

180.14
(47.15)

LDL, mean (SD)

88.83
(31.36)

HDL, mean (SD)

51.57
(13.35)

Triglycerides, mean (SD)

207.57
(111.99)

Note: Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data
includes last recorded measure weeks 9, 10, 11, 12. Standard deviation are in
parenthesis. A p-value less than or equal to .05 is statistically significant.
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Figure 4.8. Primary outcomes mean (SD) weeks 1, 4 and 12

PRIMARY OUTCOMES MEANS (SD)
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228.96
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(Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data
includes last recorded measure weeks 9, 10, 11, 12)
Figure 4.9. Secondary outcome data mean (SD)

SECONDARY OUTCOME DATA MEAN (SD)
Week 12
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46.15
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(Week 4 data includes last recorded measure weeks 2, 3 or 4 and week 12 data
includes last recorded measure weeks 9, 10, 11, 12)
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Chapter 5
DISCUSSION
This EBP project attempted to answer the PICOT question, “Will the use of a
tailored multicomponent intervention, compared to standard clinical care, improve
indicators of obesity in a primary care adult population over a period of 3 months?”
Indicators of obesity include BMI, waist circumference and waist to-hip ratio. Secondary
indicators related to obesity include BP, HbA1c, total cholesterol, HDL, LDL,
triglycerides, depression, and anxiety.
This project examined the impact of a tailored multicomponent intervention that
combines the following care activities into the “NEWER ME” protocol: Nutrition
counseling; Exercise counseling; Weight loss support and motivation; Emotional support
and use of screening of depression and anxiety, behavioral health referrals and
medication; Referrals for added support and care; Medications; and Expanded
accountability and goal setting, for use within the primary care setting of a free clinic.
The goal was to reduce weight by a 3% total weight loss, reduce BMI, reduce blood
pressure, reduce depression and anxiety and reduce biometric markers. This chapter
will describe and interpret project findings; address strengths and limitations of the
project; evaluate the theoretical framework and EBP model used to guide the project;
and explore implications for future practice, research and education.
Explanation of Findings
Project findings indicate that an individualized multicomponent approach was
effective for reduction of weight, BMI and depression symptoms. These results are
consistent with the literature. Contrary to the literature, however, SBP and DBP did not

142

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
significantly improve after the intervention. No results were obtained at week 12 for
waist to hip ratio, anxiety screening, HbA1c or lipids, so the impact of the intervention on
these variables is uncertain.
Participant Findings
The size of this project sample was considerably smaller (n = 26) than that used
in most empirical studies about weight loss, although it was felt by clinic providers that
this was a representative cross-section of the clinic’s adult population. The small sample
size was a limitation caused by various factors and will be discussed further later in this
chapter. The sample was predominately white and Hispanic or Latino (77%), female
(81%), and between 38 and 47 years old (57%). This distribution was expected as these
groups tend to be the most common consumers of free or low-cost primary care
services (Arvisais-Anhalt et al., 2018; Hunt, Adamson, Hewitt & Nazareth, 2011), and
this was consistent with the demographic composition of patients at the project site. All
participants were at or below 200% of the lower federal poverty limit, and no participants
had health insurance. This rate of uninsured patients was not consistent with the
literature study that provided rates between 43% to 94%; however, the study included
clinics that accepted health insurance (Arvisais-Anhalt et al., 2018) and the clinic for this
project did not accept patients with insurance. Most participants could read, write, and
speak in English (77%) (Figure 4.5). This was not consistent with the literature that
reported English as the primary language for 94% (Arvisais-Anhalt et al., 2018).
Weight loss and BMI. Most participants who continued with project lost a
significant amount of weight initially (Appendix L) and continued to trend down at week
12. Others had fluctuations with weight loss and weight gain, re-gaining much of what
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they had lost within 3 months. This finding is consistent with other weight-loss literature
as adults tend to have cyclical periods of weight gain and loss (Cheatham et al. 2018;
Hageman et al., 2017; Kroes et al., 2016; Rolls et al., 2017; Samdal et al., 2017). It is
unknown if those participants who initially lost weight and continued to trend down
maintained their weight loss past the twelve weeks.
Twelve participants completed at least one follow up visit between weeks 2 and
4. The mean weight decreased from baseline to week 4 (i.e.: the last follow up visit
week 2, 3 or 4) (228.96 lbs. [47.16] vs 214.87 lbs. [44.67]) respectively, which was
statistically significant (p = .026). However, the mean decrease in weight was less from
baseline to Week 8, (i.e. the last follow up visit week 5-8) as weight fluctuated among
participants with some gaining weight. Mean weight decreased (228.96 [47.16] vs
221.73 [37.01], respectively; p = .753). From baseline to week 12 (i.e. the last follow up
visit weeks 9-12) the mean weight mean decreased (228.96 lbs. [47.16] vs 221.57 lbs.
[52.20], respectively; p = .088); however, the week 12 decrease was not statistically
significant (Table 4.3) (Figure 4.8). This may have been caused by attrition which may
have influenced the sample mean. The varied sample size and the specific participants
measured changed from week to week, thus changing the week’s baseline mean and
subsequently creating a potential sample or measurement bias.
At baseline the mean participant (n=26) BMI was 39.87 kg/m2 (6.19). At the week
12 follow up the group (n=16) mean BMI mean was 38.64 kg/m2 (6.93, p = .046) (Table
4.3). The comparison of BMI at week 12 to baseline was statistically significant.
Regardless of statistical significance, most participants who experienced weight loss
closely met the pound per week guidelines from the AHA (2018) and Guidelines 2013
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for Managing Overweight and Obesity in Adults (Jensen et al., 2014) with a group mean
loss of 11.77 (13.95) lbs. over the three months. Additionally, a total body weight
reduction of 5% to 10% reduction over one year (Perreault, 2019c) is considered to
lower health risk (Batsis et al., 2016; Eaton et al., 2016; Hageman et al., 2017; Jensen
et al., 2014; Kroes, Osei-Assibey and Baker-Searle, 2016; Jensen et al., 2014; Kushner
& Ryan, 2014; Perreault, 2019c).
Given the length of the program of twelve weeks, a 3% total body weight loss
was considered significant. Nine of the participants (n=16) that completed the week 12
visit lost weight, and seven met the 3% total body weight reduction goal to reduce
health risk. This may have been caused by attrition which may have influenced the
sample mean; The varied sample size and specific participants measured changed from
baseline to week 12, thus changing the mean and subsequently creating a potential
sample or measurement bias. It is unknown if all original participants had completed the
full program whether the results would have changed.
Waist-to-hip (W-to-H) ratio. At baseline, consenting participants (n=17)
completed waist and hip measurements. W:H of greater than 0.95 in males and 0.85 in
females was indicative of increased risk for cardiovascular disease and diabetes
(Marshall, 2019). At baseline the mean W:H was 0.97 (SD = 0.10). Only one participant
provided both baseline and week 12 data; and their W:H ratio did not change
significantly (0.87 to 0.88, respectively). The lack of W:H measurements may have
occurred due to a lack of clinical resources, time, staff understanding of the project
protocol, language barrier or it may have been due to participant preference.
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HbA1c. Participants (n=11) had a mean baseline HbA1c of 6.28% (SD = 1.04).
No week 12 data were available for comparison analysis. This may have been due to
the same reasons that there were no follow-up data for W:H ratio, or that the patients or
clinicians did not feel that this blood test was clinically necessary. It may have also been
due to a language barrier, misunderstanding about the relationship between obesity and
diabetes mellitus, or a fear of having blood drawn. However, literature suggests that
HbA1c should improve with weight reduction (Beeken et al., 2017; Delahanty, 2020;
Rolls et al., 2017; Tapsell et al., 2017). Specifically, HbA1c reductions of 0.02 % to
0.11% could be expected depending upon the amount of weight lost as well as
adherence to the dietary regimen (Bauman et al., 2019).
Lipids. Participants (n=7) had a mean total cholesterol, LDL, HDL and triglyceride
count of 180.14 mg/dL (SD = 47.15), 88.83 mg/dL (SD = 31.37), 51.57 mg/dL (SD =
13.37) and 207.57 mg/dL(SD = 111.99) respectively. No week 12 data were available
for comparison analysis. This was likely due to the same factors that led to missing
HbA1c data at week 12. The literature suggests that lipid values should improve with
weight reduction (Hageman et al., 2017; Rodriguez-Cristobal et al., 2017; Rolls et al.,
2017; Tapsell et al., 2017). Following a diet of healthy fresh vegetables and fruits, lean
proteins and legumes, whole grains and unsaturated fats can result in a total cholesterol
reduction (-7.4 mg/dL) and a reduction of LDL (-3.3mg/dL) and increase HDL and
improve triglycerides (Tangney & Rosenson, 2019).
Depression. Depression is often linked to obesity in a cyclical nature (Kroes et
al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls et al., 2017; Samdal et
al., 2017; Tapsell et al., 2017). This relationship was demonstrated in this sample
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between baseline and follow up results as global PHQ-9 scores improved (p=.014),
often coinciding with weight loss. The direct cause of improved scores is unknown and
may or may not be related to weight loss; however, when asked about improved scores,
one participant stated “I just feel better since I lose the weight”. This improvement may
have been impacted by improved nutrition and activity levels, environmental factors,
lifestyle, or use of medication. Nine participants in the project sample were referred to
their primary care provider due to PHQ-9 global scores of ten or greater as
recommended in the literature (Kroes et al., 2016; Tapsell et al., 2017; Wellbourn et al.,
2018). It is unknown how many of these participants received a prescription for an
antidepressant or was compliant with antidepressant use, or how this may have affected
weight loss outcomes.
Anxiety. Literature suggests that anxiety often accompanies depression and
weight gain (Kroes et al., 2016; Rodriguez-Cristobal et al., 2017; Ma et al., 2019; Rolls
et al., 2017; Tapsell et al., 2017; Welbourn et al., 2018). Although 17 participants
completed the GAD-7 at baseline, only one completed it at Week 12. The participant
who completed both anxiety assessments had improved anxiety symptoms from
baseline to Week 12, though it is not possible to estimate the relationship between
anxiety and weight loss in the overall sample. After further investigation it was found
that anxiety screening was not routinely performed at this clinic. Unlike depression
screening, it was only completed if the patient expressed having symptoms. Despite the
obesity program protocol having been in place, this may have been a systematic error
that may have been caused by a change in or limited staffing resources, lack of
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knowledge or understanding of the protocol, staff may have forgotten as it was not part
of the usual routine, language barrier or simply that the patient may have declined.
Blood pressure. Blood pressure was measured at each visit however sample
sizes varied, and though participants obtained their medications from the clinic,
participants’ anti-hypertensive medication compliance is unknown. Overall, mean SBP
and DBP did not change significantly from baseline to any follow-up time. This is
inconsistent with most of the literature, which suggests that BP should improve with
weight loss (Hageman et al., 2017; Rodriguez-Cristobal et al., 2017; Rolls et al., 2017;
Tapsell et al., 2017; Thabault et al., 2016). It was expected that there would be a blood
pressure decrease of 1 mm/Hg for every pound lost (Basile & Bloch, 2019).
Blood pressure may have remained unchanged in this sample for a variety of
reasons, including attrition of patients with better adherence to the NEWER-ME
intervention (leaving only those with poor adherence in the final sample), participant
experiences and or feelings just prior to or at the time of measurement, undertreatment
of hypertension in those who remained in the project, or poor adherence with
antihypertensive regimens and or sodium restrictions. Clinical technique used when
measuring blood pressure may have created systematic error or measurement bias.
Systems were put in place to measure BP with the same Welch Allyn portable digital
blood pressure device in the clinic using appropriate cuff sizes, however because
different clinicians completed the measures, it is not possible to know if all followed
procedures and used correct technique.
Strengths and Limitations of the DNP Project
Strengths
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This EBP project had several strengths. First, there was a clear need for and
interest in the project from the provider, staff, and administrative team. This translated
into sustained enthusiasm about the project, an eagerness to engage patients in the
intervention, and ability to initiate this new and ambitious weight loss protocol in the
clinic.
Second, patients felt emotionally and financially supported in their weight loss
journey. A significant portion of the time during each clinic visit was spent on promoting
autonomous decision-making and self-efficacy about their weight loss, which were new
territory for many of these project participants, all of whom were impoverished and
disenfranchised. Participants were not paid, but were provided free health care,
pharmaceuticals, laboratory studies, social services and community resources to aid
them in their weight loss journey. Providing this kind of support was crucial to their
sustained involvement in the project.
Third, participants were provided Evidence-Based educational guidelines about
weight loss. This education was delivered using individual nutrition and behavioral
counseling, a voiced Microsoft Power Point ® and written education, as well as a list of
free EBP on-line resources (Appendices, M, N,O, and P). Participants in this sample
had limited access to health education content on their own, so the clinic was willing to
provide these educational resources at no cost so that participants could refer to them
after their clinic visit. This strategy gave participants the opportunity to remain engaged
with their tailored weight loss “prescription” between visits to the clinic.

149

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
Fourth, clinic staff received a thorough orientation to the project (Appendix Q)
and to the various weight loss interventions before they were shared with patients. This
ensured that patients would receive consistent messaging from one provider to another
about the tailored interventions they would be prescribed as part of their weight loss
program. The project manager created an outline of the weight loss project via a
narrated Microsoft Power Point ®, (Appendix O) and this resource was then translated
from English to Spanish. This content served as the topical outline for weight loss
discussions with clinic patients. These tools were all available to the clinic providers and
staff to ensure project continuity and continuity of the project. Furthermore, the project
manager was available at the clinic most days of the week to facilitate the intervention
and support the clinic staff.
Finally, this project used the JHNEBP Model (Appendix D) to provide a clear path
and guidance for the management of the project. It allowed the project manager to
anticipate and overcome possible barriers to implementation, which was essential for
the success of this project in this complicated clinical setting.
Limitations
Though this project had many strengths there were also some barriers and
limitations to this EBP project that affected data collection and patient outcomes. Most
importantly, the sample size in this project was very small. While demographic
characteristics of the sample were felt to accurately represent the population served by
the clinic, the distribution of outcomes data from this sample may not have accurately
represented how the overall clinic population might have responded to the intervention.
Therefore, the results from this project, thought promising, may not apply to other
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patients at the clinic. Continuing this project with a larger sample would likely produce
results that could be applied to other patients seen at this clinic.
The clinic setting, which was a free clinic that provided care to patients who were
uninsured, provided a unique set of challenges. Patients were required to be uninsured
in order to receive care at the clinic. Without insurance, patients were unable to access
some of the most effective weight loss interventions – pharmacotherapy and bariatric
surgery – that patients with insurance would have been able to receive. Of the 26
participants in this project, 20 qualified for a referral to bariatric surgery based on their
BMI and comorbidities (Kushner & Ryan, 2014; Jensen et al., 2014). This restriction of
services required patients to fully maximize lifestyle and behavioral interventions, which
is notoriously difficult for people with a fixed or unpredictable income.
This specific EBP Project addressed these issues by providing educational tools
and resources as well as weight loss counseling and follow up visits free of charge.
Participants could also be referred for psychological or behavioral health counseling or
to the dietician when warranted free of charge. They also had access to a limited
number of free weight loss medications such as phentermine and topiramate are the
drugs usually prescribed and were available at the clinic pharmacy; however, no
participant chose to utilized weight loss medications during this project.
A third limitation was the restricted availability of clinical resources. The included
clinic’s sources of revenue, staffing, and clinical resources available. Funding largely
consisted of donations, grants and federal funding, thus limiting capital resources for
staffing. Therefore, much of the work was completed by volunteers, clinical staff as well
as physicians who may or may not have treated the participant previously. This created
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bottlenecks in which project interventions could not be reliably completed from patient to
patient or from visit to visit. This primarily affected the measurement of project outcomes
including the GAD-7, weight loss readiness assessments, anthropometric
measurements, waist and hip measurements, W:H ratio, and routine biometric
measures (HbA1c and lipid panel). Additionally, with the high turnaround in staffing as
well as staffing with volunteers, the clinicians needed to be frequently retrained as
technique varied from person to person (e.g. collecting height and weight data in the
same way with decimal). These challenges may have resulted in systematic errors in
protocol adherence and data collection from one patient or visit to another.
This was mitigated through additional staff education and training, as well as reevaluation of clinical resources by the project manager as to intervention importance in
this clinical setting. This involved prioritizing interventions against available resources
and trimming what was not essential to the success and sustainability of a weight loss
program. Essential measures were found to include accurate weight and BMI,
depression screening and when possible HbA1c and lipid panels, along with follow up
care when possible.
Attrition from baseline to Week 12 was another important limitation that affected
data collection and protocol adherence. Because of the attrition rates it became
necessary to provide all resource materials at the baseline visit rather than over the first
four visits. This amount of information may have become overwhelming, creating
barriers especially with time spent providing behavioral counseling. However, it also
allowed participants who would likely not have completed follow up care to have the
necessary information to achieve successful weight loss on their own.
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Attrition may have skewed weight loss outcomes as the sample sizes varied
limiting consistency in number and specific participants being measured, thus changing
the mean and subsequently creating a potential sample or measurement bias. It is
unknown if all original participants had completed the full twelve weeks whether the
results would have changed. Attrition in this population was slightly higher than in the
traditional primary care setting and underserved primary care clinics as represented in
the literature (Mallow et al., 2014). A variety of factors account for this difference in
attrition between underserved settings including the distance to travel from their
residence to the clinic (which was considerable for some patients in this sample);
employment and financial limitations such as securing time off work, unpaid time from
work, working capital; attainment of insurance resulting in the patient being refused care
at the free clinic; impact of comorbidities on functional status; having an inconsistent
desire to lose weight; and competing obligations such as family obligations, work
schedule, legal concerns-court appointments (Arvisais-Anhalt et al.,2018; Birs et al.,
2016; Mallow et al., 2014).
In effect, a free clinic may not necessarily mean totally “free” care. Because of
the indirect costs of receiving care, which would affect patients in varying ways (e.g. a
patient with good adherence and substantial weight loss who could not find time off
work to follow up at the clinic, compared to a patient with poor adherence and weight
gain who could not come to the clinic due to lack of transportation), the effectiveness of
this intervention could not be fully evaluated without being able to control for these
variables. The only controls available at the clinic were the safety net of the Social
Services department and the free community resources. All clinic patients have access
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to Social Services. Participants who were deemed in need could be referred to social
service for further counseling and would be offered these resources. All participants
were provided with a list of community food pantries as well as a booklet of community
resources in either English or Spanish at their first visit as well as the community
resources information available in the clinic lobby that they could access at any time
during clinic hours Monday through Saturday.
Because the vast majority of patients who receive care at the free clinic are not
citizens of the United States, fear of deportation was another possible limitation that
may have differentially affected follow-up and/or intervention adherence. As a rule,
providers did not ask if patients were citizens, and if the participant disclosed the
information, they were reassured that they would be receiving care and that we could
not divulge any patient information outside of HIPAA guidelines.
Many of these patients were also unable to speak English, and even though an
interpreter was used to facilitate communication, they may not have fully understood
their weight loss prescription or their plan for follow-up. To mitigate this each participant
scheduled their follow up appointment and received an appointment card with their next
follow up visit time and date before they left. Participants were also given a routine
telephone reminder approximately 24 to 72 hours in advance by clinical staff. If
possible, Spanish speaking staff members completed appointment scheduling and calls
when needed.
Because of the limited clinical staff resources, both in terms of number and
qualifications of staff, as well as time constraints, the project had to be altered many
times to make it viable and sustainable. This limited interventions that could be used
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and how they could be used. To alleviate these limitations, the project manager created
an outline of the weight loss project and a narrated Microsoft Power Point ® describing
the weight loss program that provided education and counseling. This resource was
then to be translated from English to Spanish. This was both a limitation and a strength.
It was a limitation because once it was sent to the clinic’s translator it was not returned
to the project manager or available for use with Spanish speaking participants. It was a
strength because the English version, that was available, provided consistency and
could be advanced at the participant’s own pace and translated at the point of care by
their on-site translator. Additionally, various tools (eg.: PHQ-9, GAD-7, educational
materials) needed to be available in Spanish or needed to be translated by the
participant’s interpreter. To overcome these obstacles, both the PHQ-9 and GAD-7
were available in both English and Spanish as well as various other languages at the
clinic. Many of the educational tools used in this project were available or could be
accessed on-line in multiple languages, and all participants had access to the internet
either on their mobile phone or through the library or at home. Participants were
provided a list of web addresses for all referenced materials and resource tools.
Implications for the Future
Practice: The need for weight loss protocols within primary care will continue to
be in demand as obesity has been consistently on the rise since the 1970s (WHO,
2018). This individualized multicomponent weight loss intervention provided steady
weight loss for participants at this free clinic who consistently followed the plan;
however, due to the limitations described in this chapter, it is unclear if implementation
at other primary care clinics will result in a similar outcome. Furthermore, resource
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limitations at free clinics such as the project site may prevent patients from being
referred to weight loss specialists. This is a barrier that patients in other primary care
clinics may not face, which could dramatically affect weight loss outcomes in that
population. Utilizing expanded resources such as pharmaceuticals and referrals, when
available, may increase the participants chance for successful weight loss. The
intervention tested in this project is best suited for clinics with limited resources or as a
foundational step for patients in the primary care setting who are unable to safely
undergo medical or surgical weight loss therapies.
This EBP project can be easily transferred into any primary care setting using the
prescribed methods at a low cost, as many of the resource materials used can be found
on publicly available web sites (e.g. government, professional associations, private
organizations) and either viewed electronically or printed at a low cost (Appendix P).
The PowerPoint ® was created at no cost by the project manager. Along with the
references listed in this project report, an outline for this media can be found in
Appendix O that can be used to format a presentation applicable to specific clinical
settings to promote weight loss and reduce health risks.
Theory: The theory used for this project was The Health Promotion Model
(Pender,1982; Pender, 2011). As discussed in chapter two, in this theory, Pender states
that each person has a unique set of experiences, beliefs, and attitudes that affect their
willingness and ability to change detrimental health behaviors. The initial purpose of the
model was to “assist nurses in understanding the major determinants of health
behaviors, as a basis for behavioral counseling to promote healthy lifestyles” (Pender,
1982, p.2; Pender, 2011, p. 2). This model recognizes that a person’s context – their
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experiences, feelings, emotions, resources, social barriers, etc. – impacts their health
behavior.
Evidence from this project support many assertions of the Health Promotion
Model. Selection of the tailored weight loss interventions was heavily influenced by the
culture, lived experiences, resources, limitations, and individual health status of each
participant. Although this project did not use predictive modeling to test whether or not
the amount of weight loss depended on individual demographic or cultural factors, it
was clear through anecdotal evidence gathered during clinic visits that the patient’s age,
ethnicity, primary language, financial resources, and social support may have played a
significant role in how much weight the patient was able to lose.
The model used to guide the project was the JHNEBP Model. This model was a
perfect fit for this EBP project, providing a clear path through the P-E-T process and
guidance for the management of the project. It allowed the project manager to anticipate
and overcome possible barriers to implementation, which was essential in this
complicated setting. Anticipating project needs was necessary in this environment as it
had very limited resources and the time to complete this project was very brief.
However, re-evaluating the project was also necessary because the clinic was in
constant flux with changing providers, volunteer staff, and an inconsistent patient
caseload. Therefore, it was often necessary to alter the project protocols to meet
changing demands and to ensure that the project would be sustainable into the future.
Research: Further research could be completed using this program; however,
the period of intervention and follow up needs to be longer than the limited time frame
allowed within this EBP project. Evidence suggests a period of at least twelve months is
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a minimal time frame for implementation of interventions and evaluation (Jensen et al.,
2014; Kushner & Ryan, 2014; Kozica et al., 2016). A longer timeline may have
produced a larger sample, larger data sets and more conclusive results. This program
could also be implemented in multiple sites that provide care for the underserved
population, thus further increasing the sample size and the ability to obtain and analyze
data.
Further research is needed to address the genesis of the high attrition rates
(Arvisais-Anhalt et al.,2018; Birs et al., 2016; Mallow et al.,2014) among this population
and what can be done to resolve it. This was a significant barrier in this project and
despite an exhaustive literature search, little of the research found prior to the project
implementation addressed this issue. This information would have been useful for
project design and may have partly eliminated necessary revisions. Many of the
participants of this program did not complete the full twelve weeks but were able to lose
weight on their own after the initial visit using the resources provided. This information
could be translated into future research that could address the use of a dual mechanism
weight loss program, initiated with their provider, who provides the initial guidance and
education resources and then is completed at home, with periodic follow up.
Research is also needed to evaluate the cultural impact of obesity among the
underserved and how culture drives rising obesity rates and health risk. The white and
Hispanic or Latino community tend to have a diet that is higher in carbohydrate, fats and
caloric content. Based upon anecdotal information, this culture tends to enjoy a great
deal of family socialization in which food is largely incorporated and where eating large
portions is accepted. This aspect of their culture may impact rising levels of obesity, and
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health risks among this population (Drieling, Ma & Stafford, 2011). This is opportunity
for research as well as education through further study.
Research is needed into the role that genetics and hormones play in obesity.
Evidence suggests that as much as 21% of overweight and obesity is linked to genetics.
There are many known genetic or hormone causes of overweight and obesity. Among
them is a mutation that causes alterations in the gene known as GWAS or FTO gene
and chromosome 16 that are related to fat mass and obesity. Additionally, the leptin
gene may contribute to overweight and obesity in some people. Leptin signals the brain
whether the amount of fat stored is enough for survival. A leptin-deficiency causes loss
of signaling, leading to hyperplagia, hyperinsulinemia, insulin resistance, decreased
energy, weight gain and infertility. Another known cause is the congenital deficiency of
proprotein convertase subtilisin/kexin type 1 gene (PCSK1) which causes early onset
obesity via a multihormonal disorder (Perreault, 2019a). Further research could be used
to develop treatment and education to reduce bias associated with overweight and
obesity.
Education: Providers need to be taught that weight loss is not a one size fits
everyone method, but rather that each patient is unique and requires individualized
attention and interventions specific to them. Interventions need to fit the person, and
must also address what they have tried in the past, if anything, as well as incorporating
lifestyle and abilities, culture and goals. Providers must address their own perceptions
of the overweight obese patient. Weight stigma and bias are seen throughout society,
even among health care professionals. Many health care providers have strong bias
and stereotype patients with obesity, thus impacting their behavior, judgement and the
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treatment prescribed. The stigma of overweight obesity can reduce the quality of care
received despite provider intentions. People with overweight obesity may have
experienced poor treatment and have come to anticipate this from a provider. This may
cause them stress, fear, mistrust and complete avoidance of treatment and it may lead
to poor compliance (Phelan, et al., 2015). As much as 69% of overweight or obese
female patients reported that their healthcare provider was biased against them due to
their weight (Alberga et al., 2017). Anecdotal information obtained during this project
reiterates these statistics as participants frequently voiced concerns of being afraid of
being judged by the providers. As healthcare professionals, education is a key to
reducing bias and providing EBP. There are so many factors that play a role in being
overweight/obese. A few are obvious such as diet and activity level, but many are not
such as genetics, comorbidities, psychological barriers, individual cognition and real or
perceived barriers, self-efficacy, prior life experiences and experiences with weight loss
attempts, financial or cultural influences, and support systems.
Conclusion
In this EBP project report obesity has been discussed as a multifactorial,
individualized, chronic disease that increases known risk factors for significant
comorbidities and mortality. The primary purpose of this Evidence-Based practice
project was to improve indicators of obesity (weight, BMI) among patients served by a
free medical clinic, using a tailored multicomponent intervention consisting of the
NEWER ME protocol that combines Nutrition and Exercise with Weight loss and
behavioral counseling, motivation, Emotional support, Referrals for added support and
care, Medications, and Expanded accountability and goal setting. The secondary
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purpose was to determine if the weight loss intervention was associated with a
decrease in blood pressure and depression symptoms. The intervention was guided by
the Health Promotion Model by Nola Pender. The Johns Hopkins Nursing Evidence
Based Practice Model (JHNEBP) guided implementation of the project. A
comprehensive literature review was completed in five databases, and strong evidence
supported the tailored multicomponent intervention used in this project. Eligible
participants (n=26) took part in the 3-month program. To maintain consistency, a Power
Point® outline of the weight loss protocol was presented at each baseline visit. Written
education materials were provided in English and Spanish, and an interpreter was used
when appropriate. Weight, BMI, and BP were measured weekly, then at weeks 8 and
12, and depression screening was measured at baseline and at Week 12.
Mean weight significantly decreased from 228.96 lbs. (47.16) at baseline to
214.87 lbs (44.67) at week 4 (i.e. including the last visit during weeks 2, 3 and 4). Mean
BMI also significantly decreased from 39.87kg/m2 at baseline to 38.27 kg/m2 (6.57) at
week 4 (i.e. including the last visit during weeks 2, 3 and 4) and 38.64kg/m 2 (6.93) at
week 12. Significantly more patients in the intervention group achieved at least 3%
weight loss between baseline and Week 12, compared to those who did not receive the
intervention (27% vs 16%, p=.034). Depression improved significantly from baseline to
Week 12 (p = .014). There were no significant differences in SBP or DBP.
Based on these results, a tailored multicomponent weight loss program, that
focuses on individualized and limited interventions such as weight, BMI and BP
measures; nutrition and exercise education; behavioral interventions and counseling,
along with basic laboratory screening of lipids and HbA1c when possible, is an effective
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method for reducing weight, BMI, and depression in this type of primary care setting.
This type of individualized interventions could be translated and modified to fit into any
primary care practice, using the JHNEBP Model (Johns Hopkins Medicine, 2017) as
well as the Health Promotion Model (Pender,1982; Pender, 2011) patients can be
assessed and interventions can be tailored to the patient and implemented to achieve
the best weight loss outcomes. Research can lend to EBP and new information can be
translated into the protocols and interventions. Education can provide knowledge
informing EBP and reduce overweight obesity stigma and bias in health care. As health
care providers we need to educate, support and counsel patients, while allowing them
autonomy that builds self-efficacy and self-esteem. Additionally, we need to promote
self-esteem and autonomy through decreased weight bias and increased provider
education in order to work toward reducing health risk in an overweight and obese
population.
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JHNEBP: Johns Hopkins Nursing Evidence-Based Practice (Model)
LDL: Low density lipids
MA: Meta-analysis
NICE: The National Institute for Health and Care Excellence
NIH: National Heart Lung and Blood institute
NP: Nurse practitioner
PEDro: Physiotherapy Evidence Database
P-E-T: practice, evidence, translation
PhD: Doctor of Philosophy
PHQ-9: Patient health questionnaire
PICOT: Patient population, intervention, comparison, outcomes, time
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
RCT: Randomized controlled trial
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QoL-SF: Quality of Life-Short Form
Quasi-exp: Quasi-experimental
RN: Registered nurse
SBP: Systolic blood pressure
SF-12: Physical and Mental Health 12 Item Short Form Health Survey
SF-36: Short Form (36) Health Survey
SPSS: Statistical Package for Social Sciences
SR: Systematic review
WEL-SF: American Weight Efficacy Lifestyle Questionnaire Short Form
WHO: World Health Organization
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Appendix A
Protection of Human Research Participants Certificate
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Appendix B
Johns Hopkins Nursing Evidence Based Practice Model and Tools Permission
JHNEBP MODEL AND TOOLS- PERMISSION

Thank you for your submission. We are happy to give you permission to use the
JHNEBP model and tools in adherence of our legal terms noted below:
You may not modify the model or the tools without written approval from Johns
Hopkins.
All reference to source forms should include “©The Johns Hopkins Hospital/The Johns
Hopkins University.”
The tools may not be used for commercial purposes without special permission.
If interested in commercial use or discussing changes to the tool, please
email ijhn@jhmi.edu.
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Appendix C
Johns Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal
Tool
Please note that this tool was taken from Dang & Dearholt, (2017, Appendix E, pp. 281290) and appears as in text, content has been unaltered.
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Images: Dang & Dearholt, (2017, Appendix E, pp. 281-290) [Johns Hopkins Nursing
Evidence-Based Practice Research Evidence Appraisal Tool]
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Appendix D
Johns Hopkins Nursing Evidence-Based Practice Model

(Image: The Johns Hopkins Nursing Evidence-Based Practice Model, 2017).
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Appendix E
PHQ-9: English version
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Appendix F
GAD-7
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Appendix G
AAQ-W
AAQ-W: Acceptance and Action Questionnaire- Weight
Below you will find a list of statements. Please rate the truth of each statement as it
applies to you.
Use the following scale to make your choice.
Never True 1 2 3 4 5 6 7 Always True

1234567

1. It’s OK to feel fat

1234567

2. When I have negative feelings, I use food to make myself feel better

1234567

3. I try to suppress thoughts and feelings that I don’t like about my body
or weight by just not thinking them

1234567

4. I am not in control of what I eat

1234567

5. I try hard to avoid feeling bad about my weight or how I look

1234567

6. I am in control of how much physical activity I do

1234567

7. When I evaluate my weight or my appearance negatively, I am able
to recognize that this is just a reaction, not an objective fact.

1234567

8. In order to eat well and do physical activity, I need to feel like it

1234567

9. I need to feel better about how I look in order to live the life I want to

1234567

10. Other people make it hard for me to accept myself
Please continue to page 2.

198

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
Imagine that the following thoughts occurred to you right now.
How valid or believable would each be?

For each question, please circle a number from 1 through 7.
Not at all believable 1 2 3 4 5 6 7 Completely believable

1234567

11. If I’m overweight, I can’t live the life I want to

1234567

12. If I feel unattractive, there is no point in trying to be intimate

1234567

13. If I gain weight, that means I have failed

1234567

14. I’m in control of my eating behavior

1234567

15. I don’t have what it takes to be healthy for life

1234567

16. My eating urges control me

1234567

17. I need to get rid of my eating urges to eat better

1234567

18. I am a stable person

1234567

19. If I eat something bad, the whole day is a waste

1234567

20. I should be ashamed of my body

1234567

21. I need to avoid social situations where people might judge me

1234567

22. I will always be overweight

Lillis & Hayes (2008)
Scoring:
Before a sum score is taken, items 1, 6, 7, 14, and 18 are reversed keyed: Lower
scores indicate
less experiential avoidance and more psychological flexibility. The range of possible
scores is 22 to 154.
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Because it can be confusing to speak of a lower score reflecting “more psychological
flexibility” the
scoring can be changed if the clinician or user is conceptually focused on increasing
acceptance and
response flexibility. In this case, items 1, 6, 7, 14, and 18 would be scored as normally
and all other items would be reverse scored.
(Note-Permission to use AAQ-W in Appendix T)
Appendix H
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF) Tool
Weight Efficacy Lifestyle Questionnaire Short-Form (WEL-SF)
Read each situation below and decide how confident (or certain) you are that you will be able to
resist overeating in each of the different situations. On a scale of 0 (Not confident) to 10 (very
confident), choose ONE number that reflects how confident you feel now about being able to
successfully resist the desire to overeat. Write that number next to each item (in the confidence
number column).
0
1
2
3
4
5
6
7
8
9
10
Not at all
Very confident
confident
I am confident that:
Confidence number
1. I can resist overeating when I am anxious (nervous).
2. I can resist overeating on the weekend.
3. I can resist overeating when I am tired.
4. I can resist overeating when I am watching TV (or using the
computer).
5. I can resist overeating when I am depressed (feeling down).
6. I ca resist overeating when I am in a social situation (or at a party).
7. I can resist overeating when I am angry (or irritable).
8. I can resist overeating when others are pressuring me to eat.
Ames, G. E. et al., Eating self-efficacy. Development of a short-form WEL, Eating Behaviors (2012),
doi: 10.1016/j.eatbeh.2012.03.013
(Ames, Heckman, Grothe & Clark, 2012)
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Appendix I
EBP Project Timeline
Participation in the project involves a baseline data collection visit as part of the
initial clinic visit (T0), weekly follow-up visits for the next 3 weeks (T1 – T3), and monthly
follow-up visits for the next 2 months (T4 and T5). Project data will be measured
according to the following timeline:
Variable

T0

T1

T2

T3

T4

T5

Weight

X

X

X

X

X

X

Body Mass

X

X

X

X

X

X

Index
Waist

X

X

X

X

Circumference
Waist-to-Hip
Ratio
Readiness for

X

Weight Loss
Personal

X

Strengths,
Barriers, and
Resources
Inventory
Blood

X

X

X

Pressure
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X

X
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Depression

X

X

Anxiety

X

X

Lipid Panel

X

X

(Total

(if

(if

Cholesterol,

medically

medically

LDL, HDL,

indicated)

indicated)

Hemoglobin

X

X

A1c

(if

(if

medically

medically

indicated)

indicated)

Triglycerides)
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Appendix J
Anthropometric measures: Baseline

Pt.

Baseline
Weight Lb

Baseline
Weight Kg

Baseline
BMI

Height
inches

Height cm

Waist
circum. CM

Hip circ. CM

Waist: Hip
ratio (W:H)

1

190

86.2

38.4

59

149.86

120.5

123

0.979

2

295

134

52.3

63

160.02

145

153

0.947

3

195

88.4

36.8

61

154.94

109

119.5

0.912

4

259

117.7

38.2

69

175.26

120

122

0.983

5

328

148.8

51.4

67

170.18

136

152.5

0.891

6

230

104.3

42.1

62

157.48

117

125

0.936

7

180.6

81.9

34.1

61

154.94

115

122

0.942

8

207.2

93.9

35.6

64

162.56

115.5

118.5

0.974

9

225.6

102.33

38.7

64

162.56

108

125.5

0.86

10

172.8

78.38

31.6

62

157.48

114

107

1.06

11

186.6

84.64

35.3

61

154.94

12

197.2

89.44

38.5

60

152.4

134

109

1.22

13

197.6

89.62

33.9

64

162.56

102

112.5

0.906

14

212

96.16

35.3

65

166.37

106

122

0.8688

15

269.6

122.28

41

68

172.72

16

227.6

103.23

40.1

63.2

160.52

131.5

124

1.06

17

172

78.017

32.2

61.3

155.7

114

103

1.106

18

180.6

81.9

34.1

61

154.94

100

119.5

0.836

19

324

146.96

52.3

66

167.64

20

293

132.9

47.3

66

167.64

21

261.4

118.56

47.5

62.2

157.988

22

280

127.3

42.6

68

172.72

23

192.3

87.22

34.1

63

160.02

24

220.6

100.06

37.9

64

162.56

25

262

118.9

46.4

63

160.02

26

193.2

87.63

39

59

149.86

106

121.5

0.8724

228.9576923
47.16288518

103.8741154
21.4292008

39.87307692
6.186343521

63.33461538
2.73977259

160.9183846
6.994347021

117.2647059
12.721927

122.3235294
13.19557357

0.961952941
0.100733051
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Appendix K
Prospective Group Laboratory Results Available: Baseline
Participant

Total
cholesterol LDL

HbA1C
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

9.3
6.1
5.7

Triglycerides

86

77
56

406
108

150

70

56

119

133

55

47

154

6.2
5.9

203
245

109
141

44
46

250
290

6

132

72

35

126

5.6
6.2

234
164

HDL

5.6

6

6.5

MEAN: 6.281818
SD: 1.038093

180.1429 88.83333 51.57143 207.5714286
47.15022 31.36505 13.35237 111.9908585

*No Week 12 laboratory results were available.
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Appendix L
Participants Weight (Lbs.) Trends
Participant
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

Baseline
190.0
295.0
195.0
295.0
328.0
230.0
180.6
207.2
225.6
172.8
186.6
197.2
197.6
212.0
269.6
227.6
172.0
180.6
324.0
293.0
261.4
280.0
192.3
220.6
262.0
193.2

Week 2
295.0
193.2

177.6

Week 3

189.0

174.2
228.8
173.2
187.0
182.0

211.6

210.8

Week 4

Week 8

286.00
189.00

188.6

333.00
220.50
177.00
158.00

174.0

172.6

Week 12

229.00
172.40
175.00

182.0
210.4

205.40

172.4

198.00
200.80
276.00
232.00
170.00
165.40

289.0
267.00

263.00
280.40

197.00
219.0
255.0

221.00
259.6

259.60
286.00
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Appendix M
Nutrition Education

Nutrition Plans:
There are 3 Evidence-Based diet plans that have been proven to work:
1. Total caloric reduction of between 500-750 calories per day, while also limiting dining
out and use of fast foods, as well as eliminating or reducing high caloric ‘empty
calorie’ foods such as pop and chips (Kushner & Ryan, 2014).
2. Eating a healthy diet of between 1200-1500 calories for women and 1500-1800
calories for men that includes lean protein, fresh vegetables and fruits, whole grains
and legumes, low fat dairy and unsaturated fats while limiting sugars and ‘empty
calories’ (Kushner & Ryan, 2014).
3. Use of an evidence–based diets that restricts certain foods such as high fat, high
carbohydrate, low fiber foods to create caloric deficit such as
www.choosemyplate.gov or Weight Watchers ® (Kushner & Ryan, 2014; Madigan,
2014).
Healthy Nutrition:
A healthy diet should include:
• Lean protein, fresh vegetables and fruits, whole grains and legumes, low fat
dairy and unsaturated fats while limiting sugars and ‘empty calories’ (Kushner
& Ryan, 2014)
• Recommended daily intake is 3 servings of lean protein per day (3-4
ounces/serving).
• Aim for 5 servings of vegetables/ fruits (DM limit fruit intake) per day
• Use of whole grains and legumes
• Carbohydrate intake should be 45-65% of daily total calories
• Low fat dairy (2-3 servings per day)
• Unsaturated fats- olive oil, avocado
• 6-8, 8-ounce glasses of zero calorie water per day unless on fluid restriction
Limit empty calorie such as sweets, snack foods, processed foods and alcohol
as these add to caloric intake and contain added salt, sugar and fats
(ADA, 2019; AHA, 2019; Delahanty, 2020; Kushner & Ryan, 2014; Mayo Clinic,
2019; NIH, 2019; USDA-ChooseMyPlate.gov, 2019)
Cooking: bake, broil, boil, stream or grill meats and vegetables; eat fresh /raw fruits and
vegetables. Limit frying or cooking with fat (ADA; AHA).
Track your caloric intake: Learning to read food labels is very important. Weigh and measure
foods to maintain caloric intake control. Use a food journal such as MyFitnessPal®,
spreadsheet or a paper journal (Perreault & Apovian, 2019).
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Appendix N
Exercise Education

Exercise and Physical Activity
•

•
•

•
•
•
•
•

The National Guidelines and the American Heart Association recommend
increasing physical activity to at least 150 minutes per week with activity,
including “moderate-intensity aerobic activity”. (AHA, 2018; Kushner & Ryan,
2014). This is about 30 minutes per day, 4-5 days per week.
OR “75 minutes per week of vigorous aerobic activity (or a combination of
both)” (AHA, 2018).
Some aerobic activities may include: fast walking; running; use of exercise
machines like the treadmill, exercise bike, or elliptical machine; swimming;
bicycling; or taking a jazzercise or zumba class or what ever type of safe and
healthy activity you choose that increases heart rate and breathing without
causing health risk. Be realistic and safe!
Aerobic activity should increase your heart rate; “Your heart will beat faster,
and you’ll breathe harder than normal” (AHA, 2018).
STOP immediately if you experience chest, neck, back or shoulder pain or
become light-headed or feel or experience fainting or nausea with increased
activity. Seek emergency medical care or call 911.
Move More, Sit Less: “Get up and move throughout the day. Any activity is
better than none. Even light-intensity activity can offset the serious health risks
of being sedentary” (AHA, 2018).
And check with your healthcare provider before starting any new physical
exercise plan.
Be safe! Try to exercise with a friend. Always carry identification and
emergency contact when exercising especially outside.
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Appendix O
EBP Project Power Point Outline

A Multicomponent Tailored Intervention Program Protocol for Weight Loss in an
Underserved Adult Patient Population: A Power Point Outline
1. Title slide:
a. A Personalized Weight Loss Program for an Over-weight or Obese
Population (Author: Rita R. Arnold MBA, BSM, BSN, RN, DNP Student
Valparaiso University 2020)
2. Part One: The Program Plan
a. NEWER ME
3. According to the WHO (2018)
a. Since 1975 obesity has nearly tripled worldwide
b. As of 2016 approximately 39% of the world’s adult population was overweight and 13% were obese.
c. Approximately 340 million children were either overweight or obese
d. Epidemic levels
4. Health Risk of Over-weight and Obesity:
a. Cardiovascular diseases (AHA, 2019; Jensen et al., 2014; Kushner &
Ryan, 2014)
b. Diabetes Mellitus type II (ADA, 2019; Jensen et al., 2014; Kushner &
Ryan, 2014; Triplett et al., 2014)
c. Fatty liver disease (Harvard Health, 2018; Jensen et al., 2014; Kushner &
Ryan, 2014)
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d. High blood pressure/ hypertension (AHA, 2019; Jensen et al., 2014;
Kushner & Ryan, 2014)
e. Joint and back pain/injury (Jensen et al., 2014; Kushner & Ryan, 2014)
f. Infertility and Polycystic Ovarian Syndrome (ACOG, 2014)
g. Depression and anxiety (Jensen et al., 2014; Kushner & Ryan, 2014; Ma
et al, 2019; Melton & Kirkwood, 2019)
h. Certain cancers (Jensen et al., 2014; Kushner & Ryan, 2014)
i.

As well as many others . . .

5. Understanding Obesity
a. Chronic disease (ACOG,2014; ADA, 2019; AHA, 2019; Cheatham et al.,
2018; Eaton et al., 2016; Jensen et al., 2014; Kushner & Ryan, 2014; Ma
et al., 2019;; Sambal et al., 2017; Tapsell et al., 2017; Thabault Burke &
Ades, 2016).
i. ICD-10 code: E66 (.0-.9)
b. Many factors contribute
c. Cyclical nature where relapses are common: weight loss and regain
(Kushner & Ryan, 2014; Rodriguez-Cristobal, 2017; McLauglin et al.,
2017).
d. Obesity is often associated with:
i. depression (Ma et al, 2019; Melton & Kirkwood, 2019)
ii. anxiety (Ma et al, 2019; Melton & Kirkwood, 2019)
iii. loss of self-esteem (Ma et al, 2019; Melton & Kirkwood, 2019)
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iv. reduced quality of life (Kroes, Osei-Assibey and Baker-Searle,
2016; Tapsell et al., 2017)
v. risk of weight related comorbidities/ health risk (Jensen et al., 2014;
Kushner & Ryan, 2014)
vi. psychosocial isolation (Eaton et al., 2016; Kushner & Ryan, 2014;
Samdal et al., 2017; Tapsell et al., 2017; Thabault et al., 2016).
vii. stigma and bias (Phelan, et al., 2015; Welbourn et al., 2015).
6. There are many factors that contribute to over-weight and obesity. Among them
are:
Genetic or hormonal component (21%) (Doig & Huether, 2014; Perreault,
2019a).
a. Chemical imbalances or disease states
b. Depression anxiety
c. Certain medication side effects
d. Caloric intake and types of foods
e. Activity and aerobic exercise
f. Sedentary lifestyle: work and leisure
g. Fatigue: poor sleep/sleep apnea/ hours of sleep
h. Demands and over scheduling: busy lifestyle and commitments
i.

Over working, absent minded eating/ eating alone

j.

Cultural influences

k. Support systems
7. The good news is there is help: NEWER ME
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a. Weight loss is a multicomponent process that includes:
i. Nutrition: a healthy diet and reduced caloric intake (Jensen et al.,
2014; Kushner & Ryan, 2014; Perreault & Apovian, 2019)
ii. Exercise: increased physical activity: > 150 minutes per week
(AHA, 2019)
iii. Weight loss support (Curry et al., 2018; Jensen et al., 2014;
Kushner & Ryan, 2014; Perreault, 2019b;)
iv. Emotional support: behavior and lifestyle changes (Curry et al.,
2018; Ma et al., 2017; Perreault, 2019b; Samdal et al, 2017)
1. The 5 A’s: Provider use of the 5A’s (ask, assess, advise,
agree, and assist) (Thabault et al., 2016; Vallis et al., 2013)
counseling and intervention technique as well as
motivational interviewing or counseling techniques
(Rodriguez-Cristobal et al., 2017; Samdal et al., 2017,
Thabault et al., 2016; Welbourn et al., 2018)
v. Referrals for added support and care or counseling
vi. Medication: review, change, additions
vii. Expanded accountability: motivation and goals (and)
viii. Autonomy and decision making (and)
ix. Belief in one’s abilities-self-efficacy (Batsis et al., 2016; Beeken et
al., 2017; Curry et al., 2018; Eaton et al., 2016; Grossman et al.,
2017; Hageman et al., 2017; Hartman et al., 2014; Kozica et al.,
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2015; Kroes, Osei-Assibey, Baker-Searle & Huang, 2016; Jensen
et al., 2014; Kushner & Ryan, 2014; Samdal et al., 2017)
8. Weight change is achieved by:
a. Choice!
b. The balance between caloric intake and calories utilized through bodily
functions and physical activity (like a two-sided scale)
c. Each pound of body fat results from 3500 calories taken in that are not
utilized and stored as fat
d. It’s simple math!
i. Calories eaten minus calories burned = weight gain or loss
9. A Healthy Diet and Reduced caloric intake
a. According to the 2013 AHA/ACC/TOS Guideline for the Management of
Overweight and Obesity in Adults: A Report of the American College of
Cardiology/American Heart Association (2019) Task Force on Practice
Guidelines and The Obesity Society (Jensen et al., 2014).
b. There are 3 Evidence-Based diet plans that have been proven to work:
i. Total caloric reduction of between 500-750 calories per day,
while also limiting dining out and use of fast foods, as well as
eliminating or reducing high caloric ‘empty calorie’ foods such as
pop and chips (Jensen, et al., 2014; Kushner & Ryan, 2014)
ii. Eating a healthy diet of between 1200-1500 calories for women
and 1500-1800 calories for men that includes lean protein, fresh
vegetables and fruits, whole grains and legumes, low fat dairy and
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unsaturated fats while limiting sugars and ‘empty calories’ (Jensen,
et al., 2014; Kushner & Ryan, 2014)
iii. Use of an evidence–based diets that restricts certain foods such
as high fat, high carbohydrate, low fiber foods to create caloric
deficit such as www.choosemyplate.gov or Weight Watchers ®
(Jensen, et al., 2014; Kushner & Ryan, 2014; Madigan, 2014;
USDA)
10. Increased Physical Activity
a. Check with your healthcare provider before starting any new physical
exercise plan.
b. Stop immediately if you experience chest, neck, back or shoulder pain or
light-headedness/dizziness or fainting, or nausea with increased activity
and seek emergency medical care or call 911.
c. Stay hydrated, drink plenty of water!
d. Avoid exercising in extreme conditions of heat or cold.
e. Having a support system, family member or friend to exercise with can
help keep you on track.
11. Increased Physical Activity
a. The National Guidelines and the American Heart Association recommend
increasing physical activity to at least 150 minutes per week with activity,
including “moderate-intensity aerobic activity”. (AHA, 2018; Kushner &
Ryan, 2014)
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b. OR “75 minutes per week of vigorous aerobic activity (or a combination of
both)” (AHA, 2018).
12. Increased Physical Activity
a. Add Intensity; “Moderate to vigorous aerobic exercise is best” (AHA,
2018).
b. Aerobic activity should increase your heart rate; “Your heart will beat
faster, and you’ll breathe harder than normal” (AHA, 2018).
c. Some aerobic activities may include fast walking, running, use of exercise
machines, swimming, bicycling, or taking a jazzercise, dancing or zumba
class
13. Increased Physical Activity
a. Move More, Sit Less!
b. “Get up and move throughout the day. Any activity is better than none.
Even light-intensity activity can offset the serious health risks of being
sedentary” (AHA, 2018).
14. Choosing and making behavioral and lifestyle changes
a. Meal planning and shopping (www.choosemyplate.gov)
b. Making meals ahead, use your freezer
c. Packing your lunch instead of dining out or getting take-out
d. Taking a lunch or dinner break instead of eating at your desk, on the go or
skipping meals
e. Don’t eat and drive, watch TV or multi-task
i. Mindfulness-be in the moment
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ii. Enjoy your food (Perreault, 2019b; Rodriguez-Cristobal et al., 2017;
Samdal et al., 2017; Szczekala et al., 2018
f. Don’t use food as an emotional support
i. Food is fuel (Perreault, 2019b; Rodriguez-Cristobal et al., 2017;
Samdal et al., 2017; Szczekala et al., 2018; Thalbault et al., 2016;
Welbourn et al., 2018).
g. You can say ‘No Thank You’
i. when pressured to over-eat
ii. or to eat unhealthy foods
h. Look for healthy choices at social gatherings or bring your own
i.

Limit alcohol
i. Empty calories: Low calorie to nutrition ratio

j.

Plan ahead

15. Cooking TIPS
a. Bake, broil, grill, steam or boil.
b. Avoid deep frying!
c. Cooking in oil adds calories and fat to food.
d. Use a sprayer bottle with olive oil if necessary
e. Use a nonstick pan instead of adding oils.
f. Eat fruits and vegetables, washed and raw!
16. Track your food and exercise
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a. The best way to have weight loss success and maintain weight loss longterm is to keep a food and exercise diary of daily caloric intake and
activity.
i. Paper journal
ii. Technology based
iii. Phone applications (Cheatham et al., 2017; Tang et al., 2016).
17. Motivation and Goals
a. Ask yourself:
i. What are my personal reasons or motivation for losing weight?
ii. What are my weight loss goals? Set daily, weekly, short and longterm goals. Keep them realistic and attainable!
iii. Revisit and reassess them often. Why are these goals important to
me?
iv. How can I achieve weight loss? What realistic changes can I
make? (Kozica et al., 2015; Rodrguez-Cristobal et al., 2017;
Szczekala et al., 2018; Thabault et al., 2016; Wellbourn et al.,
2018),
b. Make your own choices and take ownership of choices made. Be
accountable!
c. Use positive self-talk.
d. Keep a food and exercise diary/journal.
e. Stay motivated: Each food and exercise choice bring you one step closer
to your weight loss goal!
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18. Autonomy and making your own decisions
a. EBP information
b. Making informed choices
c. Taking ownership of choices made (Samdal et al., 2017)
19. Positive self-talk
a. Accept that over-weight and obesity are a chronic disease (Cheatham et
al., 2018; Eaton et al., 2016; Ma et al., 2019; Sambal et al., 2017; Tapsell
et al., 2017; Thabault Burke & Ades, 2016)
b. Autonomy allows us to make our own choices
c. Don’t get caught in the negative self-talk trap!
d. Human’s are fallible beings- we make mistakes
e. Owning our choices
f. Make better choices next time
g. Patterns developing
h. Be Realistic-Aim for a 90:10 ratio!
i. 90% stay vigilant
ii. 10% enjoy a treat/rest
i.

Moving forward in a positive way- You can do this!

20. Belief in yourself-self-efficacy
a. Weight loss can be overwhelming
b. There can be a lot of obstacles, influences or pressures
c. Weight loss may have been hard to achieve or maintain in the past
d. Maybe you haven’t been ready
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e. One of life’s biggest hurdles is belief that you can do something
f. You can lose weight.
21. Part Two
a. NEWER ME
b. THE DIET PLANS
22. Beginning a weight loss plan
a. Learning to read food labels
b. Tracking calories
c. Choosing the right plan for me
d. A healthy diet
e. Portion distortion
f. Shopping for health
g. Party time! Planning ahead
h. When I slip, I dust myself off and start a new
i.

Specific weight loss plans

j.

Resources

23. Reviewing a food nutrition label: making calories count
a. Is eating it worth it?
b. Servings per container
c. Serving size
d. Caloric intake per serving
e. Carbohydrates/sugar
f. Fats/cholesterol
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g. Protein
h. Sodium
i.

Vitamins

j.

Minerals

24. Track food and caloric intake
a. The best way to have weight loss success and maintain weight loss longterm is to keep a food diary of daily caloric intake.
b. Paper journal
c. Technology based
d. Phone applications
e. If it goes into your mouth…COUNT IT!
25. A healthy diet includes
a. Lean protein
b. Fresh or frozen vegetables and fruits
c. Whole grains
d. No-fat or low-fat dairy
e. Unsaturated fats
f. Water
26. Incorporate Portion Control
a. Check package labeling for serving size
b. Use a smaller salad plate instead of dinner plate
c. No second helpings
d. Order small size- don’t Super-Size!
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e. Share servings
27. Shopping for health!
a. ChooseMyPlate.gov
b. Shop the perimeter
i. Fresh foods
c. Limit or eliminate processed foods
d. Limit or eliminate empty calories/snack foods
28. Party time! Planning ahead
a. Plan for special events
b. Reserve some of your weekly caloric intake so that you can enjoy special
meals
c. Exercise extra throughout the week
d. Watch out for hidden calories
e. Bring your own treats
f. It’s OK to say no thank you
29. When I slip, I dust myself off and start a new
a. Weight loss is difficult for some people
b. A misstep is not the end of your weight loss journey
c. Take ownership of your eating and exercise
d. Forgive yourself, use positive self-talk
i. Avoid words like always, and never
e. Choose to get back on track
f. Have a positive support person
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30. The three Evidence- based diet plans that have been proven to work:
a. Total caloric reduction of between 500-750 calories per day, while also
limiting dining out and use of fast foods, as well as eliminating or reducing
high caloric ‘empty calorie’ foods such as pop and chips (Jensen et al.,
2014; Kushner & Ryan, 2014)
b. Eating a healthy diet of between 1200-1500 calories for women and 15001800 calories for men that includes lean protein, fresh vegetables and
fruits, whole grains and legumes, low fat dairy and unsaturated fats while
limiting sugars and ‘empty calories’ (Jensen et al., 2014; Kushner & Ryan,
2014)
c. Use of an evidence–based diets that restricts certain foods such as high
fat, high carbohydrate, low fiber foods to create caloric deficit (Jensen et
al., 2014; Kushner & Ryan, 2014)
i. Such as the USDA www.choosemyplate.gov or Weight Watchers ®
(Madigan, 2014; USDA)
31. Total caloric reduction of between 500-750 calories per day
a. Reduce portion sizes
i. Smaller plates
ii. No second helpings
iii. Order small not super-size
iv. Share
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b. Incorporating healthy food choices: lean protein, fresh or frozen
vegetables and fruits, whole grains, non-fat or low-fat dairy, and
unsaturated fats such as olive oil.
c. Limiting dining out and use of fast foods/drive throughs
i. Higher caloric content
ii. Added ingredients
iii. Mindfulness
d. Eliminating or reducing high caloric ‘empty calorie’ foods such as pop and
chips
e. Reducing or eliminating processed foods
f. Keep a food diary to track calories
g. Weigh in weekly
h. Increase activity
i.

The goal is to burn more calories in a day through bodily function and
aerobic activity, then are taken in through foods consumed.

32. Eating a healthy diet of between 1200-1500 calories for women and 1500-1800
calories for men
a. Stay within caloric daily limits
b. Includes lean protein, fresh vegetables and fruits, whole grains and
legumes, low fat dairy and unsaturated fats (Jensen et al., 2014; Kushner
& Ryan, 2014)
c. Limiting dining out and use of fast foods/drive throughs
i. Higher caloric content
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ii. Added ingredients
iii. Mindfulness (Perreault, 2019b; Rodriguez-Cristobal et al., 2017;
Samdal et al., 2017; Szczekala et al., 2018
d. Eliminating or reducing high caloric ‘empty calorie’ foods such as pop and
chips
e. Reducing or eliminating processed foods
i. Additives sugars, salts and fats
f. Keep a food diary to track calories
g. Weigh in weekly
h. Increase activity
33. Use an Evidence-Based commercial diet
a. Restrict certain foods such as: high fat, high carbohydrate, low fiber foods
to create caloric deficit (Jensen et al., 2014; Kushner & Ryan, 2014)
b. www.choosemyplate.gov or Weight Watchers ®
(Madigan, 2014; USDA, 20)
34. On-line Resources
a. American Heart Association
i. https://www.heart.org/en/healthy-living/healthy-eating/losingweight?uid=1966
b. American Diabetes Association
i. https://www.diabetes.org/fitness/weight-loss
ii. And https://www.diabetes.org/nutrition
c. National Institutes of Health: Aim for a Healthy Weight
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i. https://www.nhlbi.nih.gov/health/educational/lose_wt/index.htm
d. USDA: ChooseMyPlate
i. English and Spanish
ii. www.ChooseMyPlate.gov
e. Cornerstones4Care
i. Diabetes Mellitus II control resources
ii. English and Spanish
iii. Free resource booklets and tracking tools
iv. www.cornerstones4care.com
35. References
a. Provided in this DNP EBP Project report reference section

Appendix P
On-line Participant Resource Tools
Weight Loss Web Sites and Tools
Herramientas y sitios web para bajar de peso
English:
Cornerstone4Care:Nutrition and Diabetes: It’s all on the label (accessed: 2019).
•

https://www.cornerstones4care.com/healthy-eating/what-to-do/nutrition-anddiabetes.html

Novomedlink Resources: professional and patient (accessed: 2019)
•

https://www.novomedlink.com/content/dam/novonordisk/novomedlink/resources/
generaldocuments/CountingCarbandMeal_EG.pdf

ChooseMyPlate.gov: Nutrition resources (accessed: 2019)
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•

https://choosemyplateprod.azureedge.net/sites/default/files/tentips/MPMW_tipsheet_14_FINAL.pdf

•

https://www.choosemyplate.gov/myplate-tip-sheets

National Institutes of Health/NIH : Healthy Eating- Tips (accessed: 2019)
•

https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/tips.htm

•

https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/calories.htm

•

https://www.nhlbi.nih.gov/health/educational/lose_wt/eat/fd_exch.htm

American Diabetes Association: What to eat with diabetes or pre-diabetes
(accessed: 2019)
•

https://diatribe.org/what-eat-diabetes-or-prediabetes-adas-new-nutritionguidelines

•

https://www.diabetes.org/nutrition

•

https://www.diabetes.org/a1c

American Diabetes Association: fitness and weight loss (accessed: 2019)
•

https://www.diabetes.org/fitness

•

https://www.diabetes.org/fitness/weight-loss

American Heart Association: Healthy living, eating and weight loss resources
(accessed 2019)
•

https://www.heart.org/en/healthy-living/healthy-eating/losing-weight

•

https://www.heart.org/en/healthy-living/healthy-eating/losing-weight/5-steps-tolose-weight-and-keep-it-off
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•

https://www.heart.org/en/health-topics/cholesterol/cholesterol-tools-andresources

•

https://www.heart.org/en/healthy-living/healthy-eating/losing-weight

Cleveland Clinic: exercise and calories burned chart (accessed:2019)
•

https://health.clevelandclinic.org/burn-off-calories-boost-heart-health-infographic/

Spanish/Espanol resources:
Novomedlink: Cornerstone4Care: weight loss, diabetic and prediabetic free
printed and online resources for clinicians and patients in Espanol (accessed
2019)
• https://www.novomedlink.com/content/dam/novonordisk/novomedlink/resources/
generaldocuments/CountingCarbandMeal_SP.pdf
American Heart Association: Healthy living, eating and weight loss resources
(accessed 2019)
• https://www.heart.org/en/health-topics/consumer-healthcare/order-americanheart-association-educational-brochures/losing-weight-the-healthy-way-spanishbrochure
•

https://www.heart.org/en/health-topics/cholesterol/cholesterol-tools-andresources

•

https://www.heart.org/-/media/files/health-topics/cholesterol/question-for-yourdoctor_spanish_2-1219_form.pdf?la=en&hash=CCCDB417A7D7BDD2ED415A49DF0C6FB1C62E26
1E

ChooseMyPlate.gov: Nutrition Spanish/ Espanol language resources (accessed:
2019)
• https://choosemyplateprod.azureedge.net/sites/default/files/printablematerials/MiniPoster_Spanish_508.pdf
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Appendix Q
Matthew 25 Health and Dental Clinic Obesity Project Program Protocol
Project Protocol
A Multicomponent Tailored Intervention Program Protocol for Weight Loss in an
Underserved Adult Patient Population with Obesity
Week One:
Complete the following screenings and measures as time allows:
• Weight and height in stocking feet.
o Encourage patient to wear same type of clothing each weigh in.
o Calculate BMI:
▪ 18-24.9= normal
▪ 25-29.9= overweight
▪ 30.0-39.9= obese
▪ > 40 = morbidly obese
▪ If the EMR does not automatically calculate this or paper
charts are used, the NIH @ nhlbi.nih.gov has an online
calculator for BMI
• Need height in feet and inches and weight in lbs.
• Blood pressure
o Complete accurately with location 1” above antecubital space,
correct cuff size, sitting with feet flat, after resting for 5 minutes,
with measuring arm held at heart height
o Monitor and refer for follow up assessment if BP above ACC/AHA
2018 guidelines on 2 or more visits.
▪ A BP of 120-129/>80 is class I elevated according to new
guidelines
• 130-139/80-89 is Stage I HTN
• > 140/90 is Stage II HTN
• Laboratory testing when possible: HbA1c and lipid panel; other
warranted assessments may include EKG, TSH, AST, ALT
•

•

(Jensen et al., 2014; Kushner & Ryan, 2014; Perreault, 2020)
PHQ-9 and GAD-7
o Assess for depression and anxiety as these often accompany
overweight/obesity in a reciprocal nature
o Refer for further evaluation if PHQ-9 score is > 10 or if GAD-7
score is > 5, or if patient requests intervention.
AAQ-W: Acceptance and action questionnaire
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•

•

o The AAQ-W is used to assess weight loss readiness; it measures
pragmatic avoidance and psychological rigidity that play a part in
health problems including weight control (Lillis & Hayes, 2008).
o The AAQ-W tool correlates with the common levels of avoidance
and rigidity, obesity-related quality of life, psychological distress
and BMI. Also there is a correlation with self-reported binge
eating and exercise sessions per week as well as making healthy
food choices while dining out (Palmeria, Cunha, Gouveia,
Carvalho & Lillis, 2016). This considered an effective and
validated tool to measure weight loss readiness.
o Scoring may range from 22 to 154 with lower scores indicating
“less experimental avoidance and more psychological flexibility”
(Lillis & Hayes, 2008, p. 34).
WEL-SF: Weight Efficacy Lifestyle Questionnaire Short-Form Tool
o The WEL-SF measures eating self-efficacy or one’s belief in their
ability to perform in a given situation. Low self-efficacy is
correlated to lower weight loss success and high self-efficacy is
correlated to greater weight loss success. Self-efficacy for eating
is a predictor of acquired weight loss behaviors. This tool asks
the participant to reflect on how confident they feel in relation to
situations in which overeating may become a problem.
o Likert format with scores that range between 0 to 10 with higher
scores representing higher confidence levels for each question.
(Ames, Heckman, Grothe & Clark, 2012; Flolo, Andersen,
Neilsen, & Natvig, 2014).
o Used to measure weight-loss readiness.
The 5 A’s: ask, assess, advise, agree, and assist (Thabault et al., 2016;
Vallis et al., 2013) counseling and intervention technique:
▪ Ask would it be alright if we talk about your weight or how
do you feel about your weight? (Do not judge-unbiased)
▪ Assess health status, weight, BMI, BP etc.
▪ Advise: collaborate- say now that we know your current
health and risks, can we work together to help improve
things/ or what can I help you with to improve your health
and lose weight?
• This is a great time for weight loss education.
▪ Agree- the patient needs to understand the treatment and
agree that it’s a good choice creating ‘buy in’ to set goals.
▪ Assist-identify barriers and facilitators to success with the
patient, talk about ways to overcome or promote these.
o Use motivational interviewing or counseling techniques
(Rodriguez-Cristobal et al., 2017; Samdal et al., 2017, Thabault
et al., 2016; Welbourn et al., 2018)
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•

•

View program instruction via: A Personalized Weight Loss Program for
an Over-weight or Obese Population -Power Point presentation
o 2-part series in 1 presentation
o voiced over
o lasts about 30 minutes
Review weight loss plan
o There are 3 plans: the first works by decreasing calories by 500750 calories per day and works if they are already below @25003000 calories per day otherwise it won’t work. The third plan- use
of Weight Watchers ® type that costs $$ but will work.
o Generally, allow them to choose but explain as written above. Try
to put patients on the second plan either the 1200-1500 calories
for women or the 1500-1800 calories for men because it provides
structured limits and guidelines. Also, this one works well for
diabetes (Jensen et al., 2014; Kushner & Ryan, 2014)
▪ Within the 1200-1500 /1500-1800 calories they need to
get:
• Carbohydrates/ Grains: 45-65% of daily total
calories (< 125-150 grams) carbohydrate from all
sources, including grains, fruit, dairy, sugars.
• Fruit /veg: 5 servings (limit to 2 servings fruit if DM)
o Corn, peas, carrots, plantains, potato, yam,
squash limit 1/2c per serving; all other veg
generally unlimited and doesn’t need to be
counted in calories due to nutrition, fiber and
low calories.
o Fresh or frozen are best due to sodium,
sugar and additives in canned.
• Protein: try to get 3 servings or between 55-75
grams of lean protein per day
o Lean beef, poultry, fish, legumes/beans,
nuts, eggs, dairy
o (limit processed meats; no pork, ground
meats or sausages)
• Fat: < 45 grams per day: Unsaturated fats such as
olive oil, avocado, banana, cooking spray
o Avoid solid fats such as white shortening
(Crisco type)
o Use banana, avocado, apple sauce for
baking, or low saturated oil.
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•

•

•

•
•

o Dairy: 2 servings per day, or supplement
calcium with green leafy veg/ mineral
supplement
• Water: 6-8, 8-ounce glasses of no calorie water per
day unless restricted.
• No food are off limits but, tell patients if it goes in
their mouth they must count it and stop eating when
they have reached their daily calorie limits.
o Bake, broil, boil, grill foods with minimal sprayed oil or fats.
o DO NOT DEEP or fat fry.
o AVOID Processed foods and empty calories in general.
o Shop the perimeter of the grocery where healthy choices are.
o Read food labels for servings/size and content
o Weight and measure foods
o Keep a food and exercise journal after EVERY Meal
Discuss healthy BMI and were patient is currently: Set 3% total body
weight loss as initial 12-week goal; then 5% from baseline at 6-month
mark and 10% from baseline by month 12. Do not overwhelm them. Let
them know this is a long-term process with no quick fix, but each day
they will weigh less.
Weigh in weekly to promote accountability
o Remind them the scale does not lie; calories in versus calories
burned makes the scale go up, down or stay the same. It is their
choice.
o Unless there is a cardiac issue/edema-then refer.
Exercise at least 150 minutes per week on most days (about 20-30
minutes per day)- moderate intensity aerobic activity of their choice:
walking, bicycling, swimming or use of exercise machines
Review S/S of CVA MI-STOP Call 911
Provide handouts:
o Food and exercise journal
o Personal daily Journal Diary: Goal setting and motivation
o What’s on your plate? (www.choosemyplate.gov) (English and
Spanish)
o Planning Healthy Meals (www.Cornerstone4Care.com)
o 5 Steps to Lose Weight and Keep It Off (www.heart.org)
o Changing Habits for Better Health (www.niddk.nih.go)v
o Make a Difference with Positive Self-Talk (www.diabetes.org)
o Conquer Cravings with These Healthy Substitutions
(www.heart.org)
o Why Do I Eat When I’m Not Hungry?
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•

o Websites for Healthy Recipes (www.cookinglight.com;
www.bbcgoodfood.com)
o Recipe card Healthy Stuffed Chicken Breast
(www.bbcgoodfood.com)
o Weight loss websites and tools list (ADA; AHA; www.heart.org;
www.choosemyplate.gov; www.cornerstone4care.com;
www.nhlbi.nih.gov; www.diabetes.org; https://diatribe.org)
o Provide Cornerstone4Care diabetes education booklets in
English or Spanish (www.cornerstones4care.com)
o Provide community resource booklet and food pantry list- contact
Social Services
This is a lot of information for patients, but because of the high ‘no show’
rate for follow up appointments at this clinical site, it provides the
necessary resource tools for them should they choose to lose weight on
their own.
o Have them bring any questions to their second visit, and monitor
progress.
o Evaluate food and exercise journal- verbal discussion.
o Evaluate and reinforce weight loss education and need for
journaling and goal setting as necessary.

Follow up. Follow up weekly for at least 4- 8 weeks; then every 2-4 weeks until at
goal; then monthly for 6 months; then every 6 months for 2 years; then if weight loss
goal is maintained meet yearly.
• Schedule next visit while the patient in clinic and provide appointment
card. Call to remind patient of appointment 24-72 hours in advance.
Each visit. Reassess Weight, BMI and BP at each visit. Reinforce education, goal
setting, behavioral interventions, food and exercise tracking, accountability and
autonomy. Do not allow bias to influence treatment. Provide EBP counsel and
support.
Re-assess for depression and anxiety. Reassess for depression and anxiety as
these often accompany overweight/obesity in a reciprocal nature
o Complete PHQ-9 and GAD-7 at baseline, week 12, 6 months,
then at each visit.
o Refer for further evaluation if PHQ-9 score is > 10 or if GAD-7
score is > 5, or if patient requests intervention.
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Appendix R
Daily Food and Exercise Journal
Daily Food and Exercise Journal/ Diario de Alimentos y Ejercicios
Meal/
Comida

Foods eaten/
Alimentos consumidos

Protein/ proteina
grams

Carbohydrates
/carbo-hidrato
grams

Fats/
grasas
grams

Total Calories /
Total de calorias

Minutes
of
exercise/
Ejercicios

=

Breakfast
Desayuno

Lunch/

+

+

+

+/=

+

+

+

+/=

+

+

+

+/=

+

+

+

+/=

=

=

=

=

Almuerzo

Dinner/
Cena

Snack/
Bocadillo

Snack/
Bocadillo

Add up the total caloric
intake for today from the
above totals / Sumar la
ingesta calorica total para
hoy de los totals
anteriores. Review your
limits /revise sus limites.

233

=

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL
Appendix S
SPSS Code Book

Demographics

1

Measure

Value

Code

Sex

Male

1

Female

2

Other

3

2

Age

True age

Number

3

Race

American Indian or
Alaska Native

1

Asian
Black or African
American

3

Native Hawaiian or
Other Pacific
Islander

4

White

Ethnicity
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2

5

More than one race

6

Unknown or not
reported

7

Hispanic or Latino

1
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4

English speaking

Not Hispanic or
Latino

2

Unknown or not
reported

3

Yes

1

No

2

50 - 75

Number

100 - 500

Number

50 - 400

Number

Measures
5

(Height in Inches)
HtInW1

6

(Weight in pounds)
WtLbs1
WtLbs2
WtLbs3
WtLbs4
WtLbs8
WtLbs12

7

(Weight In Kg)
WtKg1
WtKg2
WtKg3
WtKg4
WtKg8
WtKg12

235

A MULTICOMPONENT TAILORED WEIGHT LOSS PROTOCOL

8

(BMI)

20 - 50

Number

75-150CM

Number

75-150CM

Number

0.5-1.9

Number

75-200

Number

50-125

Number

BMIW1
BMIW2
BMIW3
BMIW4
BMIW5
BMIW6
9

WaistCircCMW1
WaistCircCMW12

10

HipCircCMW1
HipCircCMW12

11

WHRW1
WHRW12

12

(Systolic BP)
SBPW1
SBPW2
SBPW3
SBPW4
SBPW8
SBPW12

13

(Diastolic BP)
DBPW1
DBPW2
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DBPW3
DBPW8
DBPW12
14

HbA1cW1

5.5-13.9

Number

100-300

Number

0-300

Number

0-100

Number

40-500

Number

0 – 3 for each item

Number

0 – 3 for each item

Number

HbA1c:W12
15

(Chol & Lipids)
TCW1
TCW12

16

LDLW1
LDLW12

17

HDLW1
HDLW12

18

TrigW1
TrigW12

19

GAD-7:
GAD7Q1W1, GAD7Q2W1, GAD7Q3W1, . . .
GAD7Q7W1
GAD7Q1W12, GAD7Q2W12, GAD7Q3W12, . . .
GAD7Q7W12

20

PHQ-9:
PHQ9Q1W1, PHQ9Q2W1, PHQ9Q3W1 … PHQ9Q9W1
PHQ9Q1W12, PHQ9Q2W12 … PHQ9Q9W12
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21

AAQW:

0-6 for each item

Number

AAQWQ1, AAQWQ2, AAQWQ3, …, AAQWQ22

22

WELSF:

1-10 for each item

Number

WELSFQ1, WELSFQ2, WELSFQ3, …, QELSFQ8

23

WksComp

1, 2, 3, 4, 8, or 12

number

24

WtLoss

Yes

1

No

2

Yes

1

No

2

25

26

WtLossMaint

WtChange

Number
-100 – 100

Enter as
plus or
minus

27

MetWtLossGoal
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Yes

1

No

2
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Appendix T
Permission to use AAQW tool as published in 2008
Via email reply Sun., July 21, 2019, 8:07PM
Yes of course, you have my permission (though it is not needed). Best of luck with your
research!
Jason
______________
Jason Lillis, Ph.D.
Associate Editor, Journal of Contextual Behavioral Science
Assistant Professor (Research)
Brown Medical School/ The Miriam Hospital
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